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“Pain is temporary. Quitting lasts forever.” 
Lance Armstrong 
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III. Summary 
My doctoral thesis contributes to the understanding of gait, mobility, and falls in older people. All 
presented projects investigated the most prominent and sensitive markers for fall-related gait changes, 
that is gait velocity and gait variability. Based on the measurement of these spatio-temporal gait 
parameters, particularly when using a change-sensitive dual task paradigm, it is possible to make 
conclusions regarding walking, balance, activities of daily living, and falls in older people. The 
research summarized in my doctoral thesis will help in the detection of early fall risk and modulation of 
therapeutic interventions to improve gait and consequently reduce fall risk in older people. 
To identify modifiable fall risk factors, such as gait disorders, the GAITRite electronic walkway system 
was used for objective spatio-temporal gait analysis. The simplicity and feasibility of the administration 
of single and dual task gait analysis make it a desirable clinical and research measurement tool. Gait 
analysis with walking as a single task condition alone is often insufficient to reveal underlying gait 
disorders present during everyday activities. However, measuring gait with a dual task paradigm can 
detect subtle gait deficits. Dual-tasking, walking while simultaneously performing an additional task, 
was used to assess the effects of divided attention on motor performance and gait control.  
The presented publications in this doctoral thesis investigated the association between gait 
parameters and several hypothesized fall-related modalities: (a) Our first review article highlighted the 
association between gait disorders and falls, and how related motor and cognitive impairments can be 
detected by measuring gait while dual-tasking. (b) A second review looked at how the dual task 
paradigm can be used for gait assessment in older people and how spatio-temporal gait parameters 
are associated with increased fall risk. (c) Our systematic literature review provided evidence about 
effective fall prevention interventions (exercise, home modifications, footwear, and walking aids) to 
reduce the risk of falls in vulnerable older people. (d) To evaluate which exercise modalities are 
effective in modifying risk factors for falls, we conducted an eight-week salsa intervention trial and 
measured the effect of dancing on static and dynamic balance, and leg muscle power in older people. 
(e) Besides exercise, inadequate nutritional intake is another modifiable risk factor for falls in older 
people, and therefore our most recent cross-sectional study examined how serum 25-hydroxvitamin D 
levels are associated with functional mobility in older people assessed in a memory clinic. (c) Walking 
aids are commonly prescribed for older people with a high risk of falls which is why we examined the 
influence of walking aids on spatio-temporal gait parameters in older people who used a cane, a 
crutch or a walker. (g) Finally, besides predominantly investigating fall risk factors for motor abilities, 
our prolonged and ongoing randomized, double-blind, and placebo-controlled intervention trial 
explores the potential influence of ginkgo biloba on the cognitive domain relevant for dual-tasking in 
older people with mild cognitive impairment. 
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IV. Introduction 
1.1 The aging population 
Aging is not a clearly defined single entity, but the result of a combination of anatomical, biochemical, 
and physiological changes that occur over time.1 These changes can either be functional or 
pathological, modifying the individual’s health status.2 Successful aging does not only reaching a very 
old age, but also being able to live independently.3 Older people, mostly defined as people aged 65 
years and older,1 have the goal to “age gracefully”3 which includes living in their own homes, 
remaining independent and active, and contributing to social life of relatives and the community.4
In the past, life expectancy increased steadily by about two years per decade showing little sign of 
change.4-6 Higher life expectancy and declining birth rates are a worldwide phenomenon, including 
industrial3,7,8 and developing countries.9 Worldwide, the number of people over 60 years is growing 
faster than any other age group and expected to grow from 688 million in 2006 to almost 2 billion by 
2050.10 In Switzerland, the proportion of people over the age of 65 years increased from 13.9% in 
1980 to 16.6% in 2008, representing about one-sixth (1,276,400 persons) of the general population 
(57.6% female).9 This increase will continue, at least partially, due to the generation of baby boomers 
from 1955 to 1964 who will reach retirement age between 2015 and 2035.9,11 Within the population of 
older people, the sector of people aged 85 years and older is rapidly increasing (15.4% in 1970 to 
28.4% in 2008).6,9
Although population aging is one of humanity’s greatest triumphs, it presents today’s societies with 
major challenges for the health and aged care systems.7,10 The future increase of the proportion of 
older people is important for public health,12 because aging is generally associated with progressive 
decline in physiological health.13,14 Aging is further associated with an increased risk of disability and 
dependency,13 as well as an increase in the number of comorbidities.15 The research presented in this 
doctoral thesis helps to understand several of these detrimental outcomes of age-related changes in 
health and functionality (e.g. gait),4 and investigates new intervention strategies. 
1.2 Gait in older people 
Gait is defined as any method of bipedal locomotion in humans.16 The most frequently used gait in 
humans is walking.17,18 Walking requires synchronization of more than 1,000 muscles over 200 bones 
and 100 moveable joints (Clark JE in Prince et al.,1997),19 and is used to move the body forward while 
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maintaining postural stability. In this doctoral thesis the terms gait and walking are used 
interchangeably. 
1.2.1 Walking is a complex motor skill 
Walking is the primary human movement for means of transportation20,21 and physical activity22-24
across ground level, uphill, or downhill.19 The average person takes between 5,000 and 15,000 steps 
per day.18 Walking often happens effortlessly and subconsciously, and therefore it is difficult to 
appreciate the immense complexities involved.18 An important aspect of walking is the constant 
adaptation to the changing environment. The ability to walk results from coordinated processes 
involving sensory, respiratory, circulatory, cognitive, neuromuscular, musculoskeletal, and 
biomechanical systems25-28 sending nerve signals via the spinal cord and peripheral nerves to the 
muscles which in turn move joints and limbs.16,29 Thereby, walking constantly integrates numerous 
sensory, conscious, and competing inputs from all modalities of perception30,31 to control the center of 
mass in relationship to the constantly changing base of support and achieve gait stability.32
1.2.2 Safe gait in older people 
A safe and efficient gait is not only integral to functional mobility and independence,33 but also as a 
protective factor for falls.10 Older people’s gait is mainly influenced by age and the effect of 
pathological conditions.16 Typical age-related gait changes start taking place between 60 and 70 years 
of age,16 and are believed to increase gait stability while walking.16,34 To date, there are no clearly 
accepted definitions for “normal” gait in older people.35 Many older people adopt a stiffer, less 
coordinated, more conservative and precautious gait,25,36 characterized by a slower walking speed, 
widened base of support, decreased stride length, increased double support time, increased stride 
time, and increased gait variability.16,26,35,37-39 However, it is still unknown if these changes represent 
either a loss of stability or a compensatory strategy to stabilize gait39 and avoid falls.38,40
1.3 Skeletal muscles and physical function in older people 
Skeletal muscles, also known as striated or as voluntary muscles, are responsible for the movement of 
the limbs.16 A certain minimal amount of muscle strength is needed for human movement throughout 
life.41,42 However, strength eventually declines to the point where activities of daily living (ADL), such 
as walking, become challenging.42,43  
1.3.1 Aging and inactivity cause loss of skeletal muscle mass 
General causes of age-related skeletal muscle mass loss are manifold (i.e. cellular, neural, metabolic, 
hormonal contributors),14,44,45 including sedentary lifestyle, inadequate exercise, decreased functional 
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capacity, decreased basal metabolic rate, inadequate nutrition, reduced levels of trophic hormones 
(e.g. growth hormones), decreased protein metabolism (i.e. reduced rate of muscle protein synthesis, 
protein degradation exceeds synthesis),14,42,46 neurodegenerative processes (e.g. decrease in motor 
units),44 and muscle fiber atrophy.46-48 Humans loose approximately 20% to 30% of their skeletal 
muscle mass between young adulthood and 80 years of age.47 The term used to describe this age-
associated loss of skeletal muscle is sarcopenia (“sarx” is Greek for flesh and “penia” for 
deficiency)49,42,45 but to date there is no consensus on the definition of sarcopenia.50,51 Operationally, 
sarcopenia is defined as a height-adjusted appendicular skeletal muscle mass of more than two 
standard deviations (SD) below the young normal mean.46,49 The prevalence of sarcopenia increases 
from about 20% in people under the age of 70 years to over 50% in people over 80 years.49,52
Sarcopenia is a multifactorial15 condition that is associated with functional decline,53 impaired physical 
function,54 and frailty,55,56 eventually leading to disability, dependence, and death in older people.49,51
1.3.2 Loss of muscle strength and muscle power decrease postural stability 
The aforementioned loss of skeletal muscle mass leads to an age-related muscle strength (ability of 
the neuromuscular system to generate tension)57 loss.42,45 Despite the direct correlation between the 
two measurements, muscle strength decline is faster than the concomitant loss of muscle mass,58 and 
therefore may be more crucial for muscular function in older people. Beginning at age 30 to 40 years 
muscle strength declines at a rate of 3% to 5% per decade.59 By the sixth or seventh life decade the 
decline in muscle strength increases up to 20%.42,59,60 Age-related strength loss mainly depends on 
type II (fast twitch) muscle fibers15 which are used for brief bursts of powerful contractions generating 
high forces (e.g. lift grocery bags).16,18 The precise cause of the loss of type II muscle fibers is unclear, 
but it has been suggested that the number of type II muscle fiber motor neurons decreases during 
aging, eliminating innervation of these muscle fibers.42 This predominant loss of type II muscle fibers 
supports recent research which shows that muscle power is more rapidly decreasing than overall 
muscle strength.61 Muscle power reflects the maximal rate of rapid force production (generation of 
muscular work per unit of time)62,63 which is important in walking, because sometimes quick postural 
reactions are needed in response to perturbations62 to maintain balance and avoid falls.64 Older 
people often try to maintain balance by increasing the size of the base of support using the step 
strategy (fall avoidance via a rapid step) rather than the hip strategy (fall avoidance through weight 
shifts at the hip) when the center of mass is moved toward the stability limits.25,26 A decrease in 
muscle power would delay such postural reactions to external perturbations (e.g. correction step),65,66
probably leading to loss of balance67 and falls.25
1.3.3 Muscle power and mobility in older people 
Decreased muscle strength and power mostly stems from disease and inactivity rather than aging per 
se,25,36,52 and can therefore be counteracted. Traditional strength training usually consists of 
progressive resistance training (PRT) which is defined as work in form of muscle contractions against 
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an external force that is increased as muscle strength increases.68,69 PRT is required for acute and 
long-term adaptations in skeletal muscle mass and neuromuscular systems.45,46 A standard protocol of 
PRT (e.g. 80% of one repetition maximum, three times per week, for a duration of eight weeks) 
primarily results in morphological adaptations through an increase in contractile proteins which in turn 
leads to an increased skeletal muscle mass (e.g. from 11.4% to 33.5%) and muscle strength (e.g. 
from 107% to 227%).68 More recently, power training has shown to cause rather neuromuscular 
adaptations than skeletal muscle mass hypertrophy compared to PRT.61,62 For example, eight weeks 
of power training elicited significant gains in muscle strength (e.g. 82% for leg curls) and muscle power 
(e.g. 17.2 ± 18.3%, mean ± SD, for knee extension at 60°/s), leading to increased physical 
performance (e.g. 10.4% reduction in chair rise time).62 A recent study by Reid et al. (2008)61
compared a 12-week muscle power training with traditional PRT in older people. The results showed 
that both training modes significantly increased muscle strength (49% vs. 41%), but muscle power 
training lead to higher gains in leg power (55% vs. 44%).61 It can be concluded that power training 
may be superior in improving measures of physical performance and ADL in older people compared to 
traditional PRT.13,62,69-72 However, both muscle power and muscle strength training are currently 
recommended to improve physical performance and prolonged functional independence in older 
people.5,62,68,73-76
1.4 Falls in older people 
Falls are among the most common and serious public health problems77-83 facing the growing 
population of older people,84,85 and will increase to epidemic proportions in all parts of the world over 
the next few decades.10 The consequences of falls in older people can be devastating, contributing to 
a considerable increase in mortality and morbidity25,36,82,86-88 negatively impacting autonomy, health 
care systems and the community.12,89 In many societies, falls in older people are perceived as “an 
inevitable natural part of aging” or “unavoidable accidents”, but most often they are predictable and 
preventable.10,40
1.4.1 Epidemiology of falls 
Falls among older people often result in decreased physical activity, injury, and loss of autonomy 
which frequently require medical attention.10,12,90 A fall due to a sudden or unexpected event, such as 
tripping, slipping, stumbling, hitting obstacles, or by falling from stairs25,36,88,91-94 may also imply that an 
older person is not able to walk safely anymore.40 The majority of older people over the age of 65 
years falls during level-ground walking95,96 as a consequence of irregular gait,97 unstable balance, as 
well as reduced postural control, reflexes, muscle strength, and stepping height (Figure 1).25,36
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The prevalence of falls in community-dwelling older people increases with age.98 A fall is commonly 
defined as “an unexpected event in which the person comes to a rest on the ground, floor or lower 
level.”10,99-101 Between 33% and 40% of community-dwelling people aged over 65 years fall at least 
once a year, and of those 50% will have repeated falls.25,78 In people aged over 75 years the rate of 
falls and fall-related complications can increase up to 60%.25,36 Falls and fall-related injuries in older 
people generate costs of about CHF 1.4 billion per year (average in Switzerland from 2003 to 2007).102
Complications can be rather expensive, with a single fall-related hip fracture causing direct costs of 
about CHF 63,000.83,103 As a result, healthcare impacts of direct (i.e. health care) and indirect (i.e. 
societal productivity) costs of falls in older people are significantly high.10
Figure 1. Exercise, walking aids, vitamin D and ginkgo biloba possibly influence the locomotor system, gait and fall risk. Adapted from de Bruin 
ED (2012),104 Hausdorff et al. (2005),24 and Hausdorff et al. (2001).105  
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1.4.2 Fall-related injuries 
Although young children and athletes fall more often than older people, older fallers sustain more fall-
related injuries due to comorbid diseases and age-related physiological decline.25,36,85 Additionally, 
recovery from a fall injury is often delayed in older people, which in turn increases the risk of 
subsequent falls through deconditioning.25 Overall, 10% to 20% of all falls in older people result in 
injury, hospitalization, or death.25  
Although the relative proportion of falls resulting in a fracture is low, the absolute number of older 
people suffering fall-related fractures is considerably high.106 One in ten falls causes serious injuries107
of which 5% are a hip, pelvic, wrist, forearm, arm, or collar bone fracture.25,107,108 In terms of morbidity 
and mortality, one of the most devastating fall-related injuries for older people is the hip fracture.1,103,109
When older people lose their balance in the mediolateral plane,110,111 they tend to fall to the side which 
can lead to a femoral neck fracture.110 In Switzerland, accidental hip fractures have a rate of 7.7 per 
1000 persons (3.9/1000 men, 10.3/1000 women).112 Older people are prone to post-operative 
complications which often result in partial immobility, reduced ADL, and death.1,113 As a consequence, 
hip fractures often affect functional ability and the potential for independent living.103 Overall mortality 
of older people who sustained a hip fracture ranges from 11% to 23% at six months, 22% to 29% after 
one year, and up to 47% at five years after injury.109,114 In survivors, 40% of older people are able to 
ambulate independently one year after hip fracture compared to 79% before fracture.109 In this context, 
27% of older people require more walking aids one year after a hip fracture surgery.113 This hip 
fracture associated decline in functionality and mobility has a detrimental effect on living independently 
in the community and quality of life of older people.115 Despite participation in multidisciplinary 
rehabilitation programs after a hip fracture, many individuals do not regain the level of functional 
performance they had before the fracture, which often prevents them from returning to their homes.103
Hence, it is of uttermost importance to prevent a fall and possible consequent injuries in first place. 
1.4.3 Fall risk factors in older people 
Early, simple and effective detection of modifiable fall risk factors is important in geriatric medicine.110
The detection of fall risk factors is integral to implement effective fall prevention strategies, as well as 
to prevent falls and its serious consequences.92,116,117 This is a difficult endeavor, because falls in older 
people are often multifactorial,78,98 and attributed to complex interactions between several intrinsic and 
extrinsic risk factors, as well as exposure to fall risk (e.g. due to a high activity level).10,106,110,112 Fall 
risk assessment involves either the use of multifactorial assessments or functional mobility 
assessments. Multifactorial assessments identify possible fall risk factors and consequently implement
appropriate interventions adjusted for the identified fall risk factors.36,117,118 Functional mobility 
assessments identify possible fall risk factors in the physiological and functional domains of postural 
stability including strength, gait, and balance.96 Some risk factors are irreversible while others are 
potentially modifiable with appropriate interventions.1,85 The major focus of the projects in this doctoral 
thesis lies on three of the most common modifiable intrinsic fall risk factors: muscle strength (relative 
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risk ratio/odds ratio 4.4), gait (relative risk ratio/odds ratio 2.9), and balance (relative risk ratio/odds 
ratio 2.9) which are further discussed in chapters 1.3, 1.6 and 1.12 (Table 1).36,72,85 A description of 
modifiable fall risk factors within the home (home falls hazards) or outdoors (public falls hazards)118
was recently reviewed by Pighills et al. (2011)119 and Gschwind et al. (2011) (Table 2).120
1.4.4 Somatosensory decline and fall risk 
Over 400 risk factors for falls have been identified.98 Many of those risk factors also contribute to 
immobility and functional decline in older people.121 Risk factors for falls can be attributed to biological, 
medical, behavioral, environmental, and socioeconomic factors.10 Particularly, structural and functional 
declines in the somatosensory system seem to increase the risk of falling due to their association with 
postural instability.26,65,92 The affected sensorimotor functions are: vision and contrast sensitivity 
necessary to navigate safely through the environment,26 and avoid tripping over obstacles (i.e. steps, 
curbs, tree roots);26 hearing and vestibular function;26,122 tactile information from the soles of the feet 
important for walking and balance control;26 and sensory information from receptors in the muscles, 
tendons and joints providing feedback regarding joint position and body movement.26,106 Intake of 
prescription and over the counter drugs are important as fall risk factors,123 because their possible side 
effects or sedative effects may influence the somatosensory functions,36,81,117 and thus improve or 
impair physical functioning.22 It is important to critically review drug dosage and the possibility of drug 
reduction or drug withdrawal for fall risk reduction in older people.118,123,124 Furthermore, falls can also 
have psychological and social consequences. In this context, fear of falling is a well-recognized 
concept.85 Older people who fall can develop fear of falling even if the fall does not cause an injury.27
The prevalence of fear of falling (54%) and consequent avoidance of activities (38%) is considerably 
high in community-dwelling older people.10,125,126 As a result, ADL, mobility and social participation are 
decreased leading to weakness, isolation, and risk of future falls.10,27
1.4.5 Walking aids and fall risk 
For older people with gait and balance problems specific assistive devices may provide a safer gait.25
Walking aids, such as canes and crutches are used to support part of the body weight through the 
arms rather than the legs to increase stability and generate moment.16 The use of walking aids may 
stabilize gait in older people with an increased fall risk, but such aids also require considerable 
attention and energy for handling,91,127 which may paradoxically increase fall risk (see publication (f). 
Instead of improving walking ability, improper use or tripping over the walking aid may be responsible 
for developing a cautious gait pattern128 (slower walking speed, smaller steps, increased stance time, 
and decreased swing time)129 or falling. 
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1.4.6 Low vitamin D levels and fall risk 
In the past, vitamin D studies predominantly focused on bone health130 and calcium homeostasis131
(e.g. rickets in children, osteomalacia, and osteoporosis in older people).132 Vitamin D levels may 
decrease as a result of poor nutrition, missing supplementation,133 and lack of sunlight in combination 
with age-related skin structure modifications.132,134-136 Serum 25-hydroxyvitamin D [25(OH)D] 
represents the best clinical measure of systemic vitamin D status.137 In older people, 25(OH)D levels 
often lie between 50 nmol/L and 75 nmol/L (to convert to nanograms per liter divide by 2.496),138
which is markedly below healthy levels between 75 nmol/L and 190 nmol/L.137 Low 25(OH)D is defined 
as less than 50 nmol/L139 while the optimal upper level ranges over 100 nmol/L.131,138 In terms of 
improved physical, muscle, or lower limb function in older people, several lower 25(OH)D thresholds 
exist: 40 nmol/L,131 50 nmol/L,140 60 nmol/L,141 and 75 nmol/L130 Further, low 25(OH)D levels (<75 
nmol/L) are associated with lower muscle mass, greater visceral fat,142 decreased distance vision (<25 
nmol/L),143 cognitive impairment (<25 nmol/L),144 dementia (<25 nmol/L),145 and fall risk.146  
In community-dwelling older people low 25(OH)D (<50 nmol/L) is associated with poorer physical 
performance,140 lower muscle strength,133 decreased mobility, ADL disability,135 and frailty.139,147
Previous research showed that gait may be affected by low 25(OH)D concentrations adversely 
affecting different subsystems involved in gait control including muscular135,144 and neuronal 
components.148 In older people, vitamin D seems to improve muscle properties, postural and dynamic 
balance, and also executive functions which are all needed for walking.144,149 A recent study by 
Annweiler et al. (2010)144 highlighted the association between 25(OH)D and spatio-temporal gait 
parameters. Particularly, gait velocity has been linked to vitamin D by mechanisms involving skeletal 
muscles and the nervous system.144,150 In older women, slow walking speed is associated with low 
25(OH)D concentrations,144 suggesting a higher risk for disability, institutionalization, and mortality in 
older people (see publication (e).35  
Falls may be reduced by oral vitamin D supplements in older people who have low 25(OH)D levels 
(risk ratio 0.96, 95%CI 0.92 to 1.01),151 and in malnourished older people (hazard ratio 0.41, P = 
.02).87 A meta-analysis by Michael et al. (2010)89 showed that vitamin D supplementation (median, 
800 IU/d) with or without calcium is associated with a 17% (95%CI 0.77 to 0.89) reduced risk for falling 
during 6 to 36 months of follow-up. In another meta-analysis of eight randomized controlled trials 
(RCT) in older people, the pooled relative risk for any dose of vitamin D preventing a fall was 0.87 
(95%CI 0.77 to 0.99), whereas daily vitamin D doses in the range of 700 IU to 1,000 IU reduced fall 
risk by 19% (pooled relative risk 0.81, 95%CI 0.71 to 0.92).152 Additionally, a meta-analysis of 12 
RCTs in older people, vitamin D doses of more than 400 IU/d showed a pooled relative risk of 0.80 
(95%CI 0.72-0.89) for non-vertebral fractures and 0.82 (95%CI 0.69 to 0.97) for hip fractures.153 The 
importance of 25(OH)D for gait velocity and fall risk is further discussed in publication (e). 
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Table 1. Potential intrinsic fall risk factors in older people.
Domain Fall risk factor Domain Fall risk factor 
Mobility / 
Gait 
Physiological impairments27  
Low activity level78  
Activities of daily living78
Functional impairment85  
Poor mobility110,154  
Gait deficit / instability / impairment / 
disorder27,36,78,85,89,98,110,123,154-157
Reduced walking speed154  
Muscle 
strength 
Sarcopenia123  
Frailty89  
Muscle function26,98  
Muscle weakness36,85,98,156  
Decreased muscle strength72,123,155
Lower extremity impairments / weakness1,78,85,154
Reduced muscle power1  
Poor grip strength85  
Balance / 
Posture
Balance deficit / impairment36,78,82,85,89,110,123,155-157
Reduced static and dynamic balance154  
Reduced postural stability154  
Deficits in postural control72  
Cognition Disordered central nervous system25,36,98  
Cognitive deficit / impairment / disorder25,36,85,98,110,154,155  
Dementia110,123,154,157  
Executive function (i.e. attention)158  
  
Mental Mental status78,82  
Psychic disorders110  
Depression78,98,110,123  
Fear of falling98,110  
Dizziness78,107,123,155  
Vertigo155  
Delirium98  
Confusion155  
Vision Poor vision25,26,36,78,82,89,110,123,154
Visual deficit / impairment / disorder 78,85,87,98,155  
Decreased / loss of contrast sensitivity1,26,155  
Decreased depth perception1,154,155  
Visual field dependence1  
Reduced peripheral vision154  
Poorer visual construction ability158  
Cataracts155
Bone Unstable joints25,36  
Degenerative joint disease123
Osteoporosis25,36,82
Arthritis98  
Kyphosis98  
Foot problems25,36  
Foot deformity98  
Toe deformities (e.g. hallux valgus)159  
Cardiovascular Loss of consciousness  
Syncope98,107,110,155
Hypoglycemia110  
Orthostasis78,98,110,123,155  
Drop attack107,155  
Transischemic attack110  
Stroke89,157
Epilepsy98,110  
Cardiac arrhythmia110,155  
Cerebrovascular disease98  
Anemia25,36  
Cardiorespiratory insufficiency98  
Reduced endurance1  
Incontinence Urinary tract infections98  
Urinary incontinence36,78,110,123  
Nocturia123
Parkinson Parkinson’s disease89,98,107,123,154
Cerebellar syndromes98  
Cervical myelopathy107  
Sensation Impaired sensory input98  
Neuropathy1,26,98,107,154
Impaired proprioception26,155  
Hearing / 
Vestibular 
Hearing impairment78,110  
Vestibular impairment / dysfunction1,26,98,154  
Medical Chronic diseases82,154
Acute illness25,36,154  
Recent hospitalization89  
Hypothyroidism25,36
Insomnia123
Reduced reaction time1,26,154  
Normal pressure hydrocephalus107
Others Age27,82 (>75 years)123  
Sex82 (female gender)123   
Obesity160  
History of falls / fall history / previous falls89,110,123,155  
Malnutrition123
Low 25-hydroxyvitamin D146
Alcohol use25,36,82,98
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Table 2. Potential extrinsic fall risk factors in older people.
Domain Fall risk factor Domain Fall risk factor 
Drug Medication use27,81,82,89,98,110,155
Cardiovascular drugs78,98,110,123,155
Psychotropic drugs78,110  
Antiepileptic drugs117,155
Neuroleptics155  
Sedatives81  
Hypnotics81,98,155   
Antidepressants81,155  
Drug Benzodiazepines81,155
Analgesics78  
Diuretics110  
Adverse drug effects25,36,123  
Combination of drugs78,123   
Polypharmacy  
(use of 4 or more prescription drugs)85,87,98,154,155  
Environment Environmental hazards78,85,98
Streets82
Walkway cracks and ridges82,154
Ice and snow154
Home hazards89,155
Accidents155
Bedroom size in hospitals161
Stairs Stairs82
Steep stairs110
Missing stair railing / lack of handrails on stairs27,154
Missing handrails110
Bedrails36
Lack of grab bars around toilet154
Floor Unsafe floor conditions
82,98,123
Slippery floors110
Wet floors (caused by spills)36
Polished or waxed floors154
Cords and wires on the floor154
Tripping hazards27,98,123
Loose carpets / rugs27,82,85,110,154   
Furniture Low and instable furniture
98,154
Bed height36
Low toilet seat154
Shelving82
Lack of bathroom safety equipment85
Bathtubs82
Lack of grab bars around bathtub154
Walking aids Use of walking aid78,110,123,157  
Walker use154  
Footwear Inappropriate footwear
82,98,110,123
Lighting Inadequate lighting
27,36,82,85,98,110,123,154
Brightness154
Placement of switches and fixtures154  
Other Pets110  
Inappropriate clothing110
1.5 Gait analysis  
The assessment of physical functioning and mobility in older people is a crucial component in many 
clinical and research settings.162 Measures of physical performance allow the quantification of 
therapeutic treatment of older people with disability, functional decline, and gait disorders at an early 
stage.39,163,164
1.5.1 Gait analysis in older people 
Gait analysis is the systematic study of human walking16 used to improve our understanding of gait, 
and the quantification of benefit of a treatment in older people.16 As a vital sign, such as body weight 
or blood pressure, gait analysis may offer a powerful mechanism to understand and act on the health 
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of older people.165 Many gait changes are common with aging,26,33 but when gait becomes impaired 
(see chapter 1.7) this is associated with postural instability leading to falls.25,79 Gait problems 
adversely affect function in 20% to 40% of people over 65 years and 40% to 50% of people aged over 
85 years.25
Standardized performance-based measures are used to assess the contribution of gait and balance 
impairment to outcomes such as fall risk.166,167 For example, a health professional could screen older 
people using a gait assessment to identify underlying treatable medical and fall risk factors, and 
consequently attempt to intervene to prevent adverse outcomes.16,25,40,79,164 A gait assessment 
includes the synthesis of data from gait analysis, information about the older person obtained from the 
medical history and physical examination, combined with the experience of the observer.16 In general, 
a gait assessment forms a basis of clinical decision making, helps with the diagnosis of disordered 
gait, or documents a patient’s health condition.16 Quantitative gait markers may improve the 
aforementioned diagnoses and help set intervention targets in older people.29,35
1.5.2 Limitations of observing gait 
Measures of gait are not constant but rather fluctuate with time and change from one stride to the 
next, even when environmental and external conditions are fixed.24 Visual observation is the most 
common method of assessing gait disorders, but it lacks objectivity, validity and reliability. The eye has 
a limited ability to discern rapid motion,18 gives no permanent record, cannot measure forces, and 
depends entirely on the skill of the individual observer.16 Although some gait disorders can be 
identified by eye, others can only be detected with appropriate measurement systems.16
1.5.3 History of measuring gait 
The first movement recording systems were complex, expensive, required highly trained staff, took a 
long time to administer, and were not sensitive to detect clinically significant changes.154,168,169 Gait 
was measured by measuring tape, stopwatch, and adhesive felt pads with soluble dye or talcum 
powder attached to the foot.169 One of the major disadvantages of these approaches was the need to 
attach equipment to the subject’s foot or footwear, thereby inhibiting natural gait, and the time needed 
to obtain a single measurement.169 Currently a variety of clinical and laboratory measurement tools are 
commercially available for the assessment of complex neuromuscular functions of gait, balance, and 
postural control, change over time, baseline status, and the effect of interventions.82,154 Motion 
analysis systems started with cine photography, before marker systems including television screens16
were introduced.169 Passive marker systems with light reflecting material are still in use today:16 Vicon 
(Oxford Metrics Ltd., Oxford, UK), Elite (Bioengineering Tech & Systems, Milan, IT), Coda MPX 30 
(Charnwood Dynamics Ltd., Loughborough, UK)18, or Expertvision (Motion Analysis Corp., Santa 
Rosa, CA, US). Active marker systems, typically with light emitting diodes (LED)16 include: Selspot 
(Selspot AB, Molndal, SE) or Watsmart (Northern Digital Inc., Waterloo, CA, US).169 A major 
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disadvantage of these marker systems is the difficulty in appropriately placing the markers on the skin 
and digitizing the position of markers.18
In the past decades, technologies such as computer or direct video recording to a digital versatile disc 
(DVD) allowed extensive gait examination on computer or television (TV) monitor.16 A more modern 
gait analysis system is the Clinical Stride Analyzer (B&L Engineering, Tustin, CA, US) which consists 
of footswitches placed inside the shoes (e.g. instrumented insoles),17 and is attached to a portable 
data logger worn at the subject’s waist.170 Another wireless wearable system to collect quantitative gait 
data is called GaitShoe.138 The GaitShoe has the advantage that it can be worn in any shoe, is 
designed to collect data over long periods, and can be applied even outside the traditional gait 
laboratory.138 Recently, instrumented walkways are becoming increasingly popular for measuring the 
timing of foot contact, the position of the foot on the ground, or both:16 GaitMat II (E.Q. Inc., Cahlfont, 
PA, US) or GAITRite (CIR Sytems Inc., Havertown, PA, US).18 These user-friendly portable gait 
analysis systems allow a simpler measurement of spatio-temporal gait parameters, for both the 
examiner and the subject. These various gait analysis systems are often combined with 
measurements of further devices such as balance platforms (GKS 1000, IMM, Mittweide, DE),171 force 
platforms (Kistler Corp., Winterthur, SUI), accelerometers (DynaPort MiniMod, Mc Roberts Moving 
Technology, The Hague, NL), electrogoniometers (Gait Analysis System, MIE Medical Research Ltd., 
Leeds, UK), or angular velocity transducers (Swaystar, Balance International Innovations Ltd., SUI).39
Additionally, pedometers and gyro sensors can be put into small pods attached to the shoe and used 
via a wristwatch to measure steps and monitor activity: FitSense FS-1 (FitSense Technology Inc., 
Southborough, MA, US), or Nike sdm[triax 100] (Nike, Portland, OR, US).18
1.6 Quantifying gait with the GAITRite walkway system 
Electronic walkways have been developed to simplify gait analysis by eliminating the need to apply 
any instrumentation to the individual.17 A commonly used tool to collect gait data, in the form of 
footfalls representing the interface between body and floor,18 is the GAITRite instrumented walkway 
(Table 3).172 The GAITRite system is a simple, efficient173 and fast clinical tool for objective automated 
measurement of spatio-temporal gait parameters, both for the subjects and the test administrator.39,170
Quantitative gait analysis with the GAITRite system was shown to be feasible, reliable, having strong 
concurrent validity and test retest variability.170,174 GAITRite is sensitive to relevant gait changes in 
older people (e.g. detection of early signs of falls risk),174 even in vulnerable older people with mild 
cognitive impairment (MCI) or dementia.170,174,175 In addition, assessment of quantitative gait data 
using the GAITRite system is highly reliable under single and dual task conditions.174,176
22 
Table 3. Specifications of the GAITRite Platinum walkway model.
Length 972 cm 
Width 61 cm 
Number of pressure sensors 29,952 
Sample rate 60, 80, 100, 120,180, 240 Hz 
Spatial resolution ±1.27 cm 
Walkway top cover Flame retardant, anti-slip vinyl 
Walkway bottom cover Open cell neoprene rubber 
Internal materials Uncoated polyesters 
Electronic boxes (on the right-hand side of the walkway) 6 mm high 
Note: cm = centimeters; mm = millimeters; Hz = hertz.  
Adapted from Bridenbaugh and Kressig (2011).39
1.6.1 Standardization of the test environment for gait analyses 
Gait analyses require sophisticated methodology and equipment to reduce the potential for systematic 
error.18 They should be performed in a standardized, quiet, closed, and well-lit room with indirect 
lighting.177 Subjects should wear comfortable and non-restricting clothing, footwear, glasses and 
hearing aids if needed, as well as a safety-belt around the waist for easy support by the examiner in 
case of loss of balance.177 Furthermore, when using the GAITRite system, the test environment should 
be spacious while subjects can wear their own clothes, their own shoes and use their own walking 
aid.39 Although wearing shoes may reduce standardization of the measurements, they should be worn 
to closely match normal, everyday walking.18 The beginning and end of the walkway should be fixed to 
the floor to avoid tripping while an acceleration and deceleration phase of at least two meters ensures 
measurement of steady-state walking.177 It is generally recommended that walking is measured under 
steady-state conditions to exclude measurements from phases of acceleration and deceleration.18 The 
author Whittle MW (2008)16 states that a preferable length for a gait analysis walkway is 10 m to 12 m, 
while Kressig et al. (2005)177 recommend the measurement of six gait cycles, and Lord et al. (2011)172
suggest analyzing 12 steps from continuous walking. The instructions should be standardized and all 
walks conducted in the same direction.177 It is further not recommended to constrain walking by urging 
an older person to walk in time with a metronome or to step on particular places on the ground.16
1.6.2 Phases of the gait cycle 
Each time a leg goes forward, it makes a step.18 A step comprises the distance between sequential 
initial floor contacts by the ipsi- and contralateral leg. A stride, also referred to as one gait cycle,48
consists of two steps (Figure 2). Broadly described, the gait cycle starts with the initial contact (0%) of 
one foot, and ends with the next contact (100%) of the same foot.18 The gait cycle is further divided 
into stance phase (approx. 60%) which designates the entire period during which the foot is on the 
ground, and swing phase (approximately 40%) which refers to the time the foot is in the air.17,178 Both 
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the start and end of the stance phase involve bilateral foot contact (double support), while during 
middle proportion of stance only one foot has contact.17 The described phase of double support is the 
basic characteristic of walking17 comprising about 20% of the gait cycle.18 If double support were 
missing, a person would be running.18
Figure 2. Right and left footfalls indicating spatial gait parameters. Adapted from Bridenbaugh and Kressig (2011).39
The gait cycle consists of an initial contact (0% to 2%, right leg colored in black in Figure 3)17 which 
marks the beginning of the loading response equal to the first period of the stance phase.16 After the 
loading response (2% to 12%)17 the double support period between initial contact and opposite toe off 
follows.16 Toe off with the opposite foot is the end of the double support period known as loading 
response and the beginning of mid-stance (12% to 31%).16,17 Mid-stance is the period of the gait cycle 
between toe off and heel rise, reflecting the first period of single support.16 The time at which the heel 
begins to lift from the walking surface (heel rise) marks the transition from mid-stance to terminal 
stance (31% to 50%).16,17 Opposite initial contact occurs roughly at 50% of the gait cycle marking the 
end of single support and the beginning of pre-swing (50% to 62%),17 the second period of double 
support.16 The part of stance phase between the double support phases, when only one foot is on the 
ground, is also referred to as single support.18 Toe off (terminal contact) generally occurs at about 
60% of the gait cycle separating pre-swing from initial swing (62% to 75%),17 indicating the point when 
the stance phase (foot is on the ground) ends and the swing phase (foot is in the air) begins.16 The 
time when the swinging leg passes the stance phase leg and the two feet are side by side is called 
feed adjacent, separating initial swing from mid-swing (75% to 87%).16,17 When the tibia of the 
swinging leg becomes vertical at about 86% of the gait cycle, the terminal swing (87% to 100%)17
begins.16 The gait cycle ends at the next initial contact of the same foot (also known as terminal foot 
contact).16
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Figure 3. Temporal gait parameters of one gait cycle. Adapted from Bridenbaugh and Kressig (2011).39
1.6.3 Gait velocity is a vital sign for global health and functional status 
The terms gait velocity and walking speed are used interchangeably in this doctoral thesis.179 Gait 
velocity represents a simple, practical and informative “vital” clinical marker for global health (i.e. 
disability, chronic disease, physiological decline, cognitive impairment, falls, mortality)163,180,181 and 
functional status (ADL)180 in older people.18,182,183 Changes in gait velocity may occur up to six years 
before clinical manifestation.167,180 These changes in gait velocity are useful for understanding the risk 
and causes of falls,164,166,182 and when monitored over time they may also indicate a new health 
problem that requires evaluation.28
Gait velocity decreases with age in healthy older people.184 In community-dwelling older people gait 
velocity ranges from 40 cm/s to more than 140 cm/s,28,185 whereas at least 100 cm/s seem to be 
required for unimpaired walking, and greater than 120 cm/s suggests exceptional life expectancy.28,186
A walking speed of less than 100 cm/s is associated with an increased risk for limitations in gait and 
ADL.183 Higher risk for adverse outcomes (i.e. functional and/or cognitive decline) is associated with a 
walking speed of less than 80 cm/s.181 Severely impaired walking can be defined as walking slower 
than 60 cm/s186 and is a sign for increased risk of early mortality.28 In a group of older people with 
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various medical conditions, 4 cm/s to 6 cm/s was calculated as a small but meaningful improvement in 
physical performance, however, for moderate effects, 10 cm/s to 14 cm/s change were needed.165
Furthermore, meta-analytic statistics showed that the overall hazard ratio for survival for each 10 cm/s 
increase in walking speed was 0.88 (95%CI 0.87 to 0.90) in community-dwelling older people, 
especially after the age of 75 years.28 Improvement in gait velocity over time might indicate improved 
physiological health due to medical interventions or change in health behaviors such as exercise.182
Significant improvement in usual gait velocity one year after baseline is associated with a 17.7% 
reduction in absolute mortality risk through the subsequent eight years in people aged 65 and older.182
1.6.4 The association between quantitative gait parameters and gait stability 
Robust evidence supports the routine use of quantitative gait analysis182 to enhance the understanding 
of movement control in older people and to better target preventive interventions.187 The current 
literature reports several quantitative spatio-temporal gait parameters that offer important insight in 
normal and pathological walking patterns,169 to make diagnoses (e.g. identifying older people at risk 
for falling),29 determine appropriate therapy, and monitor patient progress.170 Gait analysis usually 
comprises measurements of temporal (time) and spatial (distance) parameters.169 In the literature, gait 
velocity, cadence, cycle time and stride length are common spatio-temporal gait parameters used for 
screening, performance measure, or monitoring a therapy (Table 4).18 Today the major limitation is not 
to collect gait data, but identifying changes in spatio-temporal parameters associated with significant 
clinical change.16 While established reference values for gait velocity exist, many spatio-temporal gait 
parameters, particularly those quantifying variability, are lacking.188 To date, there is no good 
consensus about normative ranges for spatio-temporal gait parameters, however, Table 5 and Table 6 
offer an overview of selected published data.18
1.6.5  Gait velocity and fall risk 
Gait velocity is a simple and quick option for measuring fall risk.35 There is a U-shaped relationship 
between gait velocity and falls with both extremes of walking speed showing higher rates of falls.189
Older people with faster (130 cm/s, incident rate ratio 2.12, 95%CI 1.48 to 3.04) and slower (<60 
cm/s, incident rate ratio 1.60, 95%CI 1.06 to 2.42) walking speed had more falls compared to those 
with normal walking speed (100 cm/s to <130 cm/s).189 Fallers often walk slower than non-fallers33 with 
walking speeds below 70 cm/s having a 1.5-fold increased risk for falls.35 Under a dual task condition 
the fall risk is already increased if gait velocity is below a threshold of a 100 cm/s.190 Any decrease in 
gait velocity of 10 cm/s is associated with a 7% increased risk for falls (risk ratio 1.07, 95%CI 1.00 to 
1.14),191 while a decline in gait velocity (relative risk 5.9, 95%CI 1.9 to 8.5), requirement of a caregiver 
(relative risk 9.5, 95%CI 1.3 to 2.5), and new falls (relative risk 5.4, 95%CI 2.0 to 4.3).180 However, 
other spatio-temporal gait parameters should be taken into account when looking at gait velocity, 
because walking is a complex functional activity and many variables influence gait velocity,179
especially cadence (steps taken per minute),16,18,178 stride length, or both.16,18 There is a relationship 
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between cadence and leg length: those with shorter legs usually have a higher cadence.18 Because 
cadence hardly changes with age (range of 100 steps/min to 130 steps/min),18,34 stride length is more 
likely to be the source of decreased walking speed.18 In addition, older people who fall may also walk 
with pronounced gait variability (see chapter 1.6.6 and 1.6.7).35,192
Table 4. Definitions of selected spatio-temporal gait parameters.
Gait parameter Definition 
Temporal parameters 
Cadence (steps/min) Number of steps per minute 
Step time (s) Time elapsed from first contact of one foot to first contact of the opposite foot 
Stride time (s) Time elapsed between the first contacts of two consecutive footfalls of the same foot 
Stance time (s) Starts with heel contact and ends with toe off of the same foot and is equal to the weight bearing portion of 
each gait cycle: time elapsed between the first contact and the last contact of two consecutive footfalls of the 
same foot 
Swing time (s) Starts with toe off and ends with heel strike: time elapsed between the last contact of the current footfall to 
the first contact of the next footfall of the same foot 
Swing time is equal to the single support time of the opposite foot 
Single support time (s) One foot is on the ground: time elapsed between the last contact of the current footfall to the first contact of 
the next footfall of the same foot 
Single support time is equal to the swing time of the opposite foot 
Double support time (s) Both feet are on the ground simultaneously: consists of two periods called initial double support and terminal 
double support; initial double support occurs from the first contact of one footfall to the last contact of the 
opposite footfall; terminal double support occurs from the first contact of the opposite footfall to the last 
contact of the support footfall; total double support is the sum of the initial double support added to the 
terminal double support 
Ambulation time (s) Time elapsed between first contact of the first and the last footfalls 
Velocity (cm/s) Distance walked divided by the ambulation time 
Stride velocity (cm/s) Stride length divided by stride time 
Spatial parameters 
Step length (cm) Measured from the heel center of the current footprint to the heel center of the previous footprint on the 
opposite foot 
Stride length (cm) Measured between the heel points of two consecutive footprints of the same foot (left to left, right to right) 
Two steps compromise one stride or one gait cycle 
Base of support (cm) Vertical distance from heel center of one footprint to the line of progression formed by two footprints of the 
opposite foot 
Step width (cm) Measured from the midline midpoint of the current footprint to the midline midpoint of the previous footprint 
on the opposite foot 
Stride width (cm) Vertical distance from midline midpoint of one footprint to the line formed by midline midpoints of two 
footprints of the opposite foot 
Gait variability 
Stride-to-stride fluctuations (%) The CV is calculated by dividing the SD across all strides by the mean times a 100 [CV = (SD / mean) x 100] 
Note: cm = centimeters; CV = coefficient of variation; min = minutes; s = seconds; SD = standard deviation.  
Modified from Hollman et al. (2011)188 and GAITRite Electronic Walkway Technical Reference (2012).193
27 
1.6.6 Gait variability and gait instability 
Research on the variability of walking began in 1960,16 but the fluctuations in gait were largely ignored, 
or erroneously viewed as instrumental and physiological noise.24,172 To date, gait variability (stride-to-
stride fluctuations) seems to be a more sensitive marker of gait performance than conventional spatio-
temporal measures such as gait velocity, step time, or cadence.172,192 Measures of gait variability 
provide a clinical index of gait instability,24,194 whereby increased variability represents a more unstable 
walking pattern174 characterized by reduce postural control and stability which probably makes older 
people more susceptible to falls.27,176,188,195 Gait variability may therefore serve as a sensitive and 
clinically relevant marker for impaired mobility,196 fall risk,24 and falls.197 Further, gait variability has 
been used as an outcome measure for frailty,198 cognitive decline, and the response to therapeutic 
interventions.24 In healthy people gait variability remains fairly stable throughout the lifespan184 which 
is why changes in gait variability seem to reflect underlying disease processes rather than age-related 
changes.199  
Stride-to-stride variability is measured by the coefficient of variation (CV) and is a marker for the 
control of leg movements when walking.200,201 The CV is calculated by dividing the SD across all 
strides176 by the mean times a 100 [CV = (SD / mean) x 100].202,203 The SD reflects the dispersion 
around the average value, and CV quantifies the magnitude of the deviations of the gait parameter 
with respect to each subject’s mean value.203 Using CV for expression of gait variability has the 
advantage of being a dimensionless unit, facilitating comparability with other studies,172 and being 
more accurate than solely reporting SD.178 The latter is often largely due to biological and instrumental 
variability making normative ranges based on SD rather wide, indicating that too many measurements 
would be considered normal (a false negative result).18
1.6.7 Stride time and stride length variability are associated with fall risk 
Stride time variability, the magnitude of the stride-to-stride fluctuations in the gait cycle duration,203 is 
considered the neural control for maintenance of a steady walking rhythm.204 The CV of stride time 
variability is a good marker of higher-level subcortical and cortical involvement in gait control.202,205,206
Significantly low and high stride time variability provide objective information for the diagnosis of gait 
unsteadiness and instability,194,205,206 and serve as a fall predictor in older people.197,201,203 Generally, 
lower stride time variability is associated with a safe gait,201,207 because older people with a history of 
falling have a higher, up to twice or more, stride time variability compared to older people who had no 
fall.192,199 The CV of stride time variability is usually below 3% among young healthy adults20 with 
higher values being associated with decreased muscle strength, balance, walking speed, functional 
status, health status, and physical performance.199 A stride time variability threshold of CV >4% for 
walking alone and CV >10% for walking during backward counting is proclaimed for older people at 
risk for falls and subsequent admission to an acute care geriatric department.173 Furthermore, high 
stride length variability is a fall predictor,197 whereas low stride length variability is associated with a 
safe gait.201,207 Stride length variability under dual task conditions is significantly greater in older 
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people compared to younger adults,208 whereas already a small increase of 1.7 cm in stride length 
variability doubles the likelihood of falling in the upcoming six months.197
Other spatio-temporal gait parameters are not covered by this doctoral thesis, because the literature 
may only provide limited evidence for their interpretation, or they are not relevant for the presented 
publications: swing time,24,178,196,209 stride width,16,18,33,126,197,210 stride width variability,196,210,211 and 
stride velocity variability.188,197,212
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1.7 Gait control and disorders  
A gait disorder is, at best, an inconvenience, and at worst, a major risk factor for falls and injury (see 
publication (a).40 Gait problems have many etiologies25 resulting from specific dysfunctions of the 
locomotor system including the nervous, muscular, skeletal, circulatory, and respiratory system.16,25,36
A gait disorder may indicate a systemic decompensation in an older person35 due to health problems 
such as stroke, different forms of arthritis, cerebral palsy, spinal cord injuries, multiple sclerosis, 
amputation, traumatic brain injuries, systemic diseases, foot deformities, and falls.18 Further 
contributing factors to gait disorders are metabolic disorders, urinary disorders, cognitive decline, 
subdural hematoma, depression, anxiety, psychotropic medication, vitamin B12 and folic acid 
deficiency.35,128 Often these problems stem from age-related changes and fall into five functional 
categories: deformity (e.g. contracture), decreased muscle strength (e.g. muscle atrophy), sensory 
loss (e.g. impaired proprioception), pain (e.g. excessive tissue tension), and impaired motor control 
(e.g. central neurological lesion in the brain or spinal cord).17,25,36
1.7.1 The generation of walking 
Human movement is controlled and monitored by the nervous system consisting of the central nervous 
system (CNS) (brain and spinal cord) and the peripheral nervous system (all branches of nerves 
outside the spinal cord).41 Three areas in the brain are particularly involved in the regulation of gait: the 
basal ganglia which learn and reproduce basic movement patterns,24 the motor cortex which calls into 
action the necessary muscles for movement, and the cerebellum which monitors activity and provides 
feedback about the performance.16,40,215 The central pattern generator which produces the nerve 
impulses initially causing walking is not located in a single place, but consists of networks of neurons 
in various parts of the brain and spinal cord.16 On the spinal level, the central pattern generator 
provides cadence and rhythm for walking.215  
Walking begins with incoming afferent sensory information from the periphery which is processed by 
the hippocampus and related regions to plan walking.30 The plan of walking is then transferred to the 
primary cortex with simultaneous processing in the basal ganglia (long-term storage of motor 
programs) and cerebellum (control of timing).30 On the efferent pathway from the brain to the 
periphery, spinal cord interneurons pass muscle firing patterns to motor neurons which activate 
skeletal muscles.30 Lastly, the skeletal muscles will be activated to perform the movement of walking.41
1.7.2 Three levels of gait control 
Gait disorders are often classified according to the location in the nervous system of the sensorimotor 
deficit.35 The low sensorimotor level classifies gait disorders into peripheral sensory impairment, 
commonly caused by vestibular disorders, peripheral neuropathy, proprioceptive deficits, or visual 
ataxia.35 Older people usually can compensate to such gait disorders and learn to overcome issues 
including Trendelenburg, antalgic and steppage gait characteristics.35 The middle sensorimotor level 
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classifies gait disorders in lower switching structures of the CNS (i.e. cerebellum, brain stem).40 Such 
middle-level deficits result from spasticity, hemiparesis, paraplegia, Parkinsonism, and cerebellar 
ataxia.35 In these middle-level disorders, posture and locomotion are also impaired, resulting in 
impaired stepping patterns such as shuffling steps, reduced arm swing, and increased trunk sway due 
to disrupted sensory and motor modulation of gait.35 High sensorimotor level gait disorders are due to 
disrupted or altered cortical control of gait.40 Such disorders can impair the generation of gait impulse40
which often results in walking patterns that are not suitable for safe ambulation.185 High level 
sensorimotor deficits are characterized by deficits in planning, intention, and executive functions,117
and are prominent in older people with frontal-related white matter lesions, normal pressure 
hydrocephalus, cognitive decline, cognitive dysfunction, slowed cognitive processing, or depression 
(see publication (a).35
1.7.3 Frontal brain areas are associated with motor control 
The prefrontal cortex which plays a prominent role in cognitive aging, cognitive flexibility, attention 
division, executive function, dual-tasking and multi-tasking,174,216-219 provides the stimulus to reach a 
destination and avoid obstacles while walking.215 In dementia, particularly with impaired executive 
function,203,204,220 dysfunction of the frontal lobe and its motor circuits may be related to balance 
disturbances, gait disorders, gait instability, and increased risk of falls.203,204,220,221 Hence, in line with 
the cognitive theory of falling, aging of the frontal cortex may alter executive function, attention 
domains, and motor responses, prior to the generalized changes seen in normal cognitive aging,92 and 
thus plays a key role in the regulation of routine walking.174
1.8 Walking while performing an attention-demanding task 
Daily life offers countless situations where locomotion requires coordination of multiple sensory stimuli 
for concurrent performance of motor and cognitive functions, such as carrying a cup of tea.219,222 Such 
multi-tasking, performing several activities simultaneously, or dual-tasking, doing two tasks 
concurrently (often a cognitive and a motor task),223 are omnipresent in daily life.31,219,223,224
1.8.1 Walking is not an automated motor activity 
Gait has been traditionally considered as an automated motor activity not involving cognition in form of 
executive control.27,225-227 However, as described in chapter 1.9, current evidence shows a close 
relationship between gait and cognition.228 Even in older people who have intact locomotor and 
cognitive function, routine walking requires executive function (e.g. attention)229 for motor 
control.31,37,203,230 This is particularly evident in frail older people who stop walking when they have to 
start a conversation with or answer a question to a walking companion.231 Older people who “stop 
walking when talking” have more future falls, impaired gait, and difficulties with ADL compared to 
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those who continue walking.231 Once they have fallen, older people may pay more active attention and 
consciously monitor their movements in an attempt to ensure safety.226 Ironically, conscious 
movement control may be another factor that contributes to disruption of automaticity of walking, 
increasing the likelihood of subsequent falls.226
1.8.2 Multi-tasking 
Young adults do not have much difficulty performing several activities at the same time,232 and 
therefore the performance of additional tasks during walking, dual-tasking per se,233 does not 
represent a threat to stability. When the postural system is quite stressed, and young adults are 
required to perform a fairly complex additional task,91 only minor changes in spatio-temporal gait 
parameters can be observed, implying that minimal attention is needed.207,209 In contrast, in older 
people many concurrently performed simple cognitive and motor tasks drastically interfere with each 
other due to divided attention (see chapter 1.8.4), and have deleterious effects on mobility and 
safety.31,39,166,224,232,234-239 This interference is often evident by a decrease in gait velocity233 and an 
increase in gait variability compared to normal walking.27,32,212 A resultant decrease in walking speed 
can be interpreted as an implicit strategy to avoid loss of balance and gait stability201 while an increase 
in gait variability is viewed as a reflection of the inconsistency in the central neuromuscular control 
system’s ability to regulate gait and maintain a steady walking pattern.24,32
1.8.3 The dual task paradigm 
In recent years, dual-tasking became the most popular method for testing the relationship between 
gait stability, executive functions and attention in older people.91,209,218,220,229 Dual task paradigms are 
used to examine impaired attention function, attention allocation between two simultaneously 
performed (cognitive challenging)27 tasks,220 and involvement of cortical control in older people.30,202,203
Instead of focusing on either motor or cognitive impairment, dual-tasking allows to assess the ability of 
an individual to pay with some attention resources for maintaining cognition, and vice versa.240 The 
use of the dual task paradigm in gait assessment consists of walking and simultaneously executing an 
attention-demanding task,232 and permits early detection of gait and cognitive impairments due to a 
central overload, which under a single task condition of walking may otherwise go unnoticed.39,240
Such deficits in dual task performance are often due to difficulties performing the attention-demanding 
task27 and predict clinically significant impairment in motor or cognitive function230 which increases the 
risk and occurrence of falls in older people.32,116,201,237
1.8.4 The attention-demanding task in dual-tasking 
Older people attempt to compensate for disrupted attention allocation between two simultaneously 
performed tasks207 by either slowing their gait to improve the cognitive output,241 or by sacrificing the 
performance of the attention-demanding task to avoid gait instability.224 In this context the 
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unconscious, healthy posture first or safety first strategy84 suggests that older people tend to protect 
their motor functioning at the expense of cognitive performance when their balance is threatened 
during walking3 in order to avoid hazards and falls.229
The choice of the attention-demanding task in dual task gait assessment has to be made carefully.92
How attention is divided between two simultaneously performed tasks depends on the efficiency of 
executive functions and the attention load of each task.91,200,202,203,207 The amount of attention needed 
for a task depends on the type and difficulty of the task,224 as well as the priority given to one or both 
tasks.91,225,229,232 Relatively simple tasks can already reveal much about the underlying limitations on 
people’s ability to perform different tasks at the same time.232 Compared to walking alone, gait 
becomes instable when walking and forward counting and even more when walking and 
simultaneously backward counting202,220 or naming animals.190,229 A verbal fluency task relies on 
semantic memory which is not directly associated with executive functions while an arithmetic task, 
like backward counting, depends on working memory which is a system for temporary storage and 
processing of information related to executive functions.92 An arithmetic task may provoke higher gait 
instability compared to a verbal fluency task,92 because counting has a strong rhythmic component 
which can influence the walking pattern when performed simultaneously (“magnet effect”).235 In this 
context it is interesting, that older people who counted fewer numbers while subtracting aloud starting 
from 50 when seated compared to when walking, had a higher risk of falling and more falls.235  
1.8.5 Motor-cognitive interference 
When older people are required to divide attention among two simultaneously performed tasks 
performance in one or both tasks may decline.30 The resultant deterioration in performance is known 
as dual task decrement or dual task interference.30,242 The most widely accepted concept of dual task 
interference is the capacity sharing theory which assumes that older people share processing capacity 
among tasks.232 If more than one task is performed at the same time, there is less capacity for each 
individual task, and performance is impaired.232 In terms of gait this assumes that walking, or the 
execution of the concurrent task, or both are altered.229 The bottleneck theory suggests parallel 
processing for certain mental operations.232 If two or more tasks need the processing capacity at the 
same time, then a bottleneck results, and one or more tasks will be delayed or impaired.232 In terms of 
gait, this results in slower walking speed or delayed performance of the concurrent task, because the 
neuronal networks involved in the two processes overlap.229 Another concept of dual task interference 
is the cross-talk model. It depends on the information being processed, suggesting that it may be 
easier to perform two tasks at the same time when they involve similar inputs and need similar 
processing machinery.232 Detection of dual task-related interference is relevant for fall prevention in 
older people, because a safe locomotion depends on efficient gait control.92 Further, dual task-related 
interference may show the need of therapeutic interventions,239 such as exercise or drugs, to improve 
attentional resources or make a particular task (e.g. walking) more routine.219
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1.8.6 Gait and executive function 
Executive function consists of initiation, planning, execution, response, inhibition, and attention 
associated with the prefrontal cortex and related brain networks.92,199,229 They are required for the 
timing and sequencing in motor control and walking,30,195,203,229 and ensure that the appropriate 
amount of attention is allocated to gait in dual-tasking and other multi-task situations.209,232 Attention is 
a complex cognitive function that describes the information processing central capacity of an 
individual.91,239  
Older people often have difficulties maintaining a stable gait pattern while dual-tasking209,228 which can 
be related to executive dysfunction.219 With aging and pathological conditions, especially when a gait 
disorder is present or under a dual task condition, executive functions become even more important 
for the performance of gait.204,229 Impairment in executive function, especially in the ability to divide209
and rapidly switch attention from one task to another219 may impair mobility and gait stability194
required to overcome hazardous situations (e.g. obstacles, uneven path),229,243 and avoid 
falls.2,209,229,233 This is particularly evident in older people with impaired cognitive function due to 
cognitive decline (e.g. dementia).194,203,225
Gait variability is sensitive to the ability to divide attention under a dual task walking condition, because 
executive function input is needed to allocate attention among simultaneously performed tasks.203
Generally, irregular gait (e.g. CV of stride time)31,194 is associated with impaired executive functions in 
older people.205,220,230 The latter possibly causes a disturbance of the automatic stepping mechanism 
due to abnormal higher cortical levels of gait control.198 Consequently, the detection of impaired 
executive function in older people emphasizes the importance of clinical gait analysis in the evaluation 
of walking,91 and the suitability of spatio-temporal gait parameters as markers in the early diagnosis of 
dementia.194,203,220,225
1.9 The association between cognitive decline and gait 
Recent findings suggest that cognition is essential for maintaining gait and balance, and that impaired 
cognition is associated with the risk of falls and fractures.30,92,117,118,203,216 Hence, one of the major aims 
of dementia research is, or at least should be, to improve or maintain not only cognitive but also 
physical functioning.218
1.9.1 Gait analysis for detection of cognitive decline 
Older people with cognitive disorders are one of the most vulnerable populations of our society and 
are more likely to experience mobility decline and falls.215 Recent evidence shows that gait disorders 
can be found in early stages of cognitive decline and dementia.37,185 Compared to older people with 
healthy cognition, those with Alzheimer’s disease (AD) have slower and more irregular gait,203 more 
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falls (a first clinical symptom of cognitive decline),107 and more fall-related injuries.30,118 Research is 
currently uncovering the associations between dementia subtypes and gait characteristics, although 
the value of gait analysis in the diagnostic process has yet to be fully recognized.29 Identifying early 
quantitative gait markers of dementia may help detecting high risk older patients for further evaluation 
and intervention.178 Spatio-temporal parameters collected during gait analysis represent such early 
markers and may be as sensitive as traditional tests of cognitive function.30 Gait depends on and is a 
marker of executive function229 which allows prediction of future risk of cognitive decline and dementia 
in initially non-demented older people.178 Hence, gait analysis can help postponing or attenuating the 
diminishing components of cognitive decline.244
1.9.2 Mild cognitive impairment 
A wide range of cognitive functions decline in older people (e.g. attention and executive functions),245
leading to MCI, a transitional zone between normal and pathological cognitive function.245,246 Early 
detection of MCI is critical in order to begin therapeutic treatment as early as possible,247 because 
older people with MCI appear to be at an increased risk of developing AD at a rate of 10% to 12% per 
year.248 There are neither generally accepted criteria nor major classification systems providing 
consensus diagnostic criteria for MCI.249 MCI is characterized by subjective and/or objective 
complaints of deterioration in cognitive performance, but no evidence of dementia.249 In addition, ADL 
are preserved and complex instrumental functions are either intact or only minimally impaired.245
Cognitive impairment can be in the memory (amnestic) or non-memory (non-amnestic) domain.245
Either single or multiple cognitive domains can be affected.245 Older people with MCI would greatly 
benefit from therapeutic interventions to prevent the progression towards dementia.248 However, there 
is a lack of treatment options for MCI patients,246 and the efficiency of drug interventions in older 
people with MCI is still unclear.250 Besides brain atrophy, older people with MCI show deficits in 
regional cerebral blood flow,245 for which ginkgo biloba with its microcirculation-increasing modalities 
offers a promising therapeutic option (see publication (g). Furthermore, exercise may substantially 
reduce the odds for developing MCI,251 but the effective characteristics of such interventions are not 
yet defined. 
1.9.3 Dementia 
Dementia is widely recognized as a global public health problem,178 and its prevalence is steadily 
increasing due to an increase in longevity.252 An estimated 30 million people in the world are affected 
by dementia, and there are about 4.6 million new cases every year (one new case every 7 s).247
Dementia is a syndrome caused by a great variety of diseases and progressively affects cognitive 
functioning in older people.247 AD represents the most common form of dementia, leads to death 
within 3 to 9 years after diagnosis,253 and accounts for over 50% of cases at autopsies and clinical 
studies.254 The pathology of dementia and AD is mainly characterized by cerebral lesions and loss of 
neuronal cells 97 causing cognitive decline and memory deterioration in older people.254,255 Brain 
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changes in AD are marked by severe neurodegenerative alterations, such as the loss of synapses and 
neurons, atrophy, and the selective depletion of neurotransmitter systems (e.g. acetylcholine) in the 
hippocampus and cerebral cortex.256 AD is characterized by an accumulation of misfolded proteins in 
the aging brain which results in oxidative and inflammatory damage and consequently to energy failure 
and synaptic dysfunction.254 Vascular injuries from strokes and white matter lesions also promote to 
the cycle of protein aggregation and oxidation in the brain contributing greatly to cognitive decline.254
Two pathological hallmarks of AD are amyloid plaques and neurofibrillary tangles.253 The deposition of 
amyloid ȕ seems to trigger neuronal dysfunction and death in the brain while changes in tau, an 
insoluble microtubule-associated protein and major constituent of neurofibrillary tangles, may disrupt 
the structure and function of neurons.253 Amyloid plaques correlate with subtle deficits in cognitive 
functioning and suggest early disease processes leading to AD.257 Expensive and time-consuming 
tools such as computer tomography (CT), magnetic resonance imaging (MRI), single-photon emission 
computer tomography (SPECT), positron emission tomography (PET), and cerebrospinal fluid (CSF) 
are used for detection of these AD markers. However, AD can only be definitely diagnosed post 
mortem,253 and gait analysis increasingly qualifies as a simple, cost-effective supportive diagnostic tool 
in the contribution to set a diagnosis for AD in vivo.253 To date, the focus in treating cognitive decline 
lies on pharmaceutical therapy (see chapter 1.10) to enhance both cognitive and motor function (i.e. 
acetylcholine esterase inhibitors (AChEI) and memantine).30,253 However, dementia does not appear to 
be contraindicated for exercise.218 Exercise may help to reduce the prevalence of the disease and the 
high rate of falls,253 as well as decrease associated morbidity (see chapter 1.11).30 Efficient exercise 
strategies in older people with AD include training of complex over-learned motor activities, such as 
gait or dancing which prevent or improve higher level gait disorders.244
1.9.4 Brain plasticity may improve cognitive function 
Traditionally, it was believed that anatomical structures of the human brain only change in morphology 
due to aging or pathological conditions.258 However, recent research suggests that the brain maintains 
its ability to change in function and structure in response to environmental stimuli throughout life.259
Theoretically based concepts suggest that structural brain plasticity plays a crucial role in coping and 
adaptation to environmental changes and disease.259,260 It has been shown that learning-induced brain 
plasticity is also reflected at structural level,258 allowing the acquisition of new skills.259 As a 
consequence, age-related functional decline in large brain systems seems to be an evitable process of 
aging and can be reduced and possibly reversed in a stimulus-response specific manner.217,261 It has 
been shown that even in older people the brain remains plastic and responsive to changes due to 
exercising.217 Exercising modulates those features of the brain anatomy specifically associated with 
the demands of the exercise,262 and therefore repetitive learning of a new skill is more critical for the 
brain to change its structure compared to continued training of an already mastered skill.260 This 
implies that exercise should consist of long-term performance of several different motor tasks 
combined with changing sensory inputs to have the greatest effect on brain plasticity and related 
functional improvement.263,264 With proficiency, lower activity in cortical motor control areas suggests 
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more efficiency in the control of movements265 and a reduction in neural effort to perform a motor 
task.266 As an example, gray matter (contains many cell bodies and nerve endings)16,267 brain plasticity 
on a structural level is specific and fast adjusting to an exercise stimulus.258-260 An increase in gray 
matter may be partially due to changes in blood flow259 while the effect of increased sensory, 
cognitive, and motor activity must be induced via enhanced synaptic and neuronal activity.268 In 
general, brains which have received increased stimulation through enhanced mental and physical 
activity are better protected from neurodegenerative processes, traumatic insults, or other forms of 
neural dysfunction.268
1.10 Cognitive enhancers and their effect on gait 
The preservation of cognitive function is important in older people to maintain independence and to 
prevent institutionalization.269 Pharmaceutical therapy with AChEI and ginkgo biloba helps to diminish 
the negative effects of cognitive decline in older people with MCI and dementia. 
1.10.1 Acetylcholine esterase inhibitors and memantine 
Usually AChEI, such as donepezil, galantamine, rivastigmine, and tacrine are used in the symptomatic 
treatment of cognitive decline in dementia.270 The molecular mechanism of action of AChEI is through 
increased cortical and hippocampal acetylcholine, an important neurotransmitter for memory 
regulation and neural plasticity.215 These drug-associated cognitive enhancements in 
neurotransmission254 may also be important for gait performance203 as shown by a study of Assal et al. 
(2008)270 which reported a significant increase of stride time under dual task conditions in the control 
group compared to a galantamine group. Memantine is another drug used to treat symptoms of 
moderate to severe AD showing similar effects on gait. It is hypothesized that combined effects on the 
glutamatergic and dopaminergic systems improve high level sensorimotor deficits.271 A recent study by 
Beauchet et al. (2011)271 showed that after 16 months of treatment with memantine 20 mg once daily, 
the CV of stride time in patients with AD was significantly lower (3.6 ± 1.3%) than at baseline (6.3 ± 
6.1%). The effect of memantine on CV of stride time was attributed to changes in higher-level gait 
control including prefrontal cortex whose atrophy is partly responsible for cognitive decline.271
1.10.2 Ginkgo biloba 
It is expected that in older people with MCI, gait and balance performance can be improved and fall 
risk reduced by treatment with cognitive enhancers due to an improvement in attention and executive 
function.215 The approach to target cognition with an outcome to improve mobility, gait, and balance 
offers a new way to improve the autonomy and quality of life in older people suffering from cognitive 
decline.215
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Ginkgo biloba derived from the Chinese “Yin-Kuo”, meaning silver apricot and “biloba” referring to its 
two-lobed, fan-shaped leaves.272 Ginkgo biloba contains of 24% flavonoids (quercetin, kaempferol, 
and isorhamnetin) and 6% terpenens (ginkgolides A, B, C, J, M, and bilobalide).256 It is gained from a 
dry extract of ginkgo biloba leafs.273 The herbal preparation is prescribed for deficits in memory, 
concentration, and depression stemming from organic brain disease.272 The costs for ginkgo biloba 
are low, ranging from USD 0.31 to 1.17 for 120 mg depending on the brand.272 In human and animal 
studies ginkgo biloba shows peripheral and central effects, including vasomodulatory (e.g. increase in 
cerebral blood flow and dilatory effects on blood vessels), metabolic (e.g. increase in glucose and 
glycogen synthesis), antiplatelet (e.g. inhibition of platelet aggregation), and receptor as well as 
transmitter (e.g. receptor density modulation) modulating properties.272 Particularly, the 
vasomodulatory properties may increase decreased regional cerebral blood flow in older people with 
cognitive decline and improve associated postural and gait disturbances (i.e. postural sway, 
decreased stride length, and increased stride length variability) (supposed mode of action in 
publication (g).255 In vitro and in vivo, ginkgo biloba may also have neuroprotective, antioxidant, and 
anti-apoptotic properties including protection against amyloid ȕ aggregation, and decreased reduction 
of age-related acetylcholine receptors.256,273,274 Ginkgo biloba is widely taken by older people with 
normal cognition or MCI for its potential effects to improve or maintain cognitive performance269,275 A 
recent study by Yoshitake et al. (2010)276 reported that, in a dose-dependent manner, ginkgo biloba 
positively affected the prefrontal cortex, the brain area that is neuroanatomically relevant to cognitive 
function and gait (see chapter 1.7.3). Once daily 240 mg ginkgo biloba for 12 weeks can improve 
aspects of quality of life in addition to cognitive functioning in older people with very mild cognitive 
impairment.249,277 Demented patients treated with ginkgo biloba improved in cognitive test 
performance, neuropsychiatric symptoms, and ADL (Syndrome Short Test scores, a 
neuropsychological test for attention and memory, and Neuropsychiatric Inventory scores, an 
assessment of behavioral disturbances).252,277  
However, the neurochemical correlates of the positive effects of ginkgo biloba on cognitive function 
are not yet fully clarified.276 There is little evidence of the effectiveness of ginkgo biloba in the primary 
prevention or delay of dementia compared with placebo (3.3/100 person-years vs. 2.9/100 person-
years, P = .21).269 Additionally, a large RCT (n = 1,545) showed that intake of 120 mg ginkgo biloba 
twice daily had no effect on cognitive decline in older people with normal cognition or with MCI 
compared to placebo.275 A possible effect of ginkgo biloba may take years to manifest,269 and despite 
showing no effect on the conversion rate from MCI to dementia, it appears that ginkgo biloba at doses 
of 120 mg to 240 mg per day may have a relevant clinical impact on specific phases of cognitive 
decline.273 Preliminary findings of a place-controlled study with ginkgo biloba showed that patients 
treated for at least four years had lower rates of developing AD compared to those who took ginkgo 
biloba for less time.278 However, long-term intake of ginkgo biloba is safe and tolerable, and the rare 
side effects mainly include gastrointestinal symptoms.249,277
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1.11 Physical activity for improving cognitive function, mobility and gait  
Physical activity is defined as any bodily movement produced by skeletal muscles that results in 
energy expenditure,279 such as exercise, activities of daily living, occupation, and leisure.280 Living 
organisms tend to decrease their physical activity as they grow older.42 In humans, the consequences 
of reduced physical activity such as exercise are manifold and include obesity, osteoarthritis, 
cardiovascular disease, osteoporosis, type II diabetes,259 and hypertension.22
1.11.1 Physical activity and exercise are important for health 
Physical activities such as walking are the most feasible, safe, and accessible mode of exercise for 
older people.10,22 Regular physical activity can maintain or improve exercise capacity in all domains 
(strength, endurance, balance, flexibility), retard the biologic aging process, modify risk factors for 
chronic diseases, alter the expression or consequences of present diseases, affect psychosocial 
functioning, and lead to a higher quality of life and independence.22,42,44 The Physical Activity 
Guidelines Advisory Committee report (2008)281 shows that physical activity and exercise reduce the 
risk of mortality by approximately 30% in older people by improving cardiovascular health outcomes 
(i.e. coronary heart disease, stroke, control of blood pressure, dyslipidemia, and cardiorespiratory 
fitness), weight stability (i.e. preventing and treating metabolic syndrome and type II diabetes), bone 
mass density (i.e. decrease in hip and spine fractures), skeletal muscle mass (i.e. strength, power, 
neuromuscular activation), and mental health (i.e. cognitive decline, onset of dementia, depression). 
Maintenance of physical activity with aging may also partially prevent gait changes, balance 
decrease,279,282,283 falls, and fall-related injuries.68,74,284
1.11.2 Exercise for fall prevention in older people
The ideal exercise program for older people is a combination of walking, dancing (see publication (d), 
resistance training, and balance training.59 Effective exercise programs for older people generally 
consist of mainly two components performed on a regular schedule:52 strength and balance.285,286
Exercises to improve strength and balance are also one of the most feasible and cost-effective 
strategies in falls prevention among older people.10 The recommended exercise interventions of the 
Panel on Prevention of Falls in Older Persons (2011)118 and the current Cochrane Review (2012)146 for 
community-dwelling older people consist of progressive balance, gait, and strength training in the form 
of tai chi group exercise, group exercise containing multi-components, individually prescribed multiple-
component home-based muscle strengthening and balance training.287,288. Of particular importance for 
fall prevention in community-dwelling older people seem to be lower limb muscle strength, gait and 
balance.5,106 Previous research shows that especially multicomponent and multifactorial interventions 
are capable of reducing falls in older people.100 On the one hand, multicomponent interventions refer 
to a set of interventions offered to all participants in a program that addresses more than one 
intervention category.118 On the other hand, multifactorial interventions (strategies using several 
interventions together)106 offer only the adjusted subset of interventions that target the risk factors that 
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have been identified through a fall risk factor assessment.118 However, it is not yet known which 
components of successful multicomponent or multifactorial interventions are essential.100 For detailed 
information about recommend exercise type, intensity, frequency, duration, and further components of 
exercise in fall prevention it is referred to a systematic review by Gschwind et al. (2011) (see 
publication (c).120
1.11.3 Exercise-induced brain changes may improve walking 
The human brain maintains the capacity to change its structure and function according to exercise 
demands at old age.289 The effects of physical activity and exercise on neurodegenerative diseases 
are not well understood, but modern medicine supports the importance of regular exercise218 to affect 
the underlying causes of a neurodegenerative disease,290 delay onset of cognitive impairment,291 and 
slow neurodegenerative disease progression.290 Aerobic exercise programs in older people are, for 
example, associated with increased neurogenesis, angiogenesis and synaptogenesis in the brain.218
Besides improving physical performance, these adaptations lead to improvements in cognition,3 and 
functional connectivity, both relevant for executive function.217 Gait control in prefrontal brain regions 
depends highly on executive functioning and may therefore be improved by exercise.3,292 Furthermore, 
exercise coupled with cognitive interventions may also make brain activity more efficient242 due to 
possible crossover effects between the motor and cognitive modalities.218,243 These crossover effects 
may help improve motor and cognitive dual-tasking performance in older people in regard to 
maintaining gait stability and reduce fall risk (see chapter 1.9.4). 
1.12 Balance exercises improve stability 
Balance requires coordinated neuromuscular, musculoskeletal, and sensory systems107 which make it 
a complex component that describes the ability to maintain equilibrium while standing or moving.29,279
Maintaining balance is fundamental to many independent ADL (e.g. transitional movements like 
standing up from a toilet seat).129,293 Walking is inherently a very challenging task to balance, because 
of the rather instable single support phase.1 Despite this thread to balance, dynamic stability during 
walking can be preserved during short periods in which the body is unsupported.18 In this context, 
compensatory strategies for recovering balance by keeping the center of mass between the base of 
support play an important functional role in preventing falls.72
1.12.1 Balance is important for safe walking and prevention of falls 
If individuals have poor static balance, then it can be inferred that their dynamic balance will be 
compromised as well which will affect their walking ability and/or increase their risk of falling.33
Impaired gait and balance are associated with a sedentary lifestyle, chronic diseases, and 
physiological changes due to aging,18,129 most of which are modifiable by exercise.22 Specific balance 
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training can affect postural control, force production, and gait stability reducing the risk of falls and fall 
rates in older people.5,8,26,86 Exercises that challenge postural stability such as ice-skating may also 
counteract age-related changes in balance.294 However, walking interventions do not generally show 
an enhancement of balance.22  
Previous research shows that balance exercises are recommended for all older people who had a 
fall.78 However, standardization of balance training, for example as part of a dance intervention, is 
difficult due to various exercise modalities.22 Balance is usually challenged by reducing the base of 
support, moving the center of gravity to the limits of tolerance, or reducing the need for upper limb 
support.12 Stressors such as perturbation of ground support, a decrease in proprioception, vision, or 
vestibular system input, and increased compliance of the support surface may additionally challenge 
balance.22 The application of balance training has been increasingly postulated in the geriatric 
population, but hardly any evidence-based guidelines concerning contents, optimal duration and 
intensity of balance training are available.72 However, static and dynamic measures of postural control 
should be trained complementary171 with a core of exercises on stable and unstable surfaces during 
bipedal or monopedal stance with eyes open or closed.72
1.13 Association between dancing and balance 
Balance involves anticipatory and ongoing postural adjustments and is thus a coordination task.5 As 
dancing requires coordination of torso and limbs according to the perceived rhythmic component of 
music,262 its practice is likely to be beneficial in maintaining balance abilities in older people.5 In this 
context, a cross-sectional study showed that older social dancers had better balance and gait patterns 
(i.e. increased gait velocity and stride length) compared to normal older non-dancers.295
1.13.1 Salsa dancing affects postural control 
Dance provides a vehicle for adequate exercises in a number of cultures.10 Salsa dance, as one of 
many dance styles, may improve static and dynamic postural control which is important for walking, 
balance, and fall prevention in older people.171 Dancing seems to be specifically suited for the 
promotion of balance due to frequent changes in direction, and because dance steps are performed 
on toes of the feet.171 After dancing, older people might be able to imagine the steps just learned.244
This in turn may improve locomotion, because motor imagery of gait is sensitive to the same brain 
areas as actual walking.296 Additionally, the rhythmic component of salsa dance may resemble a 
stable walking pattern, possibly improving spatio-temporal gait parameters.171 A recent study by 
Granacher et al. (2011)171 showed that eight weeks of salsa training increased stride velocity and 
stride length, and concomitantly decreased stride time (see publication (d). Thus, salsa dance may be 
a feasible exercise program for older people to improve static and particularly dynamic postural 
control.171
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1.13.2 Jaques Dalcroze eurhythmics improves gait stability and reduces falls  
In the early 20th century in Geneva, Switzerland, the composer Emile Jaques-Dalcroze (1865 to 1960) 
developed a program to improve rhythm in children known as Jaques-Dalcroze eurhythmics (JDR).283
JDR consists of progressive multi-task exercises depending on movement coordination, attention, 
imagination, memory, musicality, and balance, performed to the rhythm of improved piano music.177,297
The chosen music and its rhythm may play an essential role in recalling memories, especially 
memories of body sense and motor skills.298 It has been shown that older people tend to synchronize 
their cadence to the rhythmic sound from a metronome or piano (frequency modulation)18 making 
rhythmicity a key feature of walking.31 Older people need to maintain a steady walking rhythm despite 
numerous sensory inputs and competing objectives31 to adapt to any perturbations and postural 
challenges, and prevent falling.230
Repetitive motor training of complex skills from an early age on and for long periods of time263 can 
induce anatomical differences in several brain areas that are involved in motor and auditory 
processing.265 Through JDR, such automatic movement patterns may be relearned and integrated to a 
highly automated level of motor control.177 A study by Kressig et al. (2005)177 showed that women 
aged over 70 years who had practiced JDR for over 40 years had lower gait variability (CV of stride 
time, 2.1 ± 1.4%) compared to older women with no particular exercise routine (3.9 ± 0.9%). In novice 
older exercisers the positive effect on gait variability under a dual task condition could be reproduced 
with a six months once per week JDR intervention.283 Additionally, a remarkable 54% reduction in falls 
was observed in the same trial.283 Further, a major advantage of such interventions, like JDR or salsa 
dance, are high attendance rates of 78%283 and 92.5%, respectively,171 which are a key factor for 
effective long-term exercising. In summary, dance and eurythmic programs should include improvised 
movements to the rhythm of music and power-specific elements to optimally target various 
components of gait and postural stability.171
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V. Research objectives 
This doctoral thesis investigates the association between gait, mobility, and falls in older people. Fall-
related gait parameters (e.g. gait velocity and gait variability), and several aspects related to fall 
prevention are highlighted in a total of seven studies. 
(a) Walking disorders can stem from motor as well as cognitive impairments. Using a dual task 
paradigm, walking while performing an attention-demanding additional task, helps to reveal gait 
problems and cognitive impairments. Deficiencies in these domains often lead to motor-cognitive 
interference which is thought to be an important contributor to falls in older people. Hence, our 
research objective was to highlight the current evidence in terms of walking disorders and falls 
including the association with attentional resources and dual-tasking. 
(b) In the past decade, gait analysis became a routine clinical measurement and research tool. It is 
now possible to objectively quantify gait rather than relying on observation. This allows early detection 
of gait disorders before clinical symptoms become manifest which is important for early detection of 
fall risk factors and the implementation of primary fall prevention. Our research objective was to 
highlight the importance of gait analysis as part of fall risk assessments. 
(c) Once an older person’s gait is instable and prone to falls, fall prevention interventions should be 
implemented to reduce the risk of falling. Hence, the goal of our systematic literature review was to 
summarize current research about fall prevention in order to detect effective exercise, home 
modifications, footwear, and walking aids to form a basis for the implementation of evidence-based fall 
prevention in Switzerland. 
(d) Jacques-Dalcroze eurhythmics improves walking stability and reduces fall rates in older people. 
Salsa dancing consists of comparable movements and therefore is expected to elicit similar effects on 
gait and falls. The objective of our dance intervention was to show that, in addition to walking stability, 
static postural control and muscular power are affected by salsa dancing. Our hypothesis stated that 
salsa dancing improves static and dynamic postural control and leg extensor power in older people.  
(e) Vitamin D supplementation is a simple and cost-effective treatment for 25(OH)D deficiency. 
Epidemiologic studies showed that sufficient 25(OH)D levels are required for efficient fall prevention in 
older people. Despite associations between 25(OH)D, muscle and neuronal function, the exact 
mechanism of how vitamin D affects muscle strength and mobility remains unknown. The aim of our 
study was to examine the association between spatio-temporal gait parameters and 25(OH)D 
concentrations under a normal and fast walking condition in older patients referred to a memory clinic
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using the GAITRite walkway system. It was hypothesized that higher 25(OH)D levels are associated 
with faster gait velocity during normal and fast walking in older patients assessed at a memory clinic. 
(f) Walking aids such as cane or walker are used by many older people to improve static and dynamic 
postural stability. However, in the literature limited quantitative gait data is available on older people 
who use walking aids. Hence, the aim of our recent cross-sectional study was to improve the 
understanding of how spatio-temporal gait parameters are affected by walking aid use in community-
dwelling older people. We hypothesized that older people walk faster and more stable when using a 
walking aid compared to unaided walking, and that older people who use canes walk faster than those 
who use crutches or a walker.  
(g) Ginkgo biloba is prescribed to improve cognition in older people who suffer from mild cognitive 
impairment. It is thought that ginkgo biloba increases cognition, particular attention capacity, by 
improving cerebral blood flow. Higher attentional resources could further be used to increase walking 
stability, particularly under a challenging motor-cognitive dual task situation. Our hypothesis states that 
ginkgo biloba improves spatio-temporal gait parameters under dual task conditions in older people 
with mild cognitive impairment.  
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Abstract. Since approximately 30% of persons over the age of 65 fall each year, prevention of falls is a very important topic. Gait
disorders and diminished ability to walk safely are associated with an increased risk of falling. In older adults, falls commonly lead to
injuries, institutionalization, and early death. The resultant decline in activities of daily living further contributes to loss of mobility and
independence. Gait analysis using the dual-task paradigm (e.g., walking and carrying a cup of tea) offers a sensible tool for detecting
older persons prone to falling. Changes in gait patterns due to simultaneously performing a secondary attention-demanding task are
interpreted as interference by competing demands for attentional resources in gait control. Exercise interventions such as Jaques-Dalcroze
eurhythmics address these attentional properties and aim to decrease such interference. To fully stress physical capacities in older adults,
not only does automaticity of walking have to be trained, but also simultaneous performance of additional tasks. Exercise interventions
for fall prevention should focus on developing basic skeletal muscle strength as a prerequisite to training gait automaticity in dual or
multiple task situations. Recommendations for further research center on new approaches to combine exercises with additional tasks to
improve gait and functionality in older adults.
Keywords: older persons, gait disorders, falls, dual task, exercise
Gait Disorders and Falls
Falls are a prevalent and serious clinical problem faced by
older adults, often leading to morbidity, mortality, and the use
of health care services (Rubenstein, 2006). Almost all fall
incidents due to extrinsic factors, intrinsic factors, idiopathic
mechanisms, exposure to risk, and risk-taking behaviors have
one factor in common: They happen while walking (Ry-
ynänen, Kivelä, & Honkanen, 1991; Scott, Votova, Scanlan,
& Close, 2007; Todd & Skelton, 2004). Although walking
may seem to be a simple task, it is actually a complex motor
skill that takes years for humans to learn and master (Wool-
lacott & Shumway-Cook, 1990) and whose automaticity is
often diminished in older adults (Wong, Masters, Maxwell,
& Abernethy, 2008). Thus, simultaneously performing a cog-
nitive or motor task while walking may cause gait disturb-
ances and an increased fall risk, particularly in older adults
(Kelly, Schrager, Price, Ferrucci, & Shumway-Cook, 2008).
The following review focuses on gait and falls in older per-
sons. Further, the age-related reduction of muscle strength in
association with mobility and functionality is highlighted.
Conventional exercise interventions are presented and com-
pared to recent approaches aimed at decreasing fall risk.
The Epidemiology of Falls
In 2005, the Prevention of Falls Network Europe defined a
fall as “an unexpected event in which the participants come
to rest on the ground, floor, or lower level” (Lamb, Jøstad-
Stein, Hauer, & Becker, 2005; see also Gibson, Andres,
Isaac, Radenbaugh, & Worm-Petersen, 1987). Falls are one
of the most significant preventable health problems facing
older people (Duxbury, 2000). Approximately one-third of
the population over the age of 65 years falls at least once
a year. While half of those fallers suffer recurrent falls, re-
tirement, and nursing home residents, as well as women in
general are even more prone to falls (Campbell, Borrie, &
Spears, 1989; Rao, 2005). The rates of falls and their asso-
ciated complications are correlated with increasing age
(Lord, Sherrington, Menz, & Close, 2007). As a conse-
quence, falls are the leading cause of older adults’ devel-
oping a fear of falling, becoming institutionalized or dis-
abled (Nikolaus, 2005).
Falls are often caused by environment-related accidents,
gait and balance disorders, weakness and several forms of
dizziness, drop attacks, or syncope. Other specific causes
include neurological disorders, cognitive deficits, poor vi-
sion, drug side effects, alcohol intake, anemia, hyperthy-
roidism, unstable joints, foot problems, osteoporosis and
chronic illness (American Geriatrics Society, British Geri-
atrics Society, & American Academy of Orthopedic Sur-
geons Panel on Falls Prevention, 2001; Fuller, 2000; Todd
& Skelton, 2004). Consequently, since most older adults
have multiple identifiable risk factors, it is difficult to de-
termine one specific cause for falling.
A report by Beer, Minder, Hubacher, and Abelin (2000)
revealed that in Switzerland falls are the most common
type of accident sustained by older people (40.8/1000 men,
77.0/1000 women). In particular, tripping and slipping
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cause many falls in older persons (Woollacott & Shumway-
Cook, 2002). Falls are responsible for many severe injuries
such as hip fractures and head injuries (Sattin, 1992). In
fact, one out of ten falls causes severe injuries. The highest
incidence of fall-related mortality occurs after hip fractures
(3.9/1000 men, 10.3/1000 women) (Beer et al., 2000). Mor-
tality following hip fracture is approximately 22–29% at
one year from injury (Haleem, Lutchman, Mayahi, Grice,
& Parker, 2008). As a consequence of falling, older adults
often have to be institutionalized. Hospitalization after a
fall has a considerable detrimental effect on independence
and quality of life (Salkeld et al., 2000), and only about half
of those seniors admitted are alive a year later (Dowling &
Finch, 2009; Nikolaus, 2005; Rubenstein, 2006). It is note-
worthy that underlying gait disorders are likely to increase
falls (Dunn, Rudberg, Furner, & Cassel, 1992). Fallers as
well as nonfallers who suffer from a fear of falling decrease
their activities of daily living (ADL) (Nikolaus, 2005).
Hence, if gait disorders are combined with a fear of falling
(e.g., postfall anxiety syndrome), an older person may de-
crease their ADL even more drastically (Zijlstra et al.,
2007). A vicious cycle is established that decreases not on-
ly social activities, but also physical functioning and may
lead to frailty (Bauer & Sieber, 2008; Clark & Manini,
2008).
Many falls may not be reported to a health professional,
particularly those in which no injuries were sustained.
While most inpatient falls can be recorded by medical staff,
there is still no adequate fall assessment tool available for
outpatients. In most studies, falls are self-reported using
questionnaires. Thus, accurate self-reporting of falls re-
mains questionable: Do older adults define a fall the same
way as health professionals? Does a fall “count” to the per-
son if no injuries occurred? And can older adults remember
the timing and details of the fall incident? Until more ac-
curate assessments are developed and broadly available,
data about falls must be regarded with caution.
Fall Risk Factors in Relation to
Functionality and Gait
Falls are seldom the result of a single cause, but rather often
represent a multifactorial occurrence including intrinsic
and extrinsic factors. Individuals with gait and muscle dys-
functions demonstrate a substantially increased risk of falls
and fractures compared to healthy older adults (Ruben-
stein, 2006). Many falls are caused by accidents, environ-
mental hazards, gait problems, and muscular weakness.
The four most common risk factors for falls are muscle
weakness (OR = 4.4), history of falls (OR = 3.0), and gait
and balance deficits (OR = 2.9) (AGS, 2001; Rubenstein
& Josephson, 2002). Individuals with a history of falls also
often have an inferior static balance and sway more than
those who do not fall (Overstall, Exton-Smith, Imms, &
Johnson, 1977). Since increased postural sway is associat-
ed with increased postural instability, this may pose another
potential risk factor for future falling (Rogers, Rogers,
Takeshima, & Islam, 2003). Further factors related to falls
of older adults include aging, disease, reduced postural sta-
bility, decreased dynamic balance, gait disorders, strength
deficits, difficulty standing from a chair as well as other
fall contributors such as medication and environmental fac-
tors (Modreker & von Renteln-Kruse, 2009). Except for
history of falls, all major risk factors for falls (muscle
weakness, gait and balance deficits) are at least partially
related to decreased skeletal muscular strength, decreased
ADL, little exercise, and malnutrition. Hence, to retain mo-
bility, functionality and independence in old age, modifi-
cation of these risk factors is necessary (Rogers et al.,
2003).
Gait Disorders Causing Falls
Normal walking depends on several components including
muscle strength, peripheral sensibility, free mobility of
joints, neuromuscular and motor control, as well as normal
sensory input (Lord et al., 2007). Gait and balance disor-
ders have many etiologies and numerous therapeutic ap-
proaches exist. Gait problems adversely affect up to ap-
proximately 40% of older persons while half of the prob-
lems are severe (Rubenstein, 2006). Often, the first
symptom of a gait disorder is an injurious fall (Sattin,
1992).
In the past, disordered gait was defined as gait that was
slowed, esthetically abnormal or both; not necessarily an
inevitable consequence of aging, but rather often a reflec-
tion of the increased prevalence and severity of age-asso-
ciated diseases (Alexander & Goldberg, 2005). Gait disor-
ders in older adults can be an inconvenience, albeit under-
reported, because they may not cause pain or discomfort
(Duxbury, 2000). However, gait disorders can also be a ma-
jor risk factor for falls and are often a sign of specific dys-
functions of the nervous, muscular, skeletal, circulatory, or
respiratory system (Rubenstein, 2006). Often a gait disor-
der represents the combined effect of more than one coex-
isting condition, so that differentiating between disordered
and normal gait can be difficult (Alexander & Goldenberg,
2005).
Gait disorders can be due to underlying diseases such as
normal pressure hydrocephalus, sensory disorders, myelo-
pathy, Parkinson syndromes, and cerebellar diseases.
Other contributors to gait disorders include metabolic
disorders, tumors of the central nervous system (CNS),
subdural hematoma, hyperthyroidism, depression, and de-
ficiency of vitamin B12 and folate (Alexander & Goldberg,
2005).
Overviews by Alexander and Goldberg (2005) and Dux-
bury (2000) offer a classification of gait disorders based on
the level of sensorimotor nervous system deficits. Low sen-
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sorimotor diseases include peripheral sensory and periph-
eral motor impairments. Hence, CNS processing is not af-
fected, though execution through the peripheral structures
may be hindered. On this level, the patient can adapt well
to the gait disorder and can compensate with an assistive
device or altered environmental conditions. Mid-level sen-
sorimotor diseases involve lower CNS structures of cere-
bellum, midbrain, brain stem and spinal cord. As a conse-
quence, proper postural and locomotor responses may be
prevented and the motor modulation of gait is disrupted.
Consequently, the stepping pattern is abnormal, while gait
initiation might remain normal. High sensorimotor diseases
of the cerebral cortex may interfere with higher-order in-
formation processing. Cognitive dysfunction, for example,
due to dementia, affects gait initiation and ambulation. This
level of frontal lobe-related gait disorders often has a cer-
ebrovascular component that may lead to frontal disequi-
librium or gait apraxia, especially when distracted by other
stimuli. However, most older patients have several comor-
bidities and therefore gait disorders are likely to represent
deficits at more than one sensorimotor level.
Gait Disorders and Cognitive Impairment
As mentioned earlier, gait disorders are common in subpop-
ulations with cognitive impairments. Locomotor function de-
pends on executive function, which can be affected in cere-
bral diseases such as mild cognitive impairment (MCI) or
dementia (Sheridan, Solomont, Kowall, & Hausdorff, 2003).
In addition, deficits in language and visual spatial skills are
dependent on executive functioning (e.g., attention) and are
also common in cognitively impaired patients (Hulette et al.,
1998). Hence, executive dysfunctions may be associated with
the same brain networks responsible for the timing and se-
quencing of motor activity (Sheridan et al., 2003). As a con-
sequence, patients with dementia have a twofold increased
risk of falling compared to cognitive healthy older individ-
uals. Further, patientswith Alzheimer’s disease often develop
considerable difficulties with gait and postural stability
(Sheridan et al., 2003). In this context, an increased risk of
falling may be the first clinical symptom of cognitive decline
or dementia progression (Nikolaus, 2005). In the Einstein
Cohort Aging Study by Verghese et al. (2006), gait changes
(irregular gait) were identified that preceded dementia by 5
years as diagnosed by neuropsychological and cerebral imag-
ing assessments. Consequently, gait analyses may valuably
contribute to the assessment of fall risk and aid in early de-
tection of cognitive decline.
Gait Parameters as Fall Predictors
A safe and efficient gait is important for mobility and in-
dependence in older persons (Nelson et al., 1999). Studying
gait among older adults enhances our understanding of el-
ders’ movement control and is useful in quantifying out-
Table 1. Gait parameters in older adults
Gait parameters M ± SD Age Sex Reference
Velocity [m/s] 1.4 Götz-Neumann (2003)
(healthy) 1.25 ± 0.18 80.1 ± 16.0 m < f Nelson et al. (1999)
1.15 ± 0.20 70–79 m/f Öberg et al. (1993)
1.11 ± 0.19 71.1 ± 5.2 f Lord et al. (1996)
Velocity [m/s] < 1.0 Götz-Neumann (2003)
(impaired) 0.97 ± 0.23 79.6 ± 5.8 m < f Kressig et al. (2004b)
0.82 ± 0.26 79.4 ± 8.7 m < f Nelson et al. (1999)
0.66 ± 0.19 82 ± 6 m < f Maki (1997)
Cadence [steps/min] 100–130 Götz-Neumann (2003)
(healthy) 118.2 ± 11.9 70–79 m/f Öberg et al. (1993)
115.4 ± 11.2 71.1 ± 5.2 f Lord et al. (1996)
108.0 ± 8.2 79.0 ± 3.0 m < f Menz et al. (2003)
Cadence [steps/min] 105.7 ± 12.7 79.6 ± 5.8 m < f Kressig et al. (2004B)
(impaired) 78.9 ± 14.3 84.4 m < f Liu et al. (2009)
Stride length [m] 1.4 Götz-Neumann (2003)
(healthy) 1.30 ± 0.14 79.0 ± 3.0 m < f Menz et al. (2003)
1.15 ± 0.13 71.1 ± 5.2 f Lord et al. (1996)
1.15 ± 0.12 70–79 m/f Öberg et al. (1993)
Stride length [m] 1.11 ± 0.18 79.6 ± 5.8 m < f Kressig et al. (2004b)
(impaired) 0.83 ± 0.16 82 ± 6 m < f Maki (1997)
Note. Average data of men and women calculated for Öberg et al. (1993). Stride length was calculated by multiplying step length by a factor
of two.
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comes of therapeutic interventions (Kressig & Beauchet,
2004). In addition, the ability to adapt gait patterns to dif-
ferent situations plays a central role in the safety of gait.
Older adults with an increased risk of falling adopt a be-
havior pattern that often results in cautious gait (Nikolaus,
2005). Such a conservative gait pattern is characterized by
reduced velocity, shorter step length, and increased step
time variability (Menz, Lord, & Fitzpatrick, 2003).
Early detection of gait changes or deficits allows pre-
ventive measures to be implemented to stabilize gait, re-
duce fall risk, and thus maintain mobility and functional
independence. Objective spatio-temporal gait analysis is
particularly important in older persons because certain gait
parameters have been identified as fall predictors. A num-
ber of studies revealed that frail older persons and fallers
walk significantly slower, which is related to reduced ca-
dence and shorter step length (see Table 1). A study by
Studenski et al. (2003) showed that slow walkers
(< 0.6 m/s) are admitted to the hospital significantly more
often than fast walkers (> 1.0 m/s). Gait variability is a
quantifiable feature of walking that is often altered (in
terms of both magnitude and dynamics) in fallers (Sheridan
et al., 2003). Maki (1997) showed that increased gait vari-
ability represents impaired motor control, which may re-
flect errors in foot placement, as well as an increased fall
risk (see Table 2). The most important gait parameter for
postural stability in older walking adults today is stride-to-
stride variability, seen as a marker for gait regularity. If gait
from one stride to the next is completely regular, there is
no variability: The more irregular the gait, the higher the
variability (Hausdorff, Rios, & Edelberg, 2001). In other
words, stride-time variability represents the quantified
magnitude of stride-to-stride fluctuations in the gait cycle
duration (Hausdorff, 2005). Stride-to-stride variability is
measured by the coefficient of variation (CV =
[SD/mean] × 100), which is used as a clinical index of gait
steadiness and has been found to be a sensitive predictor of
falls in older persons (Allali et al., 2007; Hausdorff et al.,
2001; Maki, 1997; Priest, Salamon, & Hollman, 2008). In
fact, an increase in stride length of just 1.7 cm from one
stride to the next nearly doubles the likelihood of falling in
the next 6 months (Maki, 1997).
Under normal walking conditions (self-chosen pace)
and specifically under dual-task conditions (walking while
simultaneously performing another task, either motor or
cognitive; see “Dual-Task Paradigm for Falls Assess-
ment”), high stride-time variability is strongly associated
with impaired executive function and a high risk of falling
in older people (Hausdorff, Edelberg, Mitchell, Goldber-
ger, & Wei, 1997; Kressig, Hermann, Grandjean, Michel,
& Beauchet, 2008; Sheridan et al., 2003;). Further, frail
older adults suffering from recurrent falls without any
known organic reason may present an increase of gait vari-
ability under dual-task walking conditions which are not
detectable during walking alone (Springer et al., 2006).
Clinical Application of Gait Analysis
In the past, most movement recording systems were com-
plex, expensive, and required highly trained operators. Ba-
sic equipment such as tape, stopwatch, adhesive felt pads
impregnated with dye attached to the foot, or the use of
talcum powder dusted on the plantar surface of the foot,
were used to measure temporal and spatial gait parameters.
These research tools were not only time-consuming, but
also had substantial disadvantages such as attaching equip-
ment to the heels of patient’s footwear which consequently
influenced natural gait (Begg, Wytch, & Major, 1989).
More recent assessment tools facilitate gait analyses and
offer a simple way to collect objective, valid, and reliable
data (Menz, Latt, Tiedemann, Mun San Kwan, & Lord,
2004). To appropriately assess human gait, it is essential to
evaluate temporospatial parameters as well as kinetic and
kinematic gait data (Begg et al., 1989). Several systems are
available to measure gait, ranging from optoelectronic sys-
tems (e.g., Vicon Motion Systems, LA, USA), force plat-
forms (e.g., Kistler Corp., Winterthur, Switzerland), and
shoe-integrated wireless sensor systems (“GaitShoe,”
Bamberg, Germany; Benbasat, Scarborough, Krebs, & Pa-
radiso, 2008), to electronic walkways with integrated pres-
sure sensors (e.g., GAITRite® Gold, CIR Systems, PA,
USA). All of these motion analysis systems have individual
potential as a research tool and may be also combined with
other external devices (e.g., accelerometers or surface
EMG) in order to obtain more complete locomotion data.
In general, newer assessment tools require substantially
less time to collect data about gait, less human and financial
resources to administer gait analysis, and are less prone to
investigator-induced errors. Regardless of which system is
used, it is important that standardized procedures for that
system of gait analysis be implemented.
Dual-Task Paradigm and Falls
Rarely do we just walk without doing anything else simul-
taneously. Everyday life offers numerous situations in
which multiple sensory stimuli have to be coordinated to
perform motor tasks while a simultaneous cognitive task is
added (e.g., walking while talking on a cell phone). In the
Table 2. Gait parameters as fall predictors
Gait Parameters Change in
fallers
Reference
Stride width ↑ Maki (1997)
Stride length variability ↑ Maki (1997)
Stride velocity variability ↑ Maki (1997)
Stride time variability ↑ Hausdorff et al. (1997)
Swing time variability ↑ Hausdorff et al. (2001)
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past, gait has been described as an automated motor behav-
ior. In a study by Poldrack et al. (2005) automaticity was
defined as performance of a primary task which is mini-
mally affected by other ongoing tasks. However, there is
some evidence that gait in older persons is only partially
automatic, implying that even highly automated gait re-
quires some attentional resources (Beauchet & Berrut,
2006). Using a simple dual-task paradigm of walking and
talking, Lundin-Olsson, Nyberg, and Gustafson (1997)
showed that older patients who stopped walking in order to
answer a question had a much higher fall incidence in the
ensuing 6 months than those who could walk and talk at
the same time. Changes in gait while simultaneously per-
forming a secondary attention-demanding task are inter-
preted as dual-task interference and may play an important
role in prediction of falls (Beauchet & Berrut, 2006).
Increasing evidence links executive function to motor
skills (Yogev-Seligmann, Hausdorff, & Giladi, 2008). Im-
pairment in one of the components of executive function
(volition, self-awareness, planning, response inhibition, re-
sponse monitoring, attention/dual tasking) may impact an
individual’s ability to walk efficiently and safely. Deficits
in executive function, particularly in attention, are associ-
ated with typical gait disorders such as decreased walking
speed and increased gait variability. The more difficult and
challenging a combined task becomes under dual-task con-
ditions (walking and simultaneously performing another
difficult task), the more walking seems to rely on executive
function (Yogev-Seligmann et al., 2008).
Dual-task paradigms are now widely used to examine
attentional requirements for walking while performing a
secondary task. Woollacott and Shumway-Cook (2002) de-
fined attention as the information processing capacity of an
individual. It is hypothesized that when attentional de-
mands of a dual-task situation exceed the attentional capac-
ity of an individual, performance of one or both tasks is
impaired (capacity-sharing theory) (Lehle & Hübner,
2009). The bottleneck model is another theoretical ap-
proach to dual-task interference, which suggests that men-
tal operations may compete for a single mechanism at the
same time resulting in a bottleneck, whereby the perform-
ance of one or both tasks is delayed or impaired. Caused
dual-task interference by concurrent tasks involving simi-
lar sensory inputs and sharing processing capacities is re-
ferred to as the cross-talk model (Pashler, 1994). In terms
of fall prevention, this implies that interventions aiming to
decrease the attentional demands for either walking or an
additional task, for example, by increasing gait automatic-
ity, may likely be beneficial.
Yogev-Seligmann et al. (2008) showed that dual task-re-
lated gait performance often deteriorated in older persons,
while younger persons showed no change in gait parame-
ters while performing a secondary cognitive task unless the
postural control system was stressed by a very complex
additional task, such as serial subtraction by 7 out loud
from 500. The example of counting backwards depends on
working memory, which is directly related to executive
functions. It seems that combining an arithmetic task with
walking creates a competitive demand for executive func-
tions, which may result in a decrease of lateral stability in
older persons (Beauchet, Dubost, Gonthier, & Kressig,
2005). Other external influences such as acoustic perturba-
tions also seem to have a greater negative effect on gait
parameters in older versus younger adults. Because of high
prevalence of vision and hearing impairments in older per-
sons, cognitive tasks seem more appropriate than sensory
stimulation (e.g., visual or auditory stimulation) for testing
dual-task-related gait performance; however, spoken cog-
nitive tasks may also interfere with gait performance due
to their articulomotor and rhythmic component (Beauchet,
Dubost, Aminian, Gonthier, & Kressig, 2005).
Nevertheless, reaction times to acoustic signals while
sitting were faster in both older and younger persons than
while walking, and thus indicate a possible attention inter-
ference between walking and reaction task (Lajoie, Teas-
dale, Bard, & Fleury, 1993). It is important to consider
these differences to elicit interference for testing older
adults under dual-task conditions, because the type of
walking-associated task seems to matter. When using du-
al-task paradigms in gait analysis, one has to choose appro-
priate secondary walking-associated tasks to sufficiently
stress the attentional resources and thus to quantify deteri-
oration in either task.
Dual tasking is the most widely used approach to deter-
mine to what extent walking requires attention in an older
subject. A review by Yogev-Seligmann et al. (2008) showed
that a secondary task (e.g., holding a cup filled with water)
negatively influenced gait in healthy older adults who had
intact locomotor and cognitive function; however, as men-
tioned earlier, in older adults even walking alone is often not
an automated behavior and needs some amount of attention.
Consequently, there seems to be a walking-related attentional
component while dual tasking which can be quantified.
Measuring the interference between gait and a simulta-
neously performed additional task can provide such quanti-
tative measures. It is hypothesized that more of the total avail-
able attentional resources are allocated to walking in older
than younger persons in order to compensate for age-related
deficits such as decreased vision or skeletal muscle strength
(Anstey, Lord, & Williams, 1997). Hence, dual task-related
gait changes that occur with an additional task reflect com-
petition for attentional resources and may provide an indica-
tor of change in gait control (Beauchet & Berrut, 2006). In
this context, a study by Chen et al. (1996) demonstrated that
contact time while stepping over a virtual obstacle on a walk-
way was significantly higher in older adults when a second-
ary task was performed at the same time. The authors sug-
gested that attention was divided under the dual-task condi-
tion, which resulted in decreased physical abilities to respond
to environmental hazards. Recently, other studies also re-
vealed that cognitive activity while walking, such as mental
calculation may reduce gait velocity (Beauchet, Dubost, Her-
mann, & Kressig, 2005; Priest et al., 2008). In certain older
adults, the required attentional demands for walking and si-
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multaneously counting backwards may overload available
central resources and explain major dual task-related gait
changes as well as competitive interaction with executive
function (Allali et al., 2007; Beauchet, Dubost, Gonthier et
al., 2005b; Dubost et al., 2006). In summary, dual-task per-
formance may be explained by the concept of limited indi-
vidual attentional resources. Hence, it is evident that conduct-
ing two tasks at the same time will exceed available attention-
al resources limits more so than a single task (Krampe, Rapp,
Bondar, & Baltes, 2003). This concept is important for the
occurrence of falls, because locomotion needs sufficient at-
tentional resources for a safe gait control (Beauchet, Dubost,
Gonthier et al., 2005).
Furthermore, dual tasking-induced gait changes are also
used to explore the cortical involvement in gait control (Al-
lali et al., 2007). There is growing evidence that gait chang-
es are associated with the incidence of dementia and cog-
nitive decline (Beauchet & Berrut, 2006). Recently, Beau-
chet, Dubost, Aminian et al. (2005) reported decreased gait
speed and increased stride time variability when older sub-
jects with a broad range of cognitive function disabilities
(i.e., mild dementia) performed the dual task of walking
while counting backwards. These findings suggest that du-
al-task interference on gait is based on the cerebral capacity
to divide attentional resources between gait and an addi-
tional task (Beauchet, Najafi, Dubost, & Mourey, 2003, see
also Sheridan et al., 2003).
Gait analysis using a dual task seems a valuable mea-
surement tool to assess older adults at risk for falling com-
parable to other established screening methods, e.g., the
Timed Up & Go Test (TUG) (Shumway-Cook, Brauer, &
Woollacott, 2000). Underlying gait disorders due to atten-
tional capacity problems could be detected and used to tai-
lor preventive exercise interventions. New exercise pro-
grams including secondary or multiple tasks have to be im-
plemented to entirely stimulate bodily functions in order to
maintain or improve mobility, functionality and independ-
ence in older adults.
Exercise Interventions to Improve
Gait and Prevent Falls
On an individual basis, regular physical activity is able to
reduce functional limitations and extend years of active in-
dependent life (American College of Sports Medicine
[ACSM], 2004). However, in terms of improving gait, tar-
geted exercise programs to improve strength, walking and
balance have been among the most promising interventions
to reduce fall risk (Gillespie et al., 2009; Rubenstein, 2006;
Sherrington et al., 2009).
Postural control, reflexes, muscle strength, and height of
stepping decline with increasing age (Rubenstein, 2006).
In addition, the presence of a physical handicap prior to a
fall-related accident seems rather common and mainly con-
cerns walking and mobility (Beer et al., 2000). Hence, pri-
mary prevention of falls should focus on improving phys-
ical conditioning through exercise to decrease detrimental
fall incidents. Sufficient exercise capacity and functional
reserve is not only needed to primarily improve fall-related
risk factors (e.g., muscle weakness), but also to quicken
recovery in older adults who are more likely to fall due to
deconditioning (Rubenstein, 2006). In this context, lower
extremity strength gain is particularly important to main-
tain or improve gait performance and should therefore play
a central role in exercise prescription (Chandler, Duncan,
Kochersberger, & Studenski, 1998; Guralnik, Ferrucci, Si-
monsick, Salive, & Wallace, 1995).
Gait and Exercise-Related Determinants of
General Physical Functioning
The age-related loss of skeletal muscle mass is approximately
1–2% per year after the fifth decade (Hughes, Frontera, Rou-
benoff, Evans, & Fiatarone Singh, 2002). This decline in
skeletal muscle mass is associated with reduced muscle
strength, which in turn is responsible for sarcopenia, func-
tional decline, and frailty (Kressig & Proust, 1998). Other
factors are also important determinants of elders’ physical
performance such as neuronal muscle recruitment in terms of
intramuscular coordination, cardiac output, total number of
erythrocytes, and maximal oxygen consumption (VO2 max).
Nevertheless, when muscle strength in older adults is insuf-
ficient to rise from a chair or stand upright safely, it is inap-
propriate to immediately train endurance, balance, or flexi-
bility. The major conditioning component in older persons is
the capacity of skeletal muscle to produce strength, depend-
ing on contractions of actin and myosin filaments within the
skeletal muscle. This process is energetically dependent on
the number of adenosine triphosphate (ATP) producing mi-
tochondria within the muscle cells. Consequently, an exercise
program should primarily intend to increase the number of
mitochondria within skeletal muscle in order to create the
base for further physical functional improvement. In general,
an increase in mitochondria density is achieved, independent
of age, by repeated muscle stimuli through exercises that lead
to muscle hypertrophy and increased muscle strength (Car-
meli, Coleman, & Reznick, 2002). Adequate nutritional sta-
tus is a prerequisite for eliciting such muscular adaptations,
particularly because energy expenditure at rest and during
exercise is reduced in older persons (Hunter, McCarthy, &
Bamman, 2004).
Progressive Resistance Training
Progressive resistance training (PRT) is among the most
popular exercises involved in anabolic growth of skeletal
muscle and therefore suitable to counteract muscular weak-
ness in older people. PRT, which may be defined as the act
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of moving forward or advancing toward a specific goal
over time until the target goal has been achieved (ACSM,
2009), improves walking performance such as gait speed,
climbing steps, or standing up from a chair more quickly.
However, although these improvements are significant, the
impact on physical ability and falls seems only small (Liu
& Latham, 2009), and inappropriate training prescriptions
may even result in nonsignificant or possibly adverse out-
comes (Latham et al., 2003; Latham, Bennett, Stretton, &
Anderson, 2004). Several trials have demonstrated that
PRT, particularly in combination with nutritional supple-
mentation, improves muscle strength in healthy and frail
older people (Wieser & Haber, 2007). In a study by Fiata-
rone et al. (1994) high-resistance exercise training in-
creased muscle strength of very old people (87.1 ± 0.6
years) by 113% (± 8%) in the exercise group. Even greater
results were obtained by the group that, in addition to ex-
ercise, received a nutritional supplement containing carbo-
hydrates, protein, and fats. Their muscle strength signifi-
cantly increased to 150% above the baseline measure indi-
cating the importance of nutrition in eliciting maximal
strength gains due to exercise. Recently, studies reported
positive associations between decreased levels of vitamin
D and decreased muscle function (Annweiler, Bridenbaugh
et al., 2009) as well as quadriceps weakness (Annweiler,
Schott-Petelaz et al., 2009). Consequently, for optimal ex-
ercise performance and muscular adaptations in responses
to PRT nutrition always has to be taken into consideration.
Power Training
In recent years, another form of resistance training has been
implemented that may prove to be more beneficial in in-
creasing physical performance than ordinary strength train-
ing (Hazell, Kenno, & Jakobi, 2007; Porter, 2006). High-
velocity power training has shown similar increases of
strength compared to traditional slow-velocity strength
training in older adults (Reid, Callahan, Carabello, Phillips,
Frontera, & Fielding, 2008). Muscle power (force × veloc-
ity) decreases faster than “raw” muscle strength in older
adults and therefore may also be an additional, early pre-
dictor for fall risk, gait-related balance disorder, and func-
tional decline (de Vos et al., 2005, 2008). In fact, successful
recovery after losing balance while walking is dependent
on quick corrective limb movements and therefore muscu-
lar power. In this context, Orr et al. (2006) were able to
show that power training using a low load and high-veloc-
ity regimen significantly improved balance in community-
dwelling healthy older adults.
Although there is some indication that PRT can increase
functional outcomes such as gait velocity (Lord et al.,
1996), further research will still have to confirm whether
sole strength or power gains are equivalent to clinical im-
provements in functionality. In this context, research tools
such as the physical functional performance (PFP) test or
the short physical performance battery (SPPB) may be
helpful for transferring muscular changes into a more prac-
tical daily measure (Cress et al., 1996; Guralnik et al.,
2000). While the SPPB focuses on lower extremity func-
tion (standing balance, walking speed, and ability to rise
from a chair), the PFP-10 test consists of ten daily activities
including upper and lower extremity function (i.e., carrying
groceries, floor sweeping, or putting on a jacket). Both tests
are designed to quantify measures of functionality in older
adults by a score (Cress, Petrella, Moore, & Schenkman,
2005). The achieved scores allow quantitative descriptions
of functional limitations in older persons. Functional limi-
tations assessed by the PFP are based on measures of peak
oxygen consumption and isokinetic knee extensor torque,
which are associated with predicting dependency in living
status (Cress & Meyer, 2003). On the other hand, the SPPB
performance measures show a gradient of risk among a
population allowing identification of subgroups at very low
and high risk of disability (Guralnik et al., 1995). As a con-
sequence, strength gains could be assessed in a clinical con-
text and assessed as functional improvements.
Multidimensional Exercise Programs
Although strength training alone can provide benefits to
seniors, a multidimensional activity program tailored to the
individual that includes endurance, strength, balance, and
flexibility is considered to be optimal for older adults
(ACSM, 2004). An early study by Shumway-Cook, Gru-
ber, Baldwin, and Liao (1997) showed that a multifaceted
exercise program addressing impairments and functional
disabilities improves gait, balance, and mobility in commu-
nity-dwelling older adults with a history of falls. Another
study by Delbaere et al. (2006) suggested that a home-
based, individualized, multidimensional exercise program
reduces several physical factors associated with falls in
community-dwelling older people with moderate physical
impairment. In addition, a recent review by Baker, Atlantis,
and Fiatarone Singh (2007) highlights the efficiency of a
multidimensional approach and emphasizes the positive ef-
fect on falls prevention in older persons. In this context,
supervised home-exercise programs and group exercises
both seem beneficial in falls prevention in older communi-
ty dwellers (Sherrington, Lord, & Finch, 2004), yet chang-
es may be small and short-lived (van der Bij, Laurant, &
Wensing, 2002). In addition, intensive rather than low-in-
tensity multidimensional exercise programs seem capable
of improving physical performance in sedentary older
adults (Binder et al., 2002), whereas the former type of
exercise has been associated with greater negative effects
like injury and nonadherence (Latham et al., 2003).
Tai Chi, with its slow, low-impact movements requiring
multidirectional weight shifting, single and double support,
and awareness of alignment, proved to be another type of
exercise to challenge functional limitations related to falls
in older adults (i.e., impaired gait, poor balance, and mus-
cular weakness) (Harmer & Li, 2008). A landmark paper
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by Wolf et al. (2003) showed that a moderate Tai Chi in-
tervention improved fear of falling and reduced fall risk by
47.5% in older adults. In addition, Tai Chi also seems to
improve postural stability, which is an important attribute
of safe gait (Kressig, Beauchet, & Tharicharu, 2003).
Hence, Tai Chi has the potential to reduce falls or fall risk
among older persons (Low, Ang, Goh, & Chew, 2009).
Nevertheless, the number of randomized controlled Tai Chi
trials is low and further research is needed to warrant the
preventive effect of this particular type of exercise.
New Gait-Related Exercise Approaches to
Reduce Falls
The findings in relation to dual-task-related gait problems
may offer a promising approach for future exercise inter-
ventions. Based on the correlation between cognitive func-
tion and gait stability (Scherder et al., 2007; Sheridan &
Hausdorff, 2007), combining cognitive and motor exercis-
es might add additional functional improvements com-
pared to exclusive strength training. In particular, com-
bined cognitive and motor training may be particularly
promising because of the omnipresence of multitask situa-
tions in daily life and their relevance to falls. There are
different approaches to improve dual-task performance. In-
terventions can focus on one or both of the tasks conducted.
In terms of gait, dual-task interventions may either target
to improve automaticity of gait or to improve the secondary
task or even a combination of both. On the one hand, it
seems plausible to focus on automating gait because of its
direct relation to falls before trying to improve a secondary
cognitive task. On the other hand, a holistic approach in-
cluding training of both tasks (e.g., gait and cognition) at
the same time may be also favorable because of its inclu-
sion of all physiological and psychological dual-task vari-
ables comparable to real life situations.
Recently, interventions using functional, physiological,
and psychological components received more attention on
the basis of the dual-task paradigm. Exemplarily, approach-
es with rhythmical exercises seem promising to reduce fall
risk. The eurhythmics method of Jaques-Dalcroze, origi-
nally created for the musical education of children and in-
creasingly used with seniors, comprises multitask exercises
performed to the rhythm of improvised piano music (Win-
kelmann, Gianadda, Beauchet, & Kressig, 2005). In a study
by Kressig, Allali, and Beauchet (2005), older women who
had practiced Jaques-Dalcroze eurhythmics for over 40
years showed gait regularity under dual-task conditions
similar to that of younger adults. It was assumed that the
high expertise in the use of attentional skills required to
multitask while walking to changing rhythmic patterns may
have resulted in highly automated gait patterns, minimizing
the effect of dual tasking on gait regularity in the studied
older Dalcroze practitioners. As a consequence, a Jaques-
Dalcroze intervention may stimulate motor brain areas and
facilitate movements through a combination of music,
rhythm, and exercise in older adults (Allali et al., 2004).
Higher-dosed exercise programs that contain two or more
components of strength, balance, flexibility, or endurance can
reduce the number of people falling (Gillespie et al., 2009;
Sherrington et al., 2008). Exercising in supervised groups,
participating in Tai Chi, and carrying out individually pre-
scribed exercise programs at home are all effective for pre-
venting falls, though comparison between various studies can
be difficult. Overall, a wide range of exercise programs is
applied to improve gait parameters and prevent falls. In ad-
dition, baseline levels, power and outcome measures as well
as intervention time frames differ largely between trials (Lord
et al., 2007). Thus, especially in terms of fall risk reduction,
the most efficient type of exercise or a combination thereof
still remains unclear. Nonetheless, for all types of exercise
intervention it remains a challenge to ensure safety and long-
term adherence. In addition, it is suggested that physical ac-
tivity interventions include established principles of behav-
ioral changes to maximize recruitment, motivation and pro-
gression (ACSM, 2004).
Discussion and Conclusion
Aging is associated with several changes in gait, including
diminished gait automaticity, which increases the likeli-
hood of falling. Spatio-temporal gait analysis under dual-
task conditions offers insight into decreased gait automa-
ticity and thus the allocation of attentional resources by
quantifying gait changes during simultaneous performance
of a secondary task. Analysis of gait parameters, such as
stride-to-stride variability, may provide a sensitive marker
of gait disturbances associated with future falling. Howev-
er, the extent to which postural responses and gait make
demands on attentional resources still has to be defined. It
also remains unclear how individual gait parameters can be
optimally and clinically significantly improved, and how
they are related to the movement of other body segments
(e.g., trunk and head).
In a demographically aging population, progressive re-
sistance training and exercises including cerebral motor
control (Jaques-Dalcroze or Tai Chi) are important to main-
tain a stable gait or improve disordered gait. In fall preven-
tion, exercises should be combined with a balanced diet,
sufficient protein (Koopman & van Loon, 2009), and vita-
min D intake (Annweiler, Allali et al., 2009; Bischoff-Fer-
rari et al., 2009) to maximize physiological adaptations. In
terms of exercise prescription, not only sociocultural and
economic factors, but also the enjoyment, socializing, and
attractiveness of the exercise programs are important. In
addition, family support and integration of the general
practitioner are key determinants of a long-term exercise
adherence.
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Conclusion
This review shows that gait disorders and falls are closely
related in the older population. Various types of exercise
programs are able to improve a range of fall risk factors
and consequently reduce fall risk. The basis of functional
exercise (e.g., dual or multiple tasks) for older adults in-
volves development of skeletal muscle strength. In partic-
ular, interventions aiming at improving gait (e.g., by mus-
cle power training or practice of Jaques-Dalcroze eurhyth-
mics) seem promising. However, the inclusion of new
models such as the gait-related dual-task paradigm may
even further improve the impact of exercise interventions
on falls. Future research is needed to assess the effect and
efficacy of such programs to increase gait stability and au-
tomaticity and thus reduce falls.
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Gangveränderungen und
Sturzrisiko
Gait Changes and Fall Risk
Zusammenfassung
Gehen ist eine komplexe motorische
Aufgabe, die bei vielen älteren Men-
schen nicht mehr automatisch funk-
tioniert. Die Folge können Stürze mit
und ohne schwerwiegenden Konse-
quenzen wie Frakturen oder Sturz-
angst sein. Ganganalysen zeigen, dass
schon kleine Schritt-zu-Schritt-Ver-
änderungen das Sturzrisiko deutlich er-
höhen. Diese Gangveränderungen sind
oftmals beim normalen Gehen nicht
zu erkennen, sondern äussern sich erst
in Kombination mit einer zusätzlichen
Aufgabe, dem sogenannten Dual-
Tasking. Ein unregelmässiger Gang ist
jedoch keine Fatalität des Alters, son-
dern kann durch gezielte Interventio-
nen wieder verbessert werden.
Schlüsselwörter: Sturzrisiko – Gang-
variabilität – Dual-Task – ältere
Menschen
Einleitung
Im Alter wird dem Sturz eine ganz
andere Bedeutung zugeschrieben als in
jungen Jahren. In der Altersgruppe der
über 65-Jährigen zählen Stürze zu den
häufigsten gesundheitlichen Problemen
mit ernsthaften Folgen. Epidemiologi-
sche Daten zeigen, dass etwa 30% der
über 65-Jährigen im Laufe eines Jahres
stürzen, bei hochaltrigen Personen ist es
sogar jeder Zweite [1]. Das Problem der
Stürze ist nicht nur in der hohen Inzi-
denz verankert, sondern vielmehr in der
Kombination mit der Verletzungsanfäl-
ligkeit älterer Menschen, beispielsweise
aufgrund chronischer Erkrankungen
wie Osteoporose [2]. Etwa 10–15% der
älteren Menschen erleiden schwere Ver-
letzungen aufgrund eines Sturzes, die zu
dauerhaften Gehproblemen, Verlust der
Selbständigkeit oder gar zum Tod führen
können [3]. Auch wenn nicht jeder Sturz
zwangsläufig gravierende Verletzungen
nach sich zieht, kann die Angst vor er-
neuten Stürzen zu selbst auferlegten
Einschränkungen körperlicher Aktivität
führen [4,5], was wiederum das Risiko
für zukünftige Stürze erhöhen kann.
Die Forschung hat sich in den letzten
Jahren intensiv mit der Bestimmung
verlässlicher Sturzrisikofaktoren befasst
(Tab. 1). Unter den vielen sturzverursa-
chenden Faktoren im Alter sind insbe-
sondere die muskuläre Schwäche sowie
Gang- und Gleichgewichtsprobleme zu
nennen [2]. Unter anderem bedingt
durch diese Risikofaktoren stellt sicheres
Gehen und Stehen für ältere Menschen
eine zunehmende Herausforderung dar.
Daher erstaunt es nicht, dass sich die
meisten Sturzunfälle von über 65-Jähri-
gen während dem Gehen [6] oder bei der
zeitgleichen Ausführung anderer Tätig-
keiten ereignen [7].Von grossem Interes-
se ist dabei die frühzeitige Erkennung
von Risikofaktoren und damit sturz-
gefährdeter Personen, um rechtzeitig
Massnahmen einzuleiten, die im besten
Fall das Auftreten von Stürzen zu ver-
hindern vermögen. Der folgende Bericht
soll aufzeigen, wie anhand spezifischer
sturz-assoziierter Gangveränderungen
ein erhöhtes Sturzrisiko erkannt und die
Gangsicherheit durch geeignete Mass-
nahmen wieder verbessert werden kann.
Normales Gehen bei älteren
Menschen
Das Gangbild älterer Menschen kann
durch alters-assoziierte Veränderungen
beeinträchtigt werden. Beispielsweise
nehmen im Alter wichtige Körperfunk-
Intrinsische Faktoren Extrinsische Faktoren
• Muskelschwäche • Umgebungsgefahren wie Bodenbeschaffenheit,
• Gang- und Gleichgewichtsstörungen schlechte Lichtverhältnisse usw.
• Seh- und Hörstörungen • Ungeeignetes Schuhwerk
• Kognitive Störungen • Ungeeignete Gehhilfe
• Synkopen • Ungeeignete Sehhilfe
• Inkontinenz • Medikamente, v.a. Psychopharmaka,
• Frühere Stürze Antiarrhythmika, Diuretika
Intrinsische Faktoren betreffen den Gesundheitszustand einer Person,
extrinsische Faktoren die Einflüsse aus Umwelt und Umgebung.
Tab. 1: Risikofaktoren für einen Sturz.
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tionen wie Muskelkraft, Koordination,
Gleichgewichtsreaktion und Sinneswahr-
nehmungen ab [8], wodurch sich das
Gangbild ändern kann. Andererseits
führen Krankheiten, die mit zunehmen-
dem Alter häufiger auftreten, wie z.B.
Arthritis oder Parkinson-Erkrankung, zu
Gangveränderungen. Bleiben die krank-
haften Veränderungen unberücksichtigt,
ist das normale Gangbild gesunder älte-
rer Menschen im Vergleich zu jüngeren
durch eine reduzierte Gehgeschwindig-
keit, eine verkürzte Gangzykluslänge
und eine Zunahme der Doppelstand-
phase gekennzeichnet (Tab. 2) [9]. Ein
Gangparameter, der bis ins hohe Alter
unverändert bleibt, ist die Kadenz [9].
Gerade die Gehgeschwindigkeit ist eine
massgebliche Grösse zur Bestimmung
der Gehfähigkeit einer Person, die mit
einfachen Mitteln gemessen werden
kann. Eine reduzierte Gehgeschwindig-
keit ist ein Vorbote für die Einschrän-
kung bei Alltagsaktivitäten. Auch kann
die Teilnahme als Fussgänger am öffent-
lichen Verkehr in der Schweiz zu einem
Problem werden, wenn die Gehge-
schwindigkeit weniger als 120 cm/sek
beträgt. Folglich ist nicht mehr ge-
währleistet, die Strasse innerhalb einer
Grünphase überqueren zu können. Die
Abnahme der Gehgeschwindigkeit nach
dem 63. Lebensjahr beträgt etwa 12–
16% pro Dekade und verstärkt sich nach
dem 75. Lebensjahr [10]. Liegt die
Gehgeschwindigkeit unter 100 cm/sek,
kann davon ausgegangen werden, dass
gesundheitliche Probleme vorliegen [11].
Abklärung der Sturz-
gefährdung
Mobilitätsassessments in der Praxis
Gangprobleme beeinträchtigen bis zu
40% der älteren Menschen über 65 Jah-
re, wovon die Hälfte der Probleme
schwerwiegend sind [2].Oftmals werden
Gangprobleme erst wahrgenommen,
wenn ein Sturz Verletzungen zur Folge
hat. In der Praxis ist es daher wichtig,
Patienten mit Gangproblemen frühzeitig
zu erkennen, bevor es zu einem Sturz
kommt. Zunächst ist ein Screening der
Risikofaktoren zur Feststellung eines
generellen Sturzrisikos indiziert. Dazu
zählen unter anderem die Befragung
zur Sturzanamnese und Sturzangst, der
Ausschluss akuter medizinischer Stö-
rungen sowie die Überprüfung von
Medikamenten.
Für die Untersuchung der Funktionalität
und Mobilität älterer Menschen bietet
sich dem Allgemeinpraktiker eine Fülle
von validierten, standardisierten Scree-
ning-Tests an. Diese erfassen jeweils
unterschiedliche Aspekte der Mobilität,
wie beispielsweise Gleichgewicht oder
Beinmuskelkraft. Weil zurzeit kein um-
fassender Screening-Test vorhanden ist,
der in Kürze die Notwendigkeit für eine
weiterführende Sturzrisikoabklärung in
der Klinik eruiert, ist die Kombination
einzelner Tests ratsam. Ein Nachteil
solcher Tests ist oftmals, dass sich erst bei
gebrechlicheren älteren Menschen auf-
fällige Resultate ergeben.
Zwei Möglichkeiten, die sich in der
Praxis anbieten, um einen Mobilitäts-
abbau bei älteren Menschen rechtzeitig
zu erkennen, sind der Timed Up and Go
Test [12] und der Geh- und Sprechtest
[13]. Der Timed Up and Go Test ist ein
schneller, einfacher und globaler Mobi-
litätstest. Dieser misst die Zeit, die be-
nötigt wird, um von einem Stuhl aufzu-
stehen, drei Meter in selbstgewähltem
normalem Tempo hin und zurück zu
gehen und sich wieder hinzusetzen. Liegt
die dafür benötigte Zeit über 14 Sekun-
den, ist von einer Mobilitätseinschrän-
kung auszugehen. Der Geh- und Sprech-
test beruht auf der Beobachtung, dass
sturzgefährdete Personen stehenbleiben,
wenn sie gleichzeitig eine einfache Frage
beantworten sollen. Ergibt sich in einem
dieser Tests ein auffälliger Befund, ist
eine Zuweisung in eine Klinik für eine
detaillierte Ganganalyse in Erwägung zu
ziehen.
Ganganalyse in der Klinik
Erhärtet sich bei einem allgemeinen
Mobilitätstest der Verdacht einer vorlie-
genden Gehproblematik, kann mittels
einer spezifischen Ganganalyse das Aus-
mass des Sturzrisikos genauer bestimmt
werden. Verschiedene Ganganalyse-Sys-
teme wie beispielsweise elektronische
Schuheinlagen, reflektierende Marker an
den Füssen oder unteren Extremitäten,
Kraftmessplatten oder ein elektronischer
Teppich mit integrierten Druckrezep-
toren (Abb. 1), ermöglichen heute die
einfache, schnelle und objektive Beur-
teilung des menschlichen Gangbildes.
Diese Systeme erlauben sowohl dieQuan-
tifizierung räumlich-zeitlicher Gang-
parameter als auch kinetischer und
kinematischer Gangdaten unter stan-
dardisierten Bedingungen. Der Nutzen
des jeweiligen Systems hängt von der
klinischen Fragestellung ab. Gangana-
Gangparameter Einheit Definition
Gehgeschwindigkeit cm/sek Distanz dividiert durch die Gehzeit
Kadenz Schritte/min Anzahl Schritte pro Minute
Spurbreite cm Distanz zwischen dem Fersenzentrum des einen Fuss-
abdrucks zur Fortbewegungslinie des anderen Fusses
Gangzykluslänge cm Distanz zwischen zwei aufeinander folgenden initialen
Bodenkontakten desselben Fusses
Gangzyklusdauer sek Zeit zwischen zwei aufeinander folgenden initialen
Bodenkontakten desselben Fusses
Doppelstandphase sek Summe der Zeit von zwei Perioden im Gangzyklus,
in der beide Füsse gleichzeitig im Kontakt mit dem
Boden sind.
Tab. 2:Definition räumlich-zeitlicher Gangparameter.
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lysen ermöglichen zudem die Über-
prüfung von Behandlungen und tragen
im Rahmen wissenschaftlicher Unter-
suchungen zum Verständnis von Gang-
störungen bei.
Gangvariabilität als Sturz-
prädiktor
Während einige Gangparameter sich mit
dem Älterwerden ändern können (z.B.
die Gehgeschwindigkeit), bleibt die
Gangregelmässigkeit bei gesunden älte-
ren Menschen weitgehend unverändert.
Das heisst, dass die Abweichungen von
einem Schritt zum nächsten relativ klein
sind und die sogenannte Gangvariabi-
lität von vielen Gangparametern (z.B.
der Gangzykluslänge) in der Grössen-
ordnung von wenigen Prozenten liegt
(Abb. 2). In anderen Worten ausge-
drückt, je unregelmässiger der Gang,
desto höher die Gangvariabilität. Ver-
schiedene Studien ermittelten Verän-
derungen in bestimmten räumlichen
und zeitlichen Gangparametern als un-
abhängige Prädiktoren für zukünftige
Stürze. Maki [14] beobachtete, dass eine
Variation der Schrittlänge von 1.7 cm
von einem Schritt zum nächsten, das
Sturzrisiko für ältere Menschen in den
nächsten sechs Monaten verdoppelt.
Eine hohe Variabilität der Gangzyklus-
dauer wurde ebenfalls als potenter Sturz-
prädiktor für ein Beobachtungsintervall
von zwölf Monaten ermittelt [15]. Die
Autoren berichteten auch, dass die quan-
titative Bestimmung der Gangvariabi-
lität möglicherweise ein sensitiverer
Marker zur Eruierung des Sturzrisikos
darstellt als ein konventioneller Gang-
parameter wie die Gehgeschwindigkeit
oder die Kadenz. Diese Annahme wurde
in den letzten Jahrenwiederholt bestätigt
[16,17]. Da diesbezüglich eine Gang-
beurteilung von blossem Auge vielfach
unzureichend ist, ist die Quantifizierung
des Gangbildes mittels instrumentierter
Ganganalyse unabdingbar.
Gangveränderungen unter
Dual-Task
Obschon Gehen eine einfache Aufgabe
zu sein scheint, ist es in Wahrheit eine
komplexe motorische Aufgabe, die Jahre
benötigt, um sie zu lernen und zu festi-
gen [8]. Bedingt durch Faktoren wie
körperliche Inaktivität, Sehstörungen,
Sensibilitätsstörungen oder Sturzangst
müssen ältere Menschen mehr Auf-
merksamkeitsressourcen investieren, um
selbst eine weitgehend automatisierte
Aufgabe wie das Gehen durchzuführen
[18,19]. Oftmals sind Gangveränderun-
gen beim normalen Gehen nicht erkenn-
bar, sondern äussern sich erst in Kombi-
nation mit einer zusätzlichen Aufgabe,
wie z.B.Gehenund gleichzeitig Sprechen.
Sogenannte Dual-Task-Paradigmen (Ge-
hen während der gleichzeitigen Ausfüh-
rung einer entweder motorischen oder
kognitiven Aufgabe) finden heute eine
breite Anwendung bei der Untersuchung
des Gangbildes ältererMenschen. Ist nun
die Aufmerksamkeit für das Gehen und
eine zeitgleiche Tätigkeit gefordert, kön-
nen Interferenzen zwischen diesen kon-
kurrierenden und auf gleiche Hirnareale
zurückgreifendenAufgaben auftreten, so
dass die Ausführung in einer oder beiden
Aufgaben beeinträchtigt ist [20]. Dieser
Wettbewerb zwischen den Anforderun-
gen der Aufmerksamkeit während dem
Gehen und der konkurrierenden zweiten
Tätigkeit kann zu einer Veränderung des
Gang-bildes führen [21].
Typische Gangveränderungen, wie eine
reduzierte Gehgeschwindigkeit oder
eine zunehmende Gangvariabilität unter
Dual-Task, werden mit einem erhöhten
Sturzrisiko in Verbindung gebracht.
Hierzu zeigte Lundin et al. [13] mit
Hilfe eines einfachen Dual-Task-Para-
digmas erstmals, dass ältere Personen,
die nicht gleichzeitig Gehen und eine
einfache Frage beantworten konnten
(«stops walking when talking»), ein er-
höhtes Risiko für Stürze in den kom-
menden sechs Monaten aufweisen. Ein
erst kürzlich erschienener Übersichts-
artikel von Beauchet et al. [22] bestätigt,
Abb. 2:Die Gangvariabilität widerspiegelt die Veränderungen von einem Gangzyklus
zum nächsten. Beispiel: Schritt-zu-Schritt-Veränderung der Gangzykluslänge links.
Abb. 1:Ganganalyse mittels elektronischem Gangteppich (GAITRite® System) im Basel
Mobility Center.
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dass ein signifikant erhöhtes Sturzrisiko
besteht, wenn ältere Menschen Verände-
rungen im Gang oder in der kognitiven
Aufgabe unter Dual-Task aufweisen.
Speziell die Gangvariabilität hat sich
auch unter Dual-Task-Bedingungen als
sensitiver Marker für die Gangsicher-
heit etabliert, wobei beispielsweise ein
Anstieg des Variationskoeffizienten der
Gangzyklusdauer mit einer Abnahme
der Gangstabilität und einem Anstieg
des Sturzrisikos einhergeht [17].
Im Alltag werden oftmals Aktivitäten
durchgeführt, die den zeitgleichen Voll-
zug mehrerer Aufgaben erfordern.
Dual-Task-bezogene Gangveränderun-
gen geben einen Anhaltspunkt, um fest-
zustellen, inwieweit die gleichzeitige
Durchführung von zwei Aufgaben die
zur Verfügung stehenden Aufmerk-
samkeitsressourcen übersteigt. Darüber
hinaus ist das Konzept des Dual-Tasking
für das Auftreten von Stürzen im fort-
geschrittenen Alter von wesentlicher
Bedeutung, da die Fortbewegung ge-
nügend Aufmerksamkeitsressourcen für
die sichere Gangkontrolle benötigt. Eine
Ganganalyse ermöglicht die frühzeitige
Erkennung von Gangveränderungen
und erlaubt eine gezielteVorgehensweise
bei der Planung von geeigneten thera-
peutischen Massnahmen.
Was kann ich tun – gezielte
Interventionen
ÄltereMenschen, die über Gangunsicher-
heit und Stürze berichten, sehen dies
oftmals als Fatalität des Alters an. Stürze,
bedingt durchVeränderungen der Gang-
regelmässigkeit, müssen nicht sein,
sondern können durch gezielte präven-
tive Interventionen positiv beeinflusst
werden.
Grundsätzlich sind alle Interventionen
empfehlenswert, die auf eine verbesserte
Körperkontrolle und eine Reautomati-
sierung der Gehbewegung abzielen.
Gehhilfen können dazu beitragen, die
Gehfähigkeit zu verbessern und das
Sturzpotential zu vermindern. Da die
weise Trainingsformen, die mehr Auf-
merksamkeitsressourcen mobilisieren,
für die Verbesserung der Gehfähigkeit
wirksamer sind.
Ein erfolgversprechendes Trainingspro-
gramm ist die Jaques-Dalcroze-Rhyth-
mik (Abb. 3). Dabei handelt es sich um
motorische und kognitive Übungen
zum Rhythmus improvisierter Klavier-
musik. Ältere Menschen, die zeitlebens
Jaques-Dalcroze-Rhythmik praktizier-
ten, zeigten im Gegensatz zur Kontroll-
gruppe (keine regelmässige körperliche
Aktivität) auch unter Dual-Task eine
gute Gangvariabilität [26]. Eine kürz-
lich erschienene Studie untersuchte den
Einfluss dieses Trainingprogramms auf
das Gangbild bei zu Hause lebenden
älteren Menschen ohne vorhergehende
Erfahrung mit Jaques-Dalcroze-Rhyth-
mik. Die Resultate zeigten, dass eine
sechsmonatige Rhythmik-Intervention
nach Jaques-Dalcroze die Gangvariabi-
lität unter Dual-Task verbesserte und
die Sturzrate um 54% reduzierte [27].
Die beobachteten Verbesserungen führen
vermutlich zu einer Reduktion der Inter-
ferenzanfälligkeit, wodurch die freige-
wordenen Aufmerksamkeitsressourcen
nunmehr für die Gangkontrolle genutzt
werden können.
Indikation für eine Gehhilfe oftmals
aufgrund verminderter Muskelkraft und/
oder Kontrolle in den Beinen, Gang-
instabilität oder verminderte Proprio-
zeption der Füsse gegeben ist [3], dient
die Verwendung einer Gehhilfe lediglich
als Kompensation der zugrundeliegenden
Probleme. Daher sollten andere Strate-
gien wie z.B. Bewegungsprogramme für
die Verbesserung der Gangstabilität in
Betracht gezogen werden.
Im Rahmen der Sturzprävention erwie-
sen sich multimodale Bewegungspro-
gramme, die Kraft-, Gleichgewichts-,
Gang- und Koordinationstraining kom-
binierten, als am wirksamsten [23]. Ob
das Training eines einzelnen Konditions-
faktors, beispielsweise das muskuläre
Krafttraining, ein Sturzereignis zu ver-
hindern vermag, wird in der Literatur
kontrovers diskutiert. Krafttraining
wirkt sich primär auf die Muskel-
morphologie aus, nicht aber auf sturz-
verursachende Risikofaktoren wie
Gang- oder Gleichgewichtsprobleme
[24]. Hinsichtlich der Bewältigung des
Alltags wirkt sich ein Gleichgewichts-
training mit kognitiven oder motori-
schen Zusatzaufgaben positiv auf das
Gangbild älterer Menschen aus [25].
Dies lässt vermuten, dass möglicher-
Abb. 3: Jaques-Dalcroze-Rhythmik in einem Atelier.
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Eine weitere Trainingsform, die die
Sturzrate positiv zu beeinflussen vermag,
ist Tai Chi. Die langsamen, fliessenden
und präzisen Bewegungen beanspruchen
Konzentration und fördern das Gleich-
gewicht. Wissenschaftliche Erkenntnisse
zeigen, dass eine regelmässige Teilnahme
an Tai Chi die Sturzrate um beinahe
die Hälfte reduzieren, die Sturzangst
vermindern und das Selbstvertrauen
fördern kann [28]. Inwieweit Tai Chi
die Gangregelmässigkeit beeinflusst, ist
Gegenstand laufender Forschungen.
Die besten therapeutischen Massnahmen
nützen jedoch nichts, wenn sie von den
betroffenen Personen nicht befolgt wer-
den. Neben der Freude an der Aktivität
selbst spielen soziale Aspekte, wie die
Gelegenheit neue Kontakte zu knüpfen,
ebenso eine wichtige Rolle. Jaques-
Dalcroze-Rhythmik und Tai Chi erwie-
sen sich in dieser Hinsicht als geeignete
Trainingsformen für ältere Menschen.
Nach Studienabschluss fuhren rund
56 resp. 35% der Teilnehmer mit der
Jaques-Dalcroze-Rhythmik resp. dem
Tai Chi-Training fort [27,28].
Wenn das Gehen bei älteren Menschen
nicht mehr automatisch funktioniert,
können Gangprobleme und sogar Stürze
auftreten. Das frühzeitige Erkennen von
Gangveränderungen erlaubt die recht-
zeitige Planung sturzpräventiver Mass-
nahmen. Interventionen, die auf die
Reautomatisierung der Gehbewegung
und die Verbesserung der Koordination
motorisch-kognitiver Aufgaben abzie-
len, sind zur Reduktion der Sturzrate
bzw. des Sturzrisikos am geeignetsten.
Für ältere Menschen ist das Erhalten
bzw.Wiedererlangen eines regelmässigen
Ganges und damit der Gangsicherheit
massgebend für ein autonomes Leben
zuhause.
Abstract
Walking is a complex motor task gene-
rally performed automatically by older
adults. Falls with or without serious
consequences such as fractures or fear
of falling can be the result. Gait analy-
sis shows that even minor stride-to-
stride variations increase the risk for
falls. These gait changes are often too
small to be detected during normal
walking alone, but rather appear in
combination with an additional task,
the so-called dual tasking. Irregular
gait is not an inevitability of older age,
but can be improved by targeted inter-
ventions.
Key words: fall risk – gait variability –
dual-task – older people
Key messages
● Sicheres Gehen ist Voraussetzung für die funktionelle Unabhängigkeit, Selb-
ständigkeit und gute Lebensqualität im Alltag.
● Stürze kommen mit steigendem Alter häufiger vor und können gravierende
Folgen haben.
● Bestimmte Gangparameter, wie die Gangvariabilität, erweisen sich als aus-
sagekräftige Sturzprädiktoren. Eine einfache räumlich-zeitliche Ganganalyse
kann diese Parameter quantifizieren und dadurch ein Sturzrisiko frühzeitig
erkennen.
● Normales Gehen allein ist oftmals unzureichend, um diskrete Gangstörungen
zu erkennen. Dabei können Ganganalysen unter Dual-Task-Bedingungen
(Gehen und gleichzeitig eine zusätzliche Aufgabe lösen) helfen, sturzgefähr-
dete ältere Menschen zu identifizieren.
● Regelmässige Teilnahme an Jaques-Dalcroze-Rhythmik kann die Gangregel-
mässigkeit verbessern und das Sturzrisiko senken.
Lernfragen
1. Welches ist kein intrinsischer Risikofaktor für Stürze?
(Einfachauswahl, 1 richtige Antwort)
a) Muskelschwäche
b) Gangdefizite
c) Sturzangst
d) Osteoporose
e) Sehbeeinträchtigung
2. Was sind die Indikationen für eine räumlich-zeitliche Ganganalyse?
(Mehrfachauswahl, mehrere richtige Antworten)
a) Früherkennung des Sturzrisikos
b) Zur Überprüfung von therapeutischen Massnahmen
c) Laufstilanalyse
d) Gangunsicherheit
e) Schuhberatung
3. Welcher Gangparameter erweist sich als sensitiver Marker zur Einschätzung
des Sturzrisikos? (Einfachauswahl, 1 richtige Antwort)
a) Schrittlänge
b) Spurbreite
c) Gangzyklusdauervariabilität
d) Gehgeschwindigkeit
e) Kadenz
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Résumé
Marcher est une tâche motrice com-
plexe qui ne fonctionne souvent
plus automatiquement chez beaucoup
de personnes âgées. Des chutes, avec
ou sans conséquences graves telles que
des fractures ou une peur de tomber,
peuvent en être le résultat. L’analyse de
la marche montre que déjà de petites
modifications de durée ou de longueur
d’un pas à l’autre augmentent claire-
ment le risque de chute. Ces modifi-
cations de marche ne sont souvent pas
reconnues lors de la marche seule,
mais se manifestent plutôt en combi-
naison avec une tâche supplémentaire
(double-tâche). La marche irrégulière
n’est toutefois pas une fatalité liée à
l’âge, mais peut être améliorée par des
interventions spécifiques.
Mots-clés: risque de chute – variabili-
té de la marche – double tâche – per-
sonnes âgées
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trol was observed in the INT group as compared to the CON 
group. Significant group  ! test interactions were found for 
stride velocity, length and time. Post hoc analyses revealed 
significant increases in stride velocity and length, and con-
comitant decreases in stride time. However, salsa dancing 
did not have significant effects on various measures of gait 
variability and leg extensor power.  Conclusion: Salsa proved 
to be a safe and feasible exercise programme for older adults 
accompanied with a high adherence rate. Age-related defi-
cits in measures of static and particularly dynamic postural 
control can be mitigated by salsa dancing in older adults. 
High physical activity and fitness/mobility levels of our par-
ticipants could be responsible for the nonsignificant find-
ings in gait variability and leg extensor power. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Continuously greying societies in Western industrial-
ized countries demand intense research efforts in the field 
of neuromuscular ageing. Specific consequences of neu-
romuscular ageing are tremendous decreases in different 
 Key Words 
 Elderly   Postural sway   Gait   Force production 
 Abstract 
 Background: Deficits in static and particularly dynamic pos-
tural control and force production have frequently been as-
sociated with an increased risk of falling in older adults.  Ob-
jective: The objectives of this study were to investigate the 
effects of salsa dancing on measures of static/dynamic pos-
tural control and leg extensor power in seniors.  Methods: 
Twenty-eight healthy older adults were randomly assigned 
to an intervention group (INT, n = 14, age 71.6  8 5.3 years) 
to conduct an 8-week progressive salsa dancing programme 
or a control group (CON, n = 14, age 68.9  8 4.7 years). Static 
postural control was measured during one-legged stance 
on a balance platform and dynamic postural control was 
obtained while walking on an instrumented walkway. Leg 
extensor power was assessed during a countermovement 
jump on a force plate.  Results: Programme compliance was 
excellent with participants of the INT group completing 
92.5% of the dancing sessions. A tendency towards an im-
provement in the selected measures of static postural con-
 Received: August 11, 2011 
 Accepted: October 31, 2011 
 Published online: January 6, 2012 
 Prof. Dr. Urs Granacher 
 Institute of Sport Science, Friedrich Schiller University Jena 
 Seidelstrasse 20 
 DE–07749 Jena (Germany) 
 Tel. +49 3641 94 56 70, E-Mail urs.granacher   @   uni-jena.de 
 © 2012 S. Karger AG, Basel
0304–324X/12/0000–0000$38.00/0 
 Accessible online at:
www.karger.com/ger 
 Granacher et al. Gerontology 2
components of postural control (e.g. reactive and steady-
state balance) and force production (e.g. maximal strength, 
rate of force development, muscle power) mainly after the 
age of 60  [1–3] . These deficits are associated with an in-
creased risk of falling in older adults  [4, 5] . Thus, the pro-
motion of balance and force production represents two 
important targets in the field of fall prevention. Tradition-
ally, balance and resistance training have been applied to 
mitigate age-related processes in the neuromuscular sys-
tem. However, the effects of resistance training appear to 
be limited to gains in force production. In fact, a system-
atic review of randomized controlled trials on the efficacy 
of resistance training on balance performance could not 
detect a clear effect on various measures of standing bal-
ance in older adults (effect size = 0.11)  [6] . Balance train-
ing has proven to be effective in increasing measures of 
postural control and force production in seniors  [7, 8] . 
However, social interaction during balance training is 
limited which might negatively affect both the motivation 
of the exercisers and adherence rate during training. Re-
cently, Granacher et al.  [9] suggested an intergenerational 
approach (i.e. seniors exercise together with children) in 
the promotion of balance in older adults to specifically 
address the motivation of the exercisers. Another form of 
enhancing motivation and social interaction during train-
ing is to implement dance programmes for the promotion 
of physical activity in general and balance and force pro-
duction in particular. Thus, dance may provide a form of 
exercise that offers both a conditioning stimulus and a so-
cially interactive and motivating activity that older adults 
would like to perform on a permanent basis  [10] . A grow-
ing pool of literature indicates that different types of 
dance programmes (e.g. Turkish or Greek folklore dance, 
Latin dance, Tango) are effective in improving measures 
of postural control  [11–15] .
 Salsa dance appears to be specifically suited for the 
promotion of balance and force production. In fact, salsa 
moves are particularly challenging for dynamic postur-
al control and muscle strength/power due to frequent 
changes in direction and because the dance steps are per-
formed on the toes of the feet. In addition, salsa specifi-
cally challenges the performance of movements to the 
rhythm of the music. Moreover, a stable walking pattern 
is characterized by low fluctuations of the gait rhythm. 
Thus, salsa dancing may improve spatiotemporal fea-
tures of gait because both aesthetic dancing as well as 
stable walking require some sense of rhythm. Finally, 
over recent years salsa has become a very popular dance 
among young and middle-aged adults and might there-
fore also attract older adults. However, to the authors’ 
knowledge, there is no study available that investigated 
the effects of salsa dancing alone on measures of postur-
al control and force production in older adults.
 Given that deficits in postural control and force pro-
duction are associated with an increased risk of falling  [4, 
5] , the objectives of this study were to investigate the ef-
fects of a progressive salsa dance programme on mea-
sures of static/dynamic postural control and leg extensor 
power in a cohort of older adults. Based on previously 
published studies  [11, 13–15] , it is expected that salsa 
dance improves static and particularly dynamic postural 
control as well as muscle power of the leg extensors in 
older adults.
 Methods 
 Participants 
 Twenty-eight community-dwelling older adults between the 
ages of 63 and 82 gave written informed consent to participate in 
the study after experimental procedures were explained. The par-
ticipants’ baseline characteristics are presented in  table 1 . None of 
the participants had any history of musculoskeletal, neurological 
or orthopaedic disorders that might have affected their ability to 
conduct a salsa dance programme or to perform balance and 
strength tests. The participants were capable of walking indepen-
dently without any assistive device and they had no prior experi-
ence with the applied tests. Participants were randomly assigned 
into an intervention group (INT) and a control group (CON). The 
randomization process was done using Research Randomizer, a 
programme published on a publicly accessible official website 
(www.randomizer.org). Local ethical permission was given by the 
EKBB (Ethikkommission beider Basel) and all experiments were 
conducted according to the latest version of the declaration of 
Helsinki.
Table 1. B aseline characteristics by group
INT (n = 14) CON (n = 14)
Age, years 71.685.3 68.984.7
Body height, cm 167.1810.1 169.188.6
Body mass, kg 72.3813.0 71.9813.0
BMI, kg/m2 25.984.2 25.184.0
Sex, female/male 9/5 8/6
MMSE 28.581.8 28.380.8
CDT all participants
were classified as 
non-pathological
Physical activity, h/week 11.585.3 11.788.3
 Values are means and SDs. No group baseline differences were 
detected; p > 0.05.
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 Salsa Dancing 
 Participants of the INT group conducted a salsa dance pro-
gramme over a period of 8 weeks (twice weekly) with a total of 16 
sessions. The intervention period was chosen based on a previ-
ously published study showing that an 8-week Turkish folklore 
dance programme was effective in improving balance function in 
the elderly  [15] . Each session lasted 60 min starting with a 10-min 
warm-up programme mainly consisting of salsa-specific static 
and dynamic balance exercises and ending with a 5-min cool-
down programme (i.e. stretching). The intervention programme 
was given by a professional dance instructor in 2 separate exercise 
groups in order to keep the participant-to-instructor ratio small 
(1 instructor for 6–8 seniors).
 Salsa is a partner dance that is characterized by Latin Ameri-
can rhythm and music. The dance programme mainly consisted 
of basic steps (e.g. 3-step weight change) and simplest movements 
of salsa in forward, backward, transversal and rotational direc-
tions. At the beginning of the programme the 3-step weight 
change was taught without a partner. This pattern typically uses 
3 steps during every 4 beats, 1 beat being skipped. However, this 
skipped beat is often marked by a tap, a kick or a flick. Exercises 
like clapping hands, stomping the feet on the dance floor and 
walking individually to the rhythm of the music were incorpo-
rated in the acquisition phase. After the participants were able to 
accomplish the basic steps individually they were introduced to 
partner dance. Both men and women practiced leading while 
dancing salsa. This was accomplished in a first step by asking the 
lead person to guide their blinded partner over the dance floor. 
Progression during salsa dancing was realized by increasing the 
tempo of the music from initially 50 to 70 bpm at the end of the 
intervention. Of note, salsa can be danced to a count of up to 180 
bpm. We further progressed from forward/backward directions 
to transversal and rotational dancing directions. In addition, sal-
sa-specific moves like knee swings and hip rotations were con-
tinuously included in the programme. Finally, the participants 
learned the technique of toe dancing, which is a typical feature of 
salsa that demands high dynamic postural control and muscle 
power while moving with an extremely small base of floor con-
tact.
 Due to the small participant-to-instructor ratio, salsa dancing 
was safe without any intervention-related risk of falling. The par-
ticipants of the CON group maintained their normal physical ac-
tivities throughout the experimental period.
 Testing Procedure 
 Upon entering the gait laboratory, all participants were kindly 
asked to complete two different questionnaires (the ‘Freiburg 
questionnaire for everyday and sports activities’ ©  [16] and the 
Mini-Mental State Examination, MMSE  [17] ) and one cognitive 
test to evaluate executive function (the Clock-Drawing Test, CDT 
 [18] ). Thereafter, participants received standardized verbal in-
structions regarding the test procedure with a visual demonstra-
tion of the balance and the power tests. Prior to testing, all par-
ticipants performed one practice trial on each test instrument to 
rule out potential learning effects. Measurements of static and 
dynamic postural control were conducted in a counterbalanced 
order on a balance platform and a pressure-sensitive walkway. In 
addition, before- and after-tests included the analysis of jumping 
power on a force platform. 
 Testing Material 
 Balance Platform 
 Test circumstances (e.g. room illumination, temperature, 
noise) were in accordance with recommendations for post-uro-
graphic testing  [19] . Static postural control was assessed by means 
of a balance platform (GKS 1000, IMM, Mittweida, Germany). 
The balance platform consists of four uni-axial sensors measur-
ing displacements of the centre of pressure (CoP) in the mediolat-
eral and anterior-posterior directions. For experimental testing 
the balance platform was firmly fixed on the floor. Participants 
were asked to stand on their dominant leg on the platform with 
their supported leg in 30° flexion, hands placed on hips and gaze 
fixed on a cross on the nearby wall (the fully extended knee cor-
responds to 0°). The dominant leg was determined according to 
the lateral preference inventory  [20] . Participants were instructed 
to remain as stable as possible and to refrain from any voluntary 
movements during the trials. Data were acquired for 30 s at a sam-
pling rate of 40 Hz  [19] . Five parameters were computed from the 
time series of the CoP displacements. First, the displacements of 
the CoP in the anterior-posterior direction (CoPap, mm); second, 
the displacements of the CoP in the mediolateral direction 
(CoPml, mm); third, the total displacements of the CoP (CoPtot, 
mm), which represent the summed displacements in the medio-
lateral and anterior-posterior directions; fourth, the surface area 
covered by the trajectory of the CoP (CoParea, mm2) with a 90% 
confidence interval, and fifth, the CoP speed (CoPspeed, mm/s), 
which indicates the total distances covered by the CoP divided by 
the duration of the sampled period. All of these parameters rep-
resent traditional balance measures, which are widely employed 
in clinical practice to assess individuals’ postural control capaci-
ties during unperturbed stance  [21] . Three trials were performed 
and their mean was used for further analysis. For all the assessed 
CoP variables, intraclass correlation coefficients (ICC) were 
 6 0.75, indicating an excellent intersession reliability  [21] .
 Pressure-Sensitive Walkway 
 The walking pattern was determined during steady-state 
walking on an instrumented 10-metre walkway using the GAIT-
Rite © System (Havertown, Pa., USA). Participants walked with 
their own footwear at their own speeds, initiating and terminat-
ing each walk a minimum of 2 m before and after the 10-metre 
walkway to allow sufficient distance to accelerate to and deceler-
ate from a steady state of ambulation across the walkway. Distri-
bution of pressure during walking was monitored at 80 Hz, en-
abling spatiotemporal gait data to be collected. Because data from 
the left and right strides were not statistically different, only data 
from the left side were analysed. Besser et al.  [4] reported that 5–8 
strides are necessary for 90% of individuals tested with GAITRite 
instrumentation to have reliable mean estimates of spatiotempo-
ral gait parameters. Temporal and spatial parameters of gait seem 
to be important in the assessment of mobility in community-
dwelling elderly adults  [22] . Thus, in a first step, means and stan-
dard deviations (SD) of stride time, stride length, and stride veloc-
ity were computed. Stride time was defined as the time (s) between 
the first contacts of two consecutive footfalls of the same foot. 
Stride length was defined as the linear distance (cm) between suc-
cessive heel contacts of the same foot. Additionally, stride veloc-
ity (cm/s) was calculated as stride length divided by stride time. 
To determine gait variability, coefficients of variation (CV) were 
calculated for the above-mentioned parameters according to the 
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following formula [(SD/mean)  ! 100] and used as outcome mea-
sures  [23] . The smaller the CV value, the safer the walking pat-
tern. Intraclass correlation coefficients for the calculated gait pa-
rameters ranged from ICC 0.79 to 0.98  [1] .
 Force Platform 
 Participants performed maximal vertical countermovement 
jumps (CMJs) while standing on a one-dimensional force plat-
form (KistlerP type 9290AD, Winterthur, Switzerland). The verti-
cal ground reaction force was sampled at 500 Hz. During the 
CMJs, subjects stood in an upright position on the force platform 
and were instructed to begin the jump with a downward move-
ment, which was immediately followed by a concentric upward 
movement, resulting in a maximal vertical jump. Participants 
performed 3 CMJs with a resting period of 1 min between jumps. 
For each of these trials, subjects were asked to jump as high as 
possible. The mean of 3 trials in terms of maximal jumping pow-
er (W/kg) was taken for further data analysis. The intraclass cor-
relation coefficient was calculated for CMJ power and amounted 
to ICC = 0.81.
 Questionnaire 
 The ‘Freiburg questionnaire for everyday and sports activities’ 
 [16] assesses basic physical activity level (e.g. gardening, climbing 
stairs), leisure time physical activity level (e.g. dancing, bowling) 
and sports activity level (e.g. jogging, swimming) of people be-
tween the ages of 18 and 78. Significant test-retest reliability was 
reported for the summed physical activity level (r =  0.56). Cross-
correlation with maximum oxygen uptake revealed a significant 
correlation coefficient of r = 0.42  [16] .
 The MMSE is a valid test of cognitive function. It separates 
patients with cognitive disturbance from those without such dis-
turbance. Test-retest reliability of the MMSE is high with r =  0.89. 
Cross-correlation with the Wechsler Adult Intelligence Score re-
vealed a correlation coefficient of r = 0.78  [17] . According to Fol-
stein et al.  [17] , a MMSE total score of less than 20 separates pa-
tients with dementia or functional psychosis from cognitively in-
dependently functioning participants and those with anxiety 
neurosis or personality disorder.
 The CDT is a sensitive screening test for the evaluation of ex-
ecutive function  [18] . The elderly participants were instructed to 
draw numbers in a given circle to make the circle look like a clock. 
Thereafter, subjects were asked to draw the hands of the clock to 
a point in time of their choice which, at the end of the test, they 
had to write down in digital form. Depending on the study con-
sulted, inter-rater reliability for the CDT ranges between 75.4 and 
99.6%  [18] . Test-retest reliability can be classified as high with an 
r value of 0.90  [24] . Cross-correlation with the MMSE revealed a 
correlation coefficient of r  1 0.50  [25] . As a result, the test distin-
guishes between pathological and normal test performance.
 Statistical Analyses 
 Data are presented as group mean values  8 SD, unless other-
wise stated. A multivariate ANOVA was used to detect differenc-
es between the study groups in all baseline variables. Balance and 
strength parameters were analysed in separate 2  ! 2 [groups 
(INT, CON)  ! tests (before, after)] ANOVA with repeated mea-
sures on test. Post-hoc tests with the Bonferroni-adjusted   were 
conducted to identify the comparisons that were statistically sig-
nificant. The classification of effect sizes (ƒ) was determined by 
calculating partial η 2 p . The effect size is a measure of the effective-
ness of a treatment and it helps to determine whether a statisti-
cally significant difference is a difference of practical concern. 
 f values of 0.10 indicate small, of 0.25 medium and of 0.40 large 
effects  [26] . An a priori power analysis  [27] with an assumed type 
I error rate of 0.05 and a type II error rate of 0.20 (80% statistical 
power) was conducted for measures of balance function  [12] and 
revealed that 13 persons per group would be sufficient for finding 
statistically significant interaction effects. All analyses were per-
formed using the Statistical Package for Social Sciences (SPSS) 
version 19.0. The significance level was set at p  ! 0.05.
 Results 
 At baseline, all subjects met the inclusion criteria (i.e. 
MMSE; CDT) for participating in this study. The inves-
tigated results in the MMSE and the CDT indicate that 
the older adults of this study were cognitively healthy ( ta-
ble 1 ). Findings regarding the ‘Freiburg questionnaire for 
everyday and sports activities’ revealed that our partici-
pants could be classified as physically active ( table 1 ). All 
subjects received treatment or control conditions as allo-
cated. Fourteen participants completed the salsa dance 
programme and none reported any adverse events. Pro-
gramme compliance was excellent with participants of 
the INT group completing 92.5% of the scheduled danc-
ing sessions. Overall, there were no statistically signifi-
cant differences in baseline values between the two ex-
perimental groups.
 Standing Performance 
 The analysis based on performance during standing 
detected a main effect of time for the parameter CoPml 
[F(1, 54) = 4.39, p = 0.05, η 2 p = 0.15, ƒ = 0.42], and a ten-
dency towards a significant group  ! test interaction [F(1, 
54) = 3.20, p = 0.09, η 2 p = 0.11, ƒ = 0.35] for the variable 
CoPap. The inclusion of additional CoP parameters (e.g. 
CoPtot, CoParea, CoPspeed) did not reveal further sig-
nificant findings ( table 2 ).
 Walking Performance 
 Stride Velocity.  The analysis indicated a significant 
main effect of test [F(1, 54) = 13.00, p  ! 0.001, η 2 p = 0.33, 
ƒ = 0.70] as well as a significant group  ! test interaction 
[F(1, 54) = 11.73, p  ! 0.01, η 2 p = 0.31, ƒ = 0.67]. Post hoc 
analysis found that participants in the INT group signifi-
cantly increased their stride velocity over the training pe-
riod (p = 0.001,   11.3%) while the participants in the CON 
group showed no significant changes ( fig. 1 a). The main 
effect of group [F(1, 26) = 0.01, p  1 0.05] was not significant.
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Table 2. O utcome measures (ANOVA with repeated measures on test)
Measure INT (n = 14) CON (n = 14) p value
before after before after ti me time ! group
Standing
CoPtot, mm 1,984.48584.8 1,744.68670.7 2,192.38437.1 2,140.98457.7 0.076 0.243
CoPml, mm 1,210.58342.7 1,078.58441.0 1,448.88358.9 1,310.48297.4 0.046 0.960
CoPap, mm 1,315.08437.5 1,145.58459.9 1,335.18332.8 1,401.38403.4 0.440 0.085
CoPspeed, mm/s 67.1819.5 59.3823.0 74.3814.7 72.9815.6 0.093 0.241
CoParea, mm2 15.689.2 13.887.4 16.488.4 14.789.6 0.461 0.994
Walking
Stride velocity, cm/s 133.8820.2 148.9825.8 141.8814.4 142.2814.2 0.001 0.002
Stride time, s 1.0280.07 0.9880.07 1.0480.06 1.0580.07 0.018 0.005
Stride length, cm 136.8822.0 145.5826.8 147.6815.0 148.4813.3 0.001 0.006
Stride velocity CV, % 2.781.5 2.481.1 2.381.0 2.480.7 0.637 0.542
Stride time CV, % 1.781.0 1.980.6 1.480.7 1.680.4 0.332 0.916
Stride length CV, % 1.980.8 1.981.1 1.980.8 1.780.6 0.612 0.609
Power
CMJ power, W/kg 14.082.8 15.783.5 16.282.2 19.282.9 0.000 0.098
Val ues are means and SDs.
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 Fig. 1. Performance changes during the dancing period in stride velocity ( a ), stride time ( b ) and stride length ( c ) 
while walking on a pressure-sensitive walkway for the INT group compared to the CON group (mean  8 SD).  
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 Stride Time.  The analysis revealed a significant main 
effect of test [F(1, 54) = 6.35, p  ! 0.05, η 2 p = 0.20, ƒ = 
0.50] as well as a significant group  ! test interaction 
[F(1, 54) = 9.28, p  ! 0.01, η 2 p = 0.26, ƒ = 0.59]. Post hoc 
analysis found that participants in the INT group signifi-
cantly decreased their stride time over the training period 
(p = 0.001,   3.9%) while the participants in the CON group 
showed no significant changes ( fig. 1 b). The main effect of 
group [F(1, 26) = 3.62, p  1 0.05] was not significant.
 Stride Length.  The analysis detected a significant main 
effect of test [F(1, 54) = 13.47, p  ! 0.001, η 2 p = 0.34, ƒ = 0.72] 
as well as a significant group  ! test interaction [F(1, 54) = 
9.15, p  ! 0.01, η 2 p = 0.26, ƒ = 0.59]. Post-hoc analysis found 
that participants in the INT group significantly increased 
their stride length over the training period (p = 0.001, 
  6.4%) while the participants in the CON group showed 
no significant changes ( fig. 1 c). The main effect of group 
[F(1, 26) = 0.86, p  1 0.05] was not significant.
 Stride-to-Stride Variability.  In terms of gait variability, 
the analysis failed to detect significant main effects of 
time, group and group  ! test interactions for the CV of 
the stride velocity, time, and length parameters ( table 2 ).
 Power Performance 
 With regard to CMJ power, the analysis detected a sig-
nificant main effect of time [F(1, 54) = 41.75, p  ! 0.001, 
η 2 p = 0.74, ƒ = 1.69]. The main effect of group [F(1, 26) = 
4.32, p  1 0.05] and the interaction effect of group  ! test 
[F(1, 54) = 3.11, p  1 0.05] were not significant ( table 2 ).
 Discussion 
 To the authors’ knowledge, this is the first study that 
has investigated the impact of salsa dancing on intrinsic 
fall-risk factors (i.e. deficits in postural control and mus-
cle power of the leg extensors) in older adults. Eight weeks 
of progressive salsa dancing resulted in: (a) a tendency 
towards significant improvements in selected measures 
of static postural control; (b) a significantly enhanced gait 
pattern in terms of increases in stride velocity and length, 
and concomitant decreases in stride time, and (c) no sig-
nificant changes in gait variability and muscle power of 
the leg extensors.
 The present findings are in accordance with the litera-
ture regarding the effects of dancing on measures of bal-
ance function in older adults. Federici et al.  [11] assessed 
the impact of Latin dance in a randomized controlled 
clinical trial on measures of balance in community-based 
inactive seniors. Study participants (age range 56–68 
years) were randomized to either a dance or a control 
group for 3 months. While the dance group participated 
in 60-min Latin dance (e.g. Merengue, Bachata) classes 
twice a week, the control group did not engage in any 
physical activity. Before and after the intervention peri-
od, balance was assessed using 4 different clinical tests 
(the Tinetti, Romberg, improved Romberg and Sit-Up 
and Go tests). The findings indicated significant im-
provements in balance capability in the dance group. 
Conversely, the control group showed a slight but not sta-
tistically significant deterioration in balance function. 
Outcomes from a short 4-item psychosocial survey 
(smoking, alcohol consumption, sexual habits, sleep 
quality) developed by the study investigators also demon-
strated improved subjective assessments of sleep quality 
and sexual activity among subjects in the dance group. 
Furthermore, 17 of the 20 dance group subjects reported 
moderate to great satisfaction with the dance activity. 
Based on their results, the authors concluded that Latin 
dance may improve balance and hence be a useful tool in 
reducing the risk of falling in older adults.
 In another study, Shigematsu et al.  [13] determined the 
effects of dance-based aerobic exercise on indices of fall-
ing in healthy community-dwelling women aged 72–87 
years. The intervention group performed an aerobic dance 
exercise (side stepping, fast walking, forward/backward 
stepping, leg lifts, etc.) for 60 min, 3 days per week for a 
total of 12 weeks. Most of the activities were accompanied 
by music with changing tempo. The main outcome mea-
sures included balance tests (i.e. single leg balance with 
eyes opened/closed, functional reach), strength tests (i.e. 
hand grip strength, keeping a half squat position), loco-
motion/agility tests (i.e. walking time around 2 cones, 
3-min walking distance), and motor processing tests (i.e. 
hand-reaction time, foot tapping). After the dance pro-
gramme, the intervention group showed significantly 
greater single-leg balance with eyes closed, improved 
functional reach and decreased walking time. However, 
measures of strength were not significantly influenced by 
dancing. The lack of finding regarding the impact of 
dancing on leg extensor power in our study can most like-
ly be explained by the high fitness/mobility level of our 
participants with average sports-related physical activities 
of 11.5 h/week and an average spontaneous stride velocity 
of 133.8 cm/s. In fact, Frey et al.  [16] reported a mean phys-
ical activity level of 9.9 h/week including basic, leisure 
time and sports-related activities for seniors aged 70 years 
and older. In addition, Oberg et al.  [28] examined habitu-
al gait speed in subjects aged 10–79 years and found that 
women and men between the ages of 70 and 79 years 
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walked with an average speed of 115 cm/s. Thus, our par-
ticipants’ physical activity and fitness/mobility levels ap-
pear to be above the average values of older age-matched 
adults. Moreover, the training stimulus during salsa danc-
ing might not have been specific enough to induce im-
provements in muscle power. It has frequently been re-
ported that power training or high-velocity strength 
training have the potential to produce gains in muscle 
power in older adults [for a review see  29 ]. Thus, the prin-
ciple of training specificity explains why we did not find 
improvements in leg extensor power in our study.
 The present study revealed significant increases in 
stride velocity in the salsa dance group as compared to the 
control group. Given that the magnitude of age-related re-
duction in gait speed varies between 0.1 and 0.7% per year 
 [28] and that decreases in gait speed are associated with an 
increased risk of falling  [30] and functional decline  [31] , it 
is of great relevance that salsa dancing had the potential to 
increase gait speed in older adults. In fact, Hoxie and Ru-
benstein  [31] reported that a walking speed of 122 cm/s is 
necessary to cross intersections safely, and observed that 
96% of individuals aged 65 and over walk at a slower gait 
speed than this when crossing an intersection. Thus, the 
regular performance of salsa dancing may delay the onset 
of functional and mobility limitations and could help pre-
serve the quality of life and independence of older adults.
 This study did not detect significant effects of salsa 
dancing on spatiotemporal measures of gait variability in 
older adults. In contrast to our findings, Trombetti et al. 
 [32] were able to examine significant decreases in stride 
length variability after 6 months of varied multi-task ex-
ercises, mostly performed to the rhythm of improvised 
piano music (i.e. Jaques-Dalcroze eurhythmics) in com-
munity-dwelling adults aged older than 65. In addition, 
the music-based exercise programme resulted in a re-
duced rate of falls and a lower risk of falling. Three meth-
odological reasons can most likely explain the discrep-
ancy in findings between our study and theirs. First, the 
duration of our salsa dance programme might not have 
been long enough to induce changes in measures of spa-
tiotemporal gait variability. Thus, future studies should 
extend the intervention period beyond 8 weeks to find out 
whether additional adaptive processes in the gait pattern 
can be observed following salsa dancing. Second, in our 
subjects, spatiotemporal gait variability scores were al-
ready low at baseline (e.g. 1.7% stride time CV) indicating 
that the gait pattern was rather stable. In contrast, Trom-
betti et al.  [32] reported a baseline stride time CV of 5.3%. 
Kressig et al.  [33] were able to identify a critical threshold 
for stride time CV ( 1 4%) that was strongly associated 
with fall events in older inpatients. Based on these find-
ings, it can be concluded that the gait pattern of our sub-
jects was stable and risk of fall was low, whereas the gait 
pattern of the participants in the study by Trombetti et al. 
 [32] was unstable and risk of fall was high. Third, with 
reference to the principle of training specificity, Jaques-
Dalcroze eurhythmics may have the potential to improve 
gait variability due to the high demands of attention 
while moving to the melody and rhythm of improvised 
and quickly changing piano music. Salsa dance on the 
other hand lacks this improvised and unexpected music-
imposed movement and pattern change, which might ex-
plain the missing effect on gait variability.
 Conclusions 
 This study proved that salsa dancing is a safe, feasible 
and highly enjoyable exercise programme for older adults. 
Salsa dancing seems to specifically be well suited for the 
promotion of static and particularly dynamic postural 
control, which makes it a useful intervention in reducing 
the risk of falling in older adults. However, if the goal is 
to induce improvements in spatiotemporal gait variabil-
ity and muscle power, more specific training stimuli ap-
pear to be necessary. Recently, it has been reported that 
Jaques-Dalcroze eurhythmics has the potential to im-
prove measures of gait variability and to reduce fall rate 
in older adults  [32] . Furthermore, a recent systematic re-
view on the effects of power training indicates that this 
training regimen enhances both muscle power and func-
tional performance in older adults  [29] . Taken together, 
these findings suggest that dance programmes should in-
clude improvising movement elements to the rhythm of 
music and power-specific exercise elements in order to 
effectively promote various components of postural con-
trol and force production. However, this hypothesis needs 
to be verified in future studies.
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ABSTRACT
OBJECTIVES 
To test whether serum 25-hydroxyvitamin D [25(OH)D] status is associated with functional mobility in 
seniors assessed in a memory clinic. 
DESIGN 
Cross-sectional. 
SETTING 
Outpatient memory clinic at a Geriatric University Hospital.  
PARTICIPANTS 
Four hundred four memory clinic patients (65 years) assessed in an ambulatory setting. 
MEASUREMENTS 
Functional mobility was assessed with three endpoints: normal and fast walking speed and the Timed 
Up and Go (TUG) test by quartile of serum 25(OH)D concentrations. Multivariate analyses were 
performed adjusting for gender, age, and body mass index, history of falls, cognitive function (Mini-
Mental State Examination, MMSE), and prescription drugs. Pre-planned subgroup analysis in less frail 
seniors (no previous fall and MMSE <26). 
RESULTS 
Among 404 seniors, mean 25(OH)D serum levels were 63.2 nmol/L (SD 33.9), and 41.3% were 
vitamin D deficient (<50 nmol/L). Seniors in the lowest 25(OH)D quartile (<39 nmol/L) had significantly 
worse functional mobility compared with seniors in the highest 25(OH)D quartile (>81 nmol/L): 
adjusted for all covariates, seniors in the highest quartile performed 9.4% better in normal (P=.02) and 
9.2% better in fast (P=.004) walking speed, and 4.4% better in the TUG test (P=.24). The association 
between 25(OH)D status and functional mobility was most pronounced in less frail seniors (P for trend 
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significant for all three mobility tests). Overall seniors with higher 25(OH)D status also had better 
cognitive function (MMSE score; P=.006). 
CONLUSION 
Among seniors assessed in a memory clinic, higher serum 25(OH)D status correlated positively with 
better functional mobility and better cognitive function. Given, the large number of seniors with vitamin 
D deficiency, 25(OH)D assessment may be warranted in this population at risk for both functional and 
cognitive decline. 
KEY WORDS 
Vitamin D, physical function, gait velocity, fall prevention, older adults 
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MANUSCRIPT 
INTRODUCTION 
Traditionally, vitamin D has been linked to bone health and vitamin D supplementation is supported as 
an evidence-based strategy in fracture risk reduction among adults age 65 and older. In a most recent 
pooled analysis of source data of 11 double blind RCTs including 31,022 seniors, vitamin D 
supplementation at an actual median intake of 800 IU per day (range: 792 to 2,000 IU per day) 
reduced hip fracture risk by 30%.1 Mechanistically, this benefit may be explained by the well-
established positive effect of vitamin D on calcium absorption. Alternatively, several lines of evidence 
support a direct effect of vitamin D on muscle,2,3 and several meta-analyses on trials of vitamin D 
supplementation support vitamin D as an effective strategy in fall prevention, as reflected in the 
American and British Geriatric Society Guidelines.4-6
At the same time the prevalence of vitamin D deficiency is reported to be 50% or more among large 
parts of the senior population worldwide.7 Serum 25-hydroxyvitamin D [25(OH)D] represents the best 
clinical measure of systemic vitamin D status.8 Seniors are at increased risk of vitamin D deficiency 
due to less time spent outside, use of sun protection, and institutionalization.7 Further, with age the 
skin capacity to produce vitamin D from UVB-exposure is reduced by a factor of 4.9  
In this large survey of seniors admitted to a memory clinic, we examined the association between 
vitamin D status and functional mobility. Further, we explored if this association differs between less 
frail and pre-frail seniors. Seniors who present at a memory clinic may be a target group for 25(OH)D 
assessment as they are at risk of further cognitive and functional decline. In the general senior 
population vitamin D deficiency has been associated with risk of nursing home admission,10 reduced 
muscle strength and functional mobility,11 increased risk of falls and fractures,12 and higher risk of 
cognitive decline.13
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METHODS 
Study Population 
In this survey, we include 404 consecutive memory clinic patients assessed in an ambulatory setting, 
age 65 and older from September 2008 to April 2011. This study was approved by the local ethics 
committee (Canton Basel). 
The examination battery applied at the Memory Clinic of the Geriatric University Hospital Basel 
includes the Mini-Mental State Examination (MMSE, maximum score is 30 points, diagnostic range 0-
10 = severe cognitive impairment, 11-20 = moderate cognitive impairment, 21-26 = mild cognitive 
impairment, 27-30 = normal cognitive function) as a measure of global cognitive function,16 and a 
functional mobility assessment (measurements of Timed Up and Go (TUG) and gait analysis) at the 
Basel Mobility Center. Further, physical exam is performed by a physician including the record of 
height and weight, the medical history and the number of prescription drugs taken (self-report, report 
from care-givers and/or documented medical history). We used the latter as a surrogate for 
comorbidity. In addition, the physician explores the history of falls in the previous 12 months, including 
observations by accompanying caregivers. A fall is defined according to the Prevention of Falls 
Network Europe (ProFaNE) as ‘an unexpected event in which the participant comes to a rest on the 
ground, floor, or lower level’.17 Further, blood is drawn by nurses at the Memory Clinic for the 
assessment of 25(OH)D status and other relevant biomarkers. 
We defined less frail and pre-frail individuals based on their cognitive performance in the MMSE and 
previous fall history (in the last 12 months). Less frail seniors had no previous fall and an MMSE score 
of 26. Pre-frail seniors either had previous fall and MMSE 26 or had no previous fall and an MMSE 
<26. 
Functional Mobility Assessment 
For functional mobility 3 tests are evaluated: normal and fast walking speed, and the TUG test. 
Patients wore their normal clothes, their own shoes, and a safety belt. The test administrator walked 
beside and slightly behind the patient to provide assistance and grab the safety belt if balance loss 
occurred while walking.  
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Normal and Fast Walking Speed 
Patients were verbally instructed regarding the gait analysis testing procedure: first to walk at their 
usual speed (self-selected pace) and then as fast as possible (fast walking, but not running). No 
practice walks were performed before testing. Each walk was performed once.  
Timed Up and Go Test 
The TUG assesses basic mobility in seniors and was conducted at the Basel Mobility Center prior to 
the walking speed assessments.18 When performing the TUG, the time in seconds that it takes an 
individual to rise from an armchair with armrests, walk 3 m at their regular walking speed, turn, walk 
back and sit down again is measured using a stopwatch. A score of 14 sec or higher is associated 
with an increased fall risk.19  
Serum 25-Hydroxyvitamin D Assay 
Blood samples for the determination of 25(OH)D concentrations were obtained by a nurse from the 
Memory Clinic and analyzed at the Laboratory of Immunology at the University Hospital Basel. An 
automated enzyme immune assay analyzer named DSX (Dynex Technologies, Chantilly, VA) was 
used for 25(OH)D quantification in human serum. Samples were diluted with biotin labeled 25(OH)D 
and incubated in microtiter wells. Enzyme labeled avidin was added and bound selectively to 
complexed biotin followed by developing color using a chromogenic substrate. The absorbance of the 
stopped reaction mixtures were read in a microtiter plate reader, color intensity developed being 
inversely proportional to the concentration of 25(OH)D. The intra assay and inter assay coefficients of 
variation for 25(OH)D were 5.3% and 4.6%, respectively.  
Statistical Analyses  
The baseline characteristics of the 404 memory clinic patients were summarized using means and 
standard deviations or frequencies and percentages, as appropriate (in all, in less frail (no previous 
fall and MMSE 26) and pre-frail (previous fall and MMSE 26/no previous fall and an MMSE <26) 
seniors and by quartile of 25(OH)D status). Serum 25(OH)D levels were assessed as quartiles (<39, 
39 to 54, 55 to 81, >81 nmol/L). General linear models (GLM) were performed to evaluate differences 
in walking speed (normal and fast) and TUG by 25(OH)D quartile for all, less frail  and pre-frail seniors 
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adjusted for age, gender, body mass index (BMI), MMSE, number of prescription drugs, and previous 
falls (yes/no). Analyses were conducted with SAS version 9.2 (SAS Institute, Cary, N.C.) software. All 
P values are two-sided.
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RESULTS 
A total of 404 memory clinic patients (mean age 77.6, standard deviation (SD) 5.8, 53.5% female) 
were included in this survey. Table 1 describes the study population for important covariates by the 
less frail and pre-frail status, and by quartile of 25(OH)D status. The overall mean MMSE score was 
24.5 (SD 4.1) points (range 5 to 30 points). 34.4% (n = 139) of seniors took more than 3 prescription 
drugs, 28.2% (n = 114) between 3 and 5, and 37.4% (n = 151) none.  
25(OH)D Status 
Mean 25(OH)D status was 63.2 (SD 33.9); 4.7% (n = 19) had serum levels below 25 nmol/L (severe 
deficiency), 41.3% (n = 134) had levels below 50 nmol/L (deficiency), and 69.8 % (n = 282) had levels 
below 75 nmol/L (threshold for optimal fall and fracture reduction).20 Seniors with higher 25(OH)D 
status had a significantly higher MMSE score (P = .006).  
Association Between 25(OH)D Status and Functional Mobility in all Seniors 
At the univariate level, seniors in the lowest 25(OH)D quartile (<39 nmol/L) had significantly worse 
functional mobility performance for all 3 functional mobility measures (normal and fast walking speed, 
and TUG) if compared to the highest 25(OH)D quartile (>81 nmol/L). Notably, there was a pattern that 
suggested all seniors in 25(OH)D quartile levels greater than 39 nmol/L had an equally better function 
than those in the lowest quartile. This pattern was maintained for all functional mobility measures also 
in the multivariate analyses after adjustment for age, gender, BMI, MMSE, prescription drugs, and 
falls (Figure 1A, 1B, 1C).  
Association Between 25(OH)D Status and Functional Mobility in Less Frail and Pre-frail Seniors 
Compared to pre-frail seniors less frail seniors (no previous fall and MMSE 26) showed a more 
pronounced association between all 3 functional mobility measures and 25(OH)D quartile level. 
Notably, in the subgroup of less frail seniors the pattern of association changed from a threshold of 39 
nmol/L as observed on the total study population to a trend between better performance with higher 
25(OH)D status. In less frail seniors this trend was significant for normal and fast walking speed and 
TUG performance (Figure 2A, 2B, 2C). 
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DISCUSSION 
In this large survey of 404 consecutive ambulatory memory clinic patients age 65 and older low serum 
25(OH)D status was not only associated with a lower MMSE score, but also with decreased functional 
mobility. Including both less frail and pre-frail seniors as defined by their cognitive status and prior fall 
status, a 25(OH)D threshold of 39 nmol/L (upper end of the lowest quartile) was suggested for better 
functional mobility. However, in the subgroup of less frail seniors (n = 124), there was a significant 
trend of better functional mobility (normal and fast walking speed, and TUG) with higher 25(OH)D 
quartile status, with a desirable threshold of >81 nmol/L for optimal functional mobility. 
Vitamin D has been linked to cognitive performance in seniors.21 In a retrospective study of older 
patients assessed in a memory clinic, 25(OH)D status was positively correlated with the MMSE.22
Another recent study evaluated the effects of vitamin D supplementation on cognition in seniors 
referred to a memory clinic and reported an 25(OH)D-associated improvement in MMSE score.23 Our 
study confirms these findings documenting a significant association between higher 25(OH)D level 
and better cognitive performance assessed with the MMSE in seniors examined at a memory clinic.  
Several previous studies,24 including EPIDOS (Epidémiologie de l’Ostéoporose),15 the Cardiovascular 
Health All Stars study,11 and the population-based NHANES III study2 support an inverse association 
between higher 25(OH)D status and faster walking speed among community-dwelling seniors. The 
benefit of vitamin D supplementation (800 to 1,000 IU) on TUG performance was recently confirmed 
in a recent meta-analysis among seniors age 60 years and older.14 Our study extends to seniors 
assessed in a memory clinic supporting at the cross-sectional level a positive association between 
higher 25(OH)D status and functional mobility, including TUG and gait performance. 
In the present study, 41.3% of individuals were vitamin D deficient and 69.8% did not reach the 
desirable threshold of 75 nmol/L for fall and fracture prevention.20 These data are consistent with 
international reports where about 50% of ambulatory seniors are expected to have vitamin D 
deficiency,7 and about 70% fall below a threshold of 75 nmol/L.1,2
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As a surprise to the authors, less frail seniors (no previous fall and MMSE 26) expressed a more 
linear association between 25(OH)D quartile status and gait and functional mobility with a desirable 
25(OH)D threshold of >81 nmol/L for optimal performance. Comparing extreme quartiles in less frail 
seniors, the threshold of >81 nmol/L was associated with an about 11% better performance in gait 
(normal and fast) and TUG compared to the lowest 25(OH)D quartile (<39 nmol/L). Our expectation 
was that pre-frail seniors may be more susceptible to 25(OH)D status. However, including these 
seniors, only the lowest quartile was associated with worse functional mobility compared to the other 
quartiles suggesting a lower threshold of 39 nmol/L. This may be explained by an added level of 
impairment by a previous fall or reduced cognitive function, which may camouflage a positive 
association between 25(OH)D status and functional mobility. 
Our study has several strengths. We measured 25(OH)D status, gait, and the TUG in a standardized 
way in a large consecutive sample of memory clinic patients. The consistency across the 3 tests 
applied lends credibility to our findings as does the observed pattern of association in all participants 
and most pronounced in less frail participants. Notably, our findings adjust for key covariates, 
including age, gender, BMI, cognitive function, number of prescription drugs, and previous fall 
(yes/no). A further strength of our study is its population, which extends previous findings to 
individuals at risk of cognitive and functional decline assessed at a memory clinic setting. Our study 
also has several limitations. A key limitation is its cross-sectional design where interpretation is limited 
to associations rather than causality. Although we were able to adjust for important confounders, we 
may have missed others, such as physical activity. However, physical activity is likely to be on the 
causal pathway between 25(OH)D and gait performance, which would have disqualified its inclusion 
in our analyses. Notably, exposure to sunlight, seasonal variations, dietary and supplement intake of 
vitamin D are reflected in the 25(OH)D status. 
In summary and according to our findings a higher 25(OH)D status may contribute to better normal 
and fast walking speed, as well as quicker TUG performance in seniors referred to a memory clinic. 
Notably, this positive association may be most pronounced in less frail seniors and a desirable 
threshold for optimal function in this subgroup may be greater than 81 nmol/L. For the whole 
population assessed, including also pre-frail seniors, it seemed important to avoid a 25(OH)D status 
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below 39 nmol/L for functional mobility. Our data support measurement of 25(OH)D status in memory 
clinic patients, also for the observed positive association between higher 25(OH)D status and better 
cognitive performance. 
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Figure 1 A, B, C show functional performance by quartile of 25-hydroxyvitamin D [25(OH)D] 
status in all 404 seniors.  
Figure 1 A shows normal walking speed (dot), Figure 1 B shows fast walking speed (triangle), and 
Figure 1 C shows Timed Up and Go performance (square) for all seniors by 25(OH)D quartile. We 
show least square means and the standard error around the least square means, adjusted for age, 
gender, body mass index, Mini-Mental State Examination score, number of prescription drugs, and fall 
history in the last 12 months (yes/no). For all 3 tests individuals in the lowest quartile of 25(OH)D 
status (<39 nmol/L) performed worse. 
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Figure 2A. 
P for trend = .02
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Figure 2B. 

P for trend = .04
Vitamin D and functional mobility 

22 

Figure 2C. 
  P for trend = .03
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Figure 2 A, B, C show functional performance by quartile of 25-hydroxyvitamin D [25(OH)D] 
status in less frail (n = 322) and pre-frail seniors (n = 82).  
Figure 2 A shows normal walking speed (dot), Figure 2 B shows fast walking speed (triangle), and 
Figure 2 C shows Timed Up and Go (TUG) performance (square) for less frail (filled marker) and pre-
frail (open marker) by 25(OH)D quartile. We show least square means and the standard error around 
the least square means, adjusted for age, gender, body mass index, Mini-Mental State Examination 
score, number of prescription drugs, and fall history in the last 12 months (yes/no). Among less frail 
seniors, there was a significant trend between quartiles of 25(OH)D status and functional mobility for 
all 3 tests of functional performance among less frail seniors with a desirable threshold of >81 nmol/L 
for optimal gait and TUG performance. Such a trend could not be documented in pre-frail seniors. In 
pre-frail seniors, individuals in the lowest quartile had worse gait at a normal and fast pace compared 
to individuals in higher quartiles. For TUG performance, we could not document a significant 
association with 25(OH)D among pre-frail seniors.  
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Abstract 
Background and aims: Gait and balance impairments lead to falls and injuries in older people. 
Walking aids are meant to increase gait safety and prevent falls, yet little is known about how their use 
alters gait parameters. This study aimed to quantify gait in older adults during walking without and with 
different walking aids and to compare gait parameters to matched controls. 
Methods: This retrospective study included 65 older (60 years) community-dwellers who used a 
cane, crutch or walker and 195 independently mobile matched controls. Spatio-temporal gait 
parameters were measured with a GAITRite electronic walkway system during normal walking. 
Results: When walking unaided, walking aid users had significantly worse gait than matched controls. 
Gait performances significantly improved when assessed with vs. without the walking aid for the cane 
(increased stride time and length, decreased cadence, stride length variability and double support), 
crutch (increased stride time and length, decreased cadence, stride time variability, stride length 
variability and double support) and walker (increased gait speed and stride length, decreased stride 
time, stride time variability, stride length variability, base of support and double support) users. 
Conclusion: Gait in older adults who use a walking aid is more irregular and unstable than gait in 
independently ambulating older adults. Walking aid users have better gait when using their walking aid 
than when walking without it. The changes in gait were different for the different types of walking aids 
used. These study results may help better understand gait in older adults and differentiate between 
pathological gait changes and compensatory gait changes due to the use of a walking aid. 
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Introduction 
The ability to walk is one of the most relevant and important activities of daily living. It is central to the 
independence, health and well-being of older people. However, walking may be impaired by many 
factors such as acute or chronic diseases and physiological changes due to aging (1; 2). Impaired gait 
can negatively affect an individual’s functionality, participation in social activities and quality of life (3). 
Gait disorders in older people are a risk factor for falling (4). Approximately one third of individuals 
over the age of 65 years sustain at least one fall over a one-year period (5; 6) and this increases to 
nearly half in adults over the age of 80 years (6). Falls represent an increasing public health problem 
with physical, psychological and social consequences.  
Walking aids, such as a cane, crutch or walker, are frequently used by older people to cope with daily 
activities and to remain functionally independent and mobile (7; 8). These aids can maintain walking 
ability and improve balance by increasing the base of support, enhancing lateral stability and reducing 
lower-limb loading (7). In addition to benefits for ambulation, walking aids can have positive 
psychological effects, such as increased feelings of safety and confidence, resulting in improvements 
in physical activity levels and independence (9–11).  
The association between walking aid use and risk of falls is less clear. The study by Rubenstein and 
Josephson (12) showed that the use of a walking aid was associated with a 2.6-fold (confidence 
interval: 1.2; 4.6) increased risk of falling. This may be due to improper use of the aid, tripping over the 
aid or the aid’s impediment of compensatory stepping and grasping mechanisms during balance 
recovery to avoid a fall (13; 14). However, the increased fall risk associated with the use of a walking 
aid as reported by Rubenstein and Josephson (12) likely reflects the decreased functional status and 
mobility of the older people using the walking aids (those with gait disturbances, muscle weakness and 
increased fall risk are the ones most likely to use a walking aid) rather than due to the walking aid 
itself. When walking aids are appropriately chosen for clinical conditions (e.g., a standard walker 
instead of a front-wheeled walker for people with Parkinsonian gait disturbances), correctly sized (not 
too high or too low) and properly implemented, they can increase walking safety and thus may reduce 
the risk of falling.  
Although walking aids are often used by those with gait impairments, little is known about the effects of 
different walking aids on gait parameters. Measurements of temporal and spatial gait parameters are 
used to identify gait deficits and to screen older people for their risk of falling (15). Impaired gait is 
characterized by reduced walking speed, shorter stride length and increased gait variability (16; 17). 
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Small changes in gait variability (stride length variability, stride time variability) have been identified as 
reliable fall predictors in older adults (17–20). Furthermore, increased base of support is also 
predictive of falls (19). Understanding how gait is influenced by different walking aids may help to 
distinguish between pathological gait alterations and healthy, compensatory reactions to the use of a 
walking aid. Although some normative gait data from a selected group of very healthy older adults has 
been  previously described (21), data from population studies is needed to know what “normal” gait is 
in a representative population of older adults, including those who use walking aids. 
The first objective of this study was to investigate whether people over the age of 60 who use a single-
tip cane, a fore-arm crutch or a four-wheeled walker have differences in spatio-temporal gait 
parameters while walking normally (self-selected pace) with versus without their usual walking aid. 
The second objective was to compare these gait parameters to an independently mobile matched 
control group. We hypothesized that walking aid users would walk faster, would have a smaller base 
of support and a decreased stride time variability with their walking aid compared to walking without 
their walking aid. Wen also hypothesized that all gait parameters would be more variable in the group 
of walking aid users when compared to a matched control group. 
Methods 
Study design and population 
In this retrospective, cross-sectional study, data was collected between January 2007 and October 
2011 from patients at the Basel Mobility Center, University Hospital of Basel, Switzerland. The study 
was approved by the local ethics committee.  
The data used for this study was extracted from an existing database. Inclusion criteria were as 
follows: (I) Age older than 60 years, (II) community-dwelling, (III) use of a walking aid during 
ambulation outdoors (those who used a walking aid only indoors were excluded, those who used a 
walking aid indoors and outdoors or only outdoors were included) for at least one month prior to their 
gait analysis, (IV) use of a single-tip cane, fore-arm crutch or four-wheeled walker, (V) available data 
for gait analysis with and without walking aid, and (VI) Mini Mental State Examination (MMSE) score 
available. Exclusion criteria were as follows: (I) Use of several different walking aids (e.g. cane for 
shorter distances and walker for longer distances), (II) use of a cane or crutch on both sides (because 
these subgroups of walking aid users were too small in this study to permit meaningful analysis), (III) 
improper use of the walking aid (moving cane/crutch with the ipsilateral rather than the contralateral 
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leg; holding the cane or crutch in air while taking multiple steps), (IV) severe neurological (normal 
pressure hydrocephalus, stroke with residual hemiplegia, Parkinson syndromes), orthopedic (severe 
osteoarthritis of the hips or knees, amputations with or without a prosthesis), or psychiatric illness 
(major depression, schizophrenia) causing inability to understand or follow task instructions or to walk 
15 meters without assistance, (V) terminal illness with life expectancy less than 12 months.  
Of the sample of 366 walking aid users, 65 fulfilled the eligibility criteria and were classified into one of 
three groups according to type of walking aid used: A single-tip cane (hereafter referred to only as 
cane), a forearm crutch (hereafter referred to only as crutch) or a four-wheeled walker (hereafter 
referred to only as walker). All walking aids were the personal property of the patients. No alternative 
walking aids were given and no setting adjustments of the aids were done at the Basel Mobility 
Center. 
The patients with walking aids were matched to controls from the same database according to gender, 
age and MMSE. 
Gait assessment 
The spatio-temporal parameters of gait were collected with the GAITRite® system (GAITRite®
Platinum, CIR System, Sparta, NJ, USA), a 10-meter-long electronic walkway with integrated pressure 
sensors (22). The walking trials were performed according to the European guidelines for spatial-
temporal gait analysis (23). The standard gait analysis at the Basel Mobility Center consists of five 
different walking tasks, whereas walking at self-selected normal walking speed (referred to as normal 
walking in this text) represents the first task. Normal walking with the aid (for those who had them) was 
performed as an additional sixth task. Details regarding the description of the gait analysis at the Basel 
Mobility Center have been reported elsewhere (15). Before testing, a trained evaluator gave 
standardized verbal instructions regarding the test procedure. In order to measure steady-state gait, 
the patients initiated and terminated each walk 1.25 m before and after the 10 m walkway allowing 
sufficient distance to accelerate and decelerate. Each subject performed one trial for each of the 
testing conditions. No practice trials were performed. To ensure safety, a belt was placed around each 
patient’s waist for easy grasp by the trained evaluator who walked behind the patients during all trials. 
The patients performed all trials wearing their own footwear and used their own walking aid for the 
walking aid condition. A video camera was used during the gait analysis to allow detailed review. 
Effect of walking aids on gait in older adults  6 
Primary outcome measures were the following nine spatio-temporal gait measures: Gait speed (cm/s), 
cadence (number of steps per minute), stride time (s), stride time variability (%), stride length (cm), 
stride length variability (%), base of support (cm), base of support variability (%) and double support 
(percentage of gait cycle). Variability variables were quantified as the coefficients of variation (CV = 
(standard deviation / mean) x 100). 
Clinical evaluation and assessments 
Clinical assessment including a physical examination was performed by a physician or a trained 
research assistant. The following data was used for the present study: age, sex, height, weight, falls
(defined as unintentionally coming to rest on the ground or other surface (24)) in the preceding 12 
months (single-item question), fear of falling (single-item question), and relevant medical problems. 
Cognitive status was evaluated by the score of the Mini Mental State Examination (25), whereby 
cognitive impairment was defined as a score less than 24 out of a maximum 30 points. Basic mobility 
was assessed with the Timed Up & Go Test (TUG) (26). The TUG measures the time in seconds that 
it takes an individual to rise from a chair with armrests, walk 3 m, turn, walk back and sit down again. 
Older adults who require 14 seconds or longer to complete the task have a high risk for falls (27). 
Statistical analysis 
Characteristics of baseline assessment and gait parameters were summarized descriptively using 
either means and standard deviations or frequencies and percentages, as appropriate. Analyses were 
performed between the walking aid group and the matched control group and between the subgroups 
according to the type of walking aid (cane, crutch, walker). Test for normality (Shapiro-Wilk test) and 
homogeneity of variance (Levene’s test) were performed for all outcomes. For continuous variables, 
comparisons between the walking aid group and the matched control group were performed using the 
t-test and between subgroups using the one way analysis of variance (ANOVA) when normally 
distributed, or the Mann-Whitney U test and the Kruskal-Wallis test when not. Post hoc tests were 
completed when a statistically significant value resulted to determine where the difference occurred. 
Gabriel’s procedure was applied in normally distributed gait parameters; Mann-Whitney test was 
applied in not normally distributed gait parameters, in this case level of significance was set at p < 
0.017. The chi-square test or Fisher’s exact test was used for nominal variables. Evaluation of the 
difference between the normal condition and the walking aid condition within the three subgroups was 
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completed by the paired t-test or the Wilcoxon test. Probability values less than 0.05 were considered 
statistically significant. Analyses were conducted using the SPSS version 19.0 (SPSS, Inc., Chicago, 
IL) software program for Windows. 
Results 
Study population  
Of the 65 walking aid users included in this study, 40 used a cane (average age 82.4 ± 5.7, 25 
females), 13 used a crutch (average age 79.4 ± 6.3, 9 females) and 12 used a walker (average age 
84.3 ± 3.9, 8 females). The patient’s duration of walking aid use ranged from one month to 15 years, 
with an average of 2.7 ± 2.7 years and a median of two years. Eleven patients were not able to recall 
how long they had been using their walking aid. Patient’s characteristics did not differ between the 
three groups of walking aid users (data not shown). Scores on the MMSE demonstrated that 49 
(75.4%) had an MMSE score  24 points and 16 (24.6%) had an MMSE score < 24 points. 
Performance on the TUG differed between the walking aid users. Those with a cane had the fastest 
TUG time (average 17.0 ± 4.4 s), followed by the crutch users (average 18.9 ± 6.1 s) and then the 
walker users (average 21.1 ± 9.2 s). However, the TUG times did not significantly differ between the 
three groups (p = 0.095).  
A summary of descriptive data of the entire group of walking aid users and matched controls is shown 
in Table 1. Compared to the control group, the walking aid group experienced more falls in the 
previous twelve months (p = 0.003), more often had fear of falling (p < 0.001), had a higher BMI (p = 
0.024), and needed more time to perform the TUG test (p < 0.001). Because of missing information for 
the variables falls, fear of falling and living arrangement, the number of patients in the walking aid 
group was reduced to 60, 56, 58 respectively and in the matched control group to 189, 185, 192 
respectively. 
Gait measurement 
Gait measures from the walking aid group as a whole without the use of a walking aid and the 
matched control group are summarized in Table 2. Gait performance for all investigated parameters (p 
< 0.001), except for base of support variability (p = 0.179), was significantly worse in the walking aid 
group compared with matched controls.
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Description and statistics of gait parameters between the different walking aid users are shown in 
Table 3. Overall for the walking aid group, gait performance without the use of a walking aid was best 
in cane users and worst in walker users. Significant group differences were found for stride time 
variability (p = 0.024) and double support (p = 0.026) between all three groups. Significant post hoc 
differences were found for double support between cane and walker users (p = 0.036). No significant 
post hoc differences were found for stride time variability (cane vs. crutch, p = 0.045; cane vs. walker, 
p = 0.023, crutch vs. walker, p = 0.789). When assessed with the use of their walking aid, no 
significant results were found between the three groups of walking aid users.  
Differences between gait measures with and without the use of the individual walking aid are 
summarized in Table 4. Comparison of gait speed, stride time variability and double support are 
presented in Fig. 1-3. Use of a cane led to significantly improved performance in cadence (p = 0.002), 
stride time (p = 0.004), stride length (p = 0.002), stride time variability (p = 0.004) and double support 
(p = 0.013). Use of a crutch led to significantly improved performances in all assessed gait parameters 
(p < 0.005), expect for gait speed and base of support measures. Use of a walker led to significantly 
improved gait performance in gait speed (p = 0.001), stride time variability (p = 0.045), stride length (p 
= 0.002), stride length variability (p = 0.019), base of support (p = 0.006) and double support (p = 
0.001). 
Discussion 
The aim of the present study was to quantify the effect of walking aids on spatio-temporal gait 
parameters in community-dwelling older people and to compare these gait parameters to an 
independently mobile matched control group. To date, no quantitative data exist on the comparison of 
gait alterations in experienced walking aid users during unassisted walking and during walking with a 
cane, crutch or walker. Our findings showed that the gait pattern among experienced walking aid users 
when they did not use their waking aid was more vulnerable and unstable compared to an 
independently mobile control group matched by age, sex and cognition. We were able to demonstrate 
that differences in spatio-temporal gait parameters during unassisted walking were relatively discrete 
between the three groups of walking aid users and that no between-group differences existed when 
the walking aid was used. We also showed that the use of a walking aid significantly improved walking 
ability within each of the three walking aid groups. Finally, the present study provides descriptive data 
of gait performance in community-dwelling older people using three different types of walking aids. 
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Gait speed is a well-known indicator of overall functional performance. Those with slower gait are at 
higher risk for functional as well as cognitive decline, institutionalization, falls and mortality (28). Gait 
speed of less than 60 cm/s is used to define slow gait, between 60 cm/s and 100 cm/s defines 
intermediate gait and more than 100 cm/s normal gait (28). In the present study, patients using 
walking aids had a significantly slower gait during unassisted walking compared to a matched control 
group (74.4 vs. 110.3 cm/sec). This indicates that the use of a walking aid is likely a marker for 
impaired gait and not that the use of a walking aid causes slower gait. In addition to gait speed, all 
investigated gait parameters, except for base of support variability, were significantly better in the 
control group than the walking aid group. Particularly gait variability is known as a marker for irregular 
and unstable gait and is associated with frailty (29) and an increased fall risk (17–19). Studies 
comparing gait parameters between fallers and non-fallers among older people have revealed that 
fallers have slower gait speed, increased double support, stride length variability and stride time 
variability (17–19). These findings are in accordance with our present study suggesting that walking 
aid users might have a greater likelihood of falling than independently mobile older people. The 
demographic characteristics of the present study support this notion showing that walking aid users 
had more falls in the previous 12 months than the matched controls (50% vs. 29%). In addition, the 
walking aid users reported to have fear of falling more often which is known to negatively influence gait 
performance (19) and is associated with an increased fall risk (30). 
This study demonstrated that there were only discrete differences in spatio-temporal gait parameters 
among the three groups of walking aid user (cane, crutch, walker). These findings are in contrast to 
our expectations. Since the selection of the walking aid depends on the individual’s functional level 
and the support of the device increases from cane to crutch to walker, it was hypothesized that cane 
users would show a better gait pattern than crutch users and that they in turn would perform better 
than walker users. Although differences in spatio-temporal gait parameters while walking unassisted 
were relatively discrete, the gait pattern of the cane users tended to be better than the gait pattern of 
crutch users and walker users with a significant difference in stride time variability and double support. 
Interestingly, neither a significant difference in one of the investigated gait parameters nor a tendency 
between the three groups during assisted walking was detected. From a clinical point of view, it would 
be of great interest to investigate if an initial objective gait analysis would help in the selection of an 
appropriate walking aid. 
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Within each subgroup of walking aid users, gait performance was significantly better in several gait 
parameters when assessed during walking with the walking aid compared to walking unaided. Using a 
walker had the greatest effect on spatial (stride length and its variability) and temporal (gait speed, 
stride time variability, double support) gait parameters. Particularly, an increase in gait speed of 14.5 
cm/s was observed in the walker group whereas using a cane or crutch did not influence gait speed. 
Verghese et al. (17) reported that each 10 cm/s decrease in gait speed was associated with a 7% 
increased risk for falls. Based on the results in gait speed, it could be concluded that only the use of a 
walker provides a benefit. However, one should be aware that walking speed may be affected by other 
gait parameters. The increase in gait speed among the walker group arising from increased stride 
length could not be observed in the cane and crutch group due to the simultaneous reduction in 
cadence. Another explanation for the increase in gait speed may be that the use of a cane or crutch 
requires the user to lift the device in time with their stepping whereas the walker allows the person to 
push the device without lifting it. However, other gait parameters in addition to gait speed are needed 
to fully understand gait stability in regard to falls prevention.  
The use of a mobility aid enlarges a person’s supporting area (not to be confused with the base of 
support gait parameter; see Fig. 2), thereby improving balance (7). In this context, Bateni and Maki (7) 
suggest that a walker enlarges the supporting area more than a cane and therefore the potential to 
increase stability is even greater. Considering the base of support measured by the GAITRite system, 
patients within the walker group had a 4 cm decrease in their base of support during assisted walking. 
Maki BE (19) reported that a 4 cm increase in the base of support of was associated with an increased 
risk for future falls. Hence, changes in gait parameters seen in our study, particularly decreased base 
of support and double support, as well as increased stride length indicate that patients adopted a more 
stable gait pattern when using their walking aid. These changes are more pronounced in the walker 
group compared to the crutch group, and this in turn more than the cane group. 
Another marker of gait stability is the stride-to-stride variability, which can be viewed as a marker of 
gait regularity. High stride-to-stride variability reflects gait instability (19). Our findings show that 
walking with a crutch or walker produced a gait pattern with decreased stride time variability and 
decreased stride length variability. The use of a cane significantly decreased stride length variability. 
Taken together, these findings indicate that patients in each group adopted a safer and less variable 
(i.e. more regular and thus more stable) gait when utilizing their individual walking aid. Previous 
studies have been shown that higher variability in stride time and stride length is associated with 
Effect of walking aids on gait in older adults  11 
increased falls in older adults (17; 19; 20). Hence, utilizing a cane, crutch or walker would indicate a 
lower fall risk in these three groups of experienced walking aid users when walking with their device 
than without it.  
Walking is generally seen as an automatic motor task in healthy adults. However, there is growing 
evidence that older adults require more attention for motor control while walking than younger adults 
(31). A common situation where attentional demands are challenged is, for example, when people 
walk while simultaneously performing one or more additional tasks. The ability to safely and effectively 
use a walking aid during ambulation characterizes such an additional attention-demanding task. Thus, 
it could be speculated that the attentional demands associated with the use of a walking aid could well 
lead to an altered gait performance. To date, only two studies used a dual task paradigm to examine 
the attentional demands of walking aid use. Wright and Kemp (32) showed that the performance on a 
voice reaction time task during ambulation in 10 healthy young adults required greater attention using
a standard pickup walker in comparison to using a rolling walker or walking unaided. Wellmon et al. 
(33) extended the work of Wright and Kemp (32) by investigating the same dual task paradigm in older 
adults who ambulated with either a rolling walker, a straight cane or used no device. Their results 
demonstrated that walking with a rolling walker required greater attention compared to not using an 
assistive device (33). In both studies, the increased attentional requirements under the dual task 
condition could only be measured in the voice reaction time task and not in gait performance.  
Another way to reveal the attentional demands of using a walking aid is the comparison of gait 
performance between experienced walking aid users and first-time users. Studies investigating the 
effect of walking aids on gait in first-time users showed that gait performance remained unchanged or 
even worsened (34–37). In contrast, studies with experienced walking aid users demonstrated an 
improvement in gait performance (38; 39), similar to the results in the present study. Due to the wide 
variety of methodological procedures and study populations a final conclusion to guide clinical practice 
needs more research in this area. However, it is of utmost importance to provide prior training before
the use of walking aids and to reevaluate its need after a certain time span to guarantee the safe and 
effective use of the device. 
When interpreting the results a few factors need to be taken into consideration. First, the number of 
patients in the crutch and walker group was small compared to the cane group, which might have 
influenced study results. However, the statistical procedures used considered the different sample 
sizes and the distribution of the gait variables. Also, patients with a range of mobility and health status 
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were included. Unfortunately, health status was not consistently measured and therefore could not be 
classified. Finally, the reason for use of the chosen walking aid was not part of the standard 
assessment which means little or nothing was known about the actual need for such devices. Future 
studies should also include standardized measures of health status and co-morbidities as well as the 
reason for use and compare the effect of walking aids among different patient groups according to 
health status, reason for using or cognitive status.  
Conclusion 
This study is the first to report on the effect of different types of walking aids on quantitatively 
measured gait parameters in community-dwelling older people. The findings of the present study 
demonstrate that the use of a cane, crutch or walker increased gait speed (only in walker group) and 
stride length, and decreased cadence (in cane and crutch group), stride time variability (in crutch and 
walker group), stride length variability and double support (in all three walking aid groups). The results 
suggest that these changes are a compensatory reaction to the use of the walking aid rather than an 
indication of a pathological gait pattern in this group of experienced older walking aid users. However, 
the walking aid group had a higher stride time variability and stride length variability, than the matched 
control group. Therefore, using a walking aid improved gait performance but not to a degree that it can 
be called a healthy, stable gait pattern. Therefore, the selection of a walking aid should depend on 
objective gait assessments and periodical reevaluation to ensure that it suits a person’s functional 
requirements and physical capabilities.
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Figure legends 
Fig. 1 - Gait speed (A) and stride time variability (B) for walking with vs. without walking aid by walking 
aid group. *Denotes significant differences within a walking aid group. 
Fig. 2 - Schematic illustration of the base of support as measured by GAITRite and of the supporting 
area of a walker. Figure modified from Bateni and Maki (7). 
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Figures 
Fig. 1A to 1B 
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Fig. 2 
Base of support 
Walker post 
Supporting area of the walker
Ground contact area of left and right foot
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Tables 
Table 1 - Participants characteristics.
Variable Walking aid group (n=65) Matched control group (n=195) p-value 
Age, years 82.1 ± 5.7 81.9 ± 5.4 0.732 
Gender  1.000 
 Male, % 35.4 35.4  
 Female, % 64.6 64.6  
MMSE score, points 25.4 ± 4.4 25.5 ± 4.2  0.906 
Previous fall in the last 12 monthsa  0.003 
 none, % 50.0 70.9  
 1 or more, % 50.0 29.1  
Fear of falling a , % 30.4 10.3 <0.001 
Living arrangementa, %  0.663 
 Lives alone 43.1 46.4  
 Cohabits 56.9 53.6  
Height, cm 164.7 ± 8.6 164.9 ± 8.8 0.877 
Weight, kg 71.9 ± 13.6 68.5 ± 12.7 0.074 
BMI, kg/m2 26.4 ± 4.1 25.1 ± 3.9  0.024 
TUG, s 18.2 ± 6.0 11.6 ± 3.0  <0.001 
aThe number of patients in each group is less than the entire sample due to missing information. Values are means ± standard deviation or 
percentages. MMSE: Mini Mental State Examination. TUG: Timed Up & Go test.
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Table 2 - Gait measures in normal walking without walking aid.
Gait parameter Walking aid group (n = 65) Matched control group (n = 195) p-valuea
Gait speed, cm/s 74.4 ± 19.0 110.3 ± 20.5 <0.001 
Cadence, steps/min 100.3 ± 11.7 111.2 ± 10.7 <0.001
Stride time, s 1.1 ± 0.14 1.1 ± 0.11 <0.001 
Stride time CV, % 3.5 ± 1.7 2.3 ± 1.0 <0.001 
Stride length, cm 88.9 ± 18.7 118.9 ± 17.1 <0.001 
Stride length CV, % 5.3 ± 3.0 3.0 ± 1.5 <0.001 
Base of support, cm 11.9 ± 4.6 8.7 ± 3.3 <0.001 
Base of support CV, % 24.6 ± 31.3 29.8 ± 25.3 0.179
Double support, % of gait cycle 36.4 ± 6.7 29.1 ± 2.7 <0.001 
aIndependent t-test. Values are means ± standard deviation. CV: coefficient of variation.
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Table 3 - Gait measures with and without walking aid.
Gait parameter Cane (n = 40) Crutch (n = 13) Walker (n = 12) p-value 
Without walking aid     
 Gait speed, cm/s 77.6 ± 18.6 70.6 ± 20.5 68.2 ± 18.0 0.237a
 Cadence, steps/min 100.3 ± 11.5 98.7 ± 10.4 101.95 ± 14.4 0.789a
 Stride time, s 1.2 ± 0.15 1.2 ± 0.13 1.2 ± 0.15 0.939b
 Stride time CV, % 3.0 ± 1.3 4.1 ± 1.8 4.4 ± 2.3 0.024b
 Stride length, cm 92.6 ± 18.1 85.5 ± 19.4 80.4 ± 18.1 0.107a
 Stride length CV, % 4.7 ± 2.0 5.3 ± 2.9 7.2 ± 4.7 0.354b
 Base of support, cm 11.3 ± 3.9 12.2 ± 6.1 13.6 ± 4.9 0.297a
 Base of support CV, % 23.3 ± 25.2 26.0 ± 33.9 27.5 ± 46.6 0.587b
 Double support, % of gait cycle 34.7 ± 6.1 38.4 ± 6.9 39.9 ± 6.8 0.026a
     
With walking aid     
 Gait speed, cm/s 78.7 ± 17.8 74.7 ± 16.9 82.7 ± 18.0 0.355b
 Cadence, steps/min 95.5 ± 9.7 92.0 ± 9.5 98.5 ± 12.5 0.285a
 Stride time, s 1.3 ± 0.13 1.3 ± 0.14 1.2 ± 0.17 0.370a
 Stride time CV, % 2.8 ± 0.9 3.0 ± 1.3 2.7 ± 0.9 0.736a
 Stride length, cm 98.8 ± 18.9 96.7 ± 15.9 100.7 ± 17.6 0.699b
 Stride length CV, % 3.9 ± 1.5 3.8 ± 1.8 4.1 ± 2.0 0.915a
 Base of support, cm 10.7 ± 3.7 10.5 ± 5.2 9.6 ± 3.4 0.338b
 Base of support CV, % 21.2 ± 18.0 22.0 ± 21.5 12.1 ± 6.5 0.151b
 Double support, % of gait cycle 33.4 ± 4.9 35.7 ± 6.3 34.2 ± 4.7 0.373a
aANOVA. bKruskal-Wallis test. Values are means ± standard deviation. CV: coefficient of variation. 
Effect of walking aids on gait in older adults  23 
Table 4 - Gait measures of differences between test results without and with walking aid.
Gait parameter Cane (n = 40) p-value Crutch (n = 13) p-value Walker (n = 12) p-value 
Gait speed, cm/s +1.1 ± 14.2 0.626 +4.0 ± 12.1 0.251 +14.5 ± 10.6 0.001 
Cadence, steps/min -4.8 ± 9.0 0.002a -6.7 ± 8.4 0.019a -3.4 ± 12.2 0.394a
Stride time, s +0.06 ± 0.12 0.004a +0.089 ± 0.11 0.019a +0.042 ± 0.12 0.410a
Stride time CV, % -0.16 ± 1.4 0.480 -1.1 ± 1.4 0.016 -1.7 ± 2.6 0.045 
Stride length, cm +6.2 ± 11.2 0.002a +11.2 ± 9.9 0.006a +20.3 ± 9.4 0.002a
Stride length CV, % -0.76 ± 1.6 0.004 -1.5 ± 2.3 0.034 -3.2 ± 4.0 0.019 
Base of support, cm -0.52 ± 1.8 0.104a -1.7 ± 2.7 0.221a -4.0 ± 3.1 0.006a
Base of support CV, % -2.1 ± 17.3 0.502a -4.0 ± 15.1 0.422a -15.3 ± 41.6 0.182a
Double support, % of gait cycle -1.36 ± 3.3 0.013 -2.7 ± 2.8 0.005 -5.7 ± 4.1 0.001 
P-values for paired t-test or aWilcoxon signed rank test. Values are means ± standard deviation. CV: coefficient of variation. 
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54. BACKGROUND 
4.1 INTRODUCTION 
The responsible and principal investigator of this investigator-driven study and PhD project of Yves 
Gschwind is Prof. Reto W. Kressig. This randomized, placebo-controlled, double-blind exploratory 
study will evaluate the effect of Symfona® forte with its active agent Ginkgo Biloba special Extract LI 
1370 (GBE) on dual-tasking in patients with Mild Cognitive Impairment (MCI). All investigations will be 
conducted at the Basel University Hospital, Switzerland. The research is supported by the Acute 
Geriatric Clinic’s research fund and an unrestricted educational grant by Vifor Société Anonyme (SA). 
4.2 MILD COGNITIVE IMPAIRMENT (MCI) 
According to the report of an international working group (Winblad et al., 2004) the diagnosis of MCI is 
based on the following 3 criteria: 
(1) The person is neither cognitively normal nor demented. 
(2)  There is evidence of cognitive deterioration shown by either objectively measured decline over 
time and/or subjective report of decline by the person and/or a proxy informant in conjunction with 
objective cognitive deficits. 
(3) Activities of daily living are preserved and complex instrumental functions are either intact or 
minimally impaired. 
Patients with MCI are further distinguished according to the cognitive domains affected: amnestic vs. 
non-amnestic and single vs. multiple domain. Thus, 4 subgroups of MCI exist: amnestic single 
domain, amnestic multiple domain, non-amnestic single domain and non-amnestic multiple domains. 
Once the clinical subclassification has been made, the proposed etiology of the clinical syndrome 
should be determined, similar to the evaluation that most clinicians perform in order to determine
subtypes of dementia. For patients with amnestic impairment (single or multiple domain(s)) who had 
been diagnosed according to the previous MCI criteria (Petersen et al., 2001), the progression rate to 
Alzheimer Disease (AD) within 3 years was reported to be more than 40% (Palmer et al., 2007). This 
rate did not change when the new criteria that are outlined above were used (Palmer K, personal 
communication with Monsch AU). At the Memory Clinic of the Basel University Hospital, 17% of 
patients diagnosed with MCI convert to AD within one year. However, to this date, the question of 
longitudinal outcomes (deterioration to dementia vs. stable vs. improvement back) remains unclear. 
4.2.1  Role of Gait in Relation to Cognition (Executive Function) for Gait Safety in Older adults 
The examination of spatio-temporal gait parameters in older adults enhances our understanding of 
movement control and is useful in quantifying outcomes of therapeutic interventions (Kressig and 
Beauchet, 2004). In particular, a safe and efficient gait is important for mobility and independence of 
the elderly (Nelson et al., 1999). In addition, the ability to adapt gait patterns to different situations has 
a central role in the safety of gait. In the elderly, the combination of daily living activities and walking 
becomes more difficult and often turns into a complex multi-task situation (Beauchet et al., 2007). 
Further, in conjunction with Alzheimer’s disease, patients often develop considerable difficulties with 
gait and postural stability (Sheridan et al., 2003). 
Walking, as an automated motor behavior, is mostly controlled by subcortical locomotor brain regions 
but might require higher levels of attention with increasing age due to sensorial losses such as low 
vision or peripheral polyneuropathy (Kressig and Beauchet, 2004). Locomotor function depends on 
executive function that can be affected in cerebral diseases such as MCI or dementia (Sheridan et al., 
2003). Deficits in language and visual spatial skills can be caused by loss of attention and are 
common in patients with mild dementia and mild cognitive impairment (MCI) (Hulette et al., 1998). 
These executive dysfunctions may be controlled by the same brain networks responsible for the timing 
6and sequencing of motor activity (Sheridan et al., 2003). In the Einstein cohort Aging Study by 
Verghese et al. (2006), typical gait changes (irregular gait) were identified that preceded dementia by 
five years as diagnosed by neuropsychological and cerebral imaging assessments.    
Further, it was shown by Nakamura et al. (1997) that in subjects with dementia, reduced regional 
cerebral blood flow was significantly correlated with worsened gait patterns (i.e. decreased walking 
speed and increased gait irregularity with increasing severity degree of dementia). 
4.2.2 Gait Parameters and Postural Stability
Gait variability is a quantifiable feature of walking that is altered (in terms of both magnitude and 
dynamics) in clinically relevant syndromes such as falling, frailty and neuro-degenerative disease 
(Sheridan et al., 2003). In the past, Maki (1997) showed that increased gait variability represents 
impaired motor control as well as an increased fall risk. 
Today’s most important gait parameter for postural stability in older walking adults is stride-to-stride 
variability (= gait regularity). Hereby, high gait variability corresponds to irregular gait whereas low gait 
variability corresponds to regular gait. Stride-to-stride variability is measured by the coefficient of 
variation (CV = [SD / mean] x 100) which is used as a clinical index of gait steadiness and has been 
found to be a sensitive predictor of falls in the elderly (Maki, 1997; Hausdorff et al., 2001; Allali et al., 
2007; Priest et al., 2008). In fact, an increase in stride length of 1.7cm from one stride to the next 
doubles the likelihood of falling in the next six months (Maki et al., 1997, Kressig et al., 2008). 
Stride time variability reflects the regularity of the walking rhythm which is considered an indicator of 
gait control (Hausdorff et al., 2001). Under normal walking and specifically under dual-task conditions 
(walking with simultaneous performance of other tasks, either motor or cognitive), high stride-time 
variability, a measure of gait unsteadiness, is strongly associated with impaired executive function and 
a high risk of falling in older people (Hausdorff et al., 2001; Sheridan et al., 2003; Hausdorff, 2005; 
Kressig et al., 2008). Hence, gait variability might represent a sensitive and relevant surrogate marker 
to measure the effects of therapeutic interventions in fall prevention (Hausdorff, 2005). 
4.2.3 Walking-Associated Dual-Tasking 
A main goal of using a dual-task paradigm while walking is to determine to what extent walking 
requires attention in an older subject. Normally, walking is a mostly automated behavior needing no or 
minimal attention. Dual-task-related gait changes provide an indicator of change in gait control 
(Beauchet and Berrut, 2006). Gait interference caused by dual-tasking is important for the occurrence 
of falls, because safe locomotion depends on efficient and mostly automated gait control (Beauchet et 
al., 2005c). Dual-tasking-induced gait changes are also used to explore the cortical involvement in gait 
control (Allali et al., 2006). In addition, there is growing evidence that gait changes are associated with 
the incidence of dementia and cognitive decline (Beauchet and Berrut, 2006). 
4.2.4 Two Types of Walking Associated Cognitive Tasks: Semantic and Working Memory Tasks 
Semantic verbal fluency relies on semantic memory counting backwards relies on working memory. 
The latter is a system for temporary storage and processing of information and is therefore more 
directly related to executive function (Beauchet et al., 2005a). Cognitive activity while walking, such as 
mental calculation may reduce gait velocity (Beauchet et al., 2005a; Priest et al., 2008). In addition, 
the required attentional demands for walking while simultaneously counting backwards may overload 
available central resources and explain major dual-task-related gait changes (Dubost et al., 2006; 
Allali et al., 2006). Verbal fluency (i.e. naming animals) on the other hand, assesses fluency and 
speed of mental processing (Sheridan et al., 2003). Consequently, combining an arithmetic task with 
walking could be related to competitive interaction with executive function in the elderly (Beauchet et 
al., 2005c).  
7Recently, Beauchet et al. (2005b) reported decreased gait speed and increased coefficient of variation 
(CV) of stride time when older subjects with a broad range of cognitive function disabilities (i.e. mild 
dementia) performed the dual-task of walking while counting backwards. These findings suggest that 
difficulties in the ability to appropriately allocate attention between two simultaneously performed tasks 
(walking and counting backwards) result in major competitive interactions with executive function 
(Beauchet et al., 2003, see also Sheridan et al., 2003). In other words, dual-task interference on gait is 
based on the cerebral capacity to divide attentional resources between gait and an additional task 
(Beauchet et al., 2005c).  
In a recent pilot trial (Assal et al, 2008) Alzheimer’s patients with impaired dual-task-associated gait 
performance (significant decrease of gait speed under a dual-task condition) normalized their dual-
task-related gait speed after 6 months of treatment with Galantamine, a cholinesterase inhibitor 
commonly used in the treatment of Alzheimer’s disease. 
4.2.5 Summary  
Deficits in executive function and attention are associated with typical gait disorders (decreased 
walking speed, increased gait variability) under dual-task conditions (walking while simultaneously 
performing cognitive tasks necessitates “divided attention”). A substance or drug with proven positive 
effects on cerebral concentration and attention might increase the ability to divide attentional 
resources in executive dysfunctional MCI patients and therefore positively influence gait performance 
under dual-task situations. Furthermore, this may improve gait safety in these patients with increased 
fall risk. 
4.3 GINKGO BILOBA EXTRACT 
4.3.1 Introduction 
Over the last three decades, the use of Ginkgo biloba special extract (GBE, standardized at 25% 
flavone glycosides and 6% terpene lactones) for the treatment of cognitive disorders has increased 
drastically. This results from a large number of pharmacological and clinical studies demonstrating the 
positive effects of ginkgo in elderly patients with cerebro-vascular insufficiency, impaired cerebral 
performance, cognitive impairment or mild to moderate dementia.  
4.3.2 Pharmacological Aspects 
Although the mechanism of action of ginkgo is only partially understood, the effects of ginkgo can be 
summarized in two main groups of actions: effects on microcirculation as well as antioxidant and 
neuroprotective effects.  
GBE might benefit CNS and vascular conditions by improving blood flow to capillaries throughout the 
body including the CNS, eyes, ears, extremities, and other tissues. GBE likely improves circulation by 
decreasing blood viscosity and affecting vascular smooth muscle. GBE restores the balance between 
prostacyclin and thromboxane A2, resulting in improved vasoregulation. Therefore, GBE relaxes 
spasmodic contracting vasculature and constricts abnormally dilated vessels. Overall, ginkgo seems 
to increase cerebral and peripheral blood flow microcirculation and reduces vascular permeability 
(Diamond et al., 2000). Moreover, ginkgolides (obtained from the ginkgo leaf) competitively inhibit 
platelet activating factor (PAF) by binding to membrane receptors of various cells (Kudolo et al., 2002). 
GBE has strong antioxidant and free radical scavenging properties (Logani et al., 2000; Ahlemeyer et 
al., 2003). The flavonoids seem to prevent or reduce cell membrane lipid peroxidation (Oken et al., 
1998), decrease oxidative damage to erythrocytes, and also protect neuronal mitochondrial function 
from oxidative stress (Eckert et al., 2003) and injury following ischemic episodes (Logani et al., 2000). 
There is preliminary evidence that GBE can inhibit toxicity and cell death induced by beta-amyloid 
peptides (Bastianetto et al., 2000; Bate et al., 2008). However, this has not yet been demonstrated in 
vivo. Ginkgo might also influence certain neurotransmitter systems, such as the cholinergic system 
8and seems to produce EEG changes similar to those caused by the acetylcholinesterase inhibitor 
tacrine (Itil et al., 1998). 
4.3.3 Clinical Data 
Numerous studies on patients with a cognitively impaired functioning have shown positive effects of 
GBE on memory (e.g. short term, verbal memory) (Graessel, 1992; Hofferberth, 1994; Semlitsch et al., 
1995; Mix and Crews, 2002), learning rate (Graessel, 1992), speed of information processing (Allain et 
al., 1993), speed of responses (Rai et al. 1991) and attention (Hofferberth, 1994) as compared to 
placebo. Furthermore, a meta-analysis of 11 controlled trials with the GBE LI 1370 confirmed the 
effectiveness of the extract, while in one study the findings were inconclusive (Hopfenmüller, 1994). 
Since the study by Le Bars et al. (1997) showed the efficacy of GBE in patients with dementia, clinical 
researcher focused more on the efficacy of GBE in dementia and several studies confirmed these 
positive results (Maurer et al., 1997; Oken et al., 1998; Kanowski and Hörr, 2003; Mazza et al., 2006; 
Napryeyenko et al., 2007; Scripnikov et al., 2007). However, two studies did not show positive effects
of ginkgo in patients with dementia (Van Dongen et al., 2000; Schneider et al., 2005). 
Most studies evaluated the efficacy of the GBE by measuring cognitive performance. Only a few trials 
investigated the impact of GBE on functioning in everyday living or on mood (Trick et al. 2004; Woelk 
et al. 2007), although a positive effect on Activities of Daily Living (ADL) might represent the patient's 
most relevant clinical impression of improvement. 
4.3.4 Safety Data 
In general, according to published studies and reports, the use of Ginkgo seems safe and well 
tolerated. Birks and Grimley (2009) found no serious adverse effects for GBE compared to placebo 
(Birks and Grimley, 2009). A recent study by Mahadevan and Park (2008) supports these findings and 
reports a relatively low toxicity risk in association with the consumption of Ginkgo leaf products. 
Although rare, reported side effects include gastrointestinal disturbances, headaches or allergic skin 
reactions (Sierpina et al., 2003). Although rare, there were reports about individual cases of 
hemorrhages, mainly in high-risk patients. To date, however, a direct causal relationship between 
GBE intake and hemorrhages could not be established.   
In conclusion, the use of GBE may be promising for treatment of certain conditions, although its long-
term use still needs to be evaluated (Mahadevan and Park, 2008). In the present study, safety of 
participants will be assessed by evaluation of patient history at baseline and monthly recalls. In case 
of adverse events or side effects patients have to report the incident immediately to the principal 
investigator and clinical physician. All corresponding data and Serious Adverse Events (SAE) will be 
listed on the Case Report Form (CRF) and conveyed to the local ethics committee (EKBB) and 
Swissmedic.  
5. TRIAL OBJECTIVES AND HYPOTHESIS 
The aim of this study is to evaluate the effects of GBE in patients with MCI and impaired executive 
function as assed by gait analysis while walking alone as well as under differing dual-task conditions. 
Therefore, we will evaluate the gait-related effects of GBE by measuring mean values and coefficients 
of variation of stride velocity, stride time and stride length for all walking conditions. In addition, we will 
determine if stride time variability (CV = [SD / mean] x 100), as the most sensitive parameter for gait 
safety while dual-tasking, can be positively affected by GBE. The primary endpoint in the evaluation of 
GBE efficacy is gait speed. The secondary endpoint is cycle time variability under dual-task 
9conditions. In addition, the study will enable further evaluation of safety and tolerability of the study 
medication in this study population. 
We hypothesize that executive function-impaired MCI patients will exhibit a difference in gait variability 
under dual-task conditions after treatment with GBE compared to placebo controls.   
6. STUDY DESIGN
6.1 INTERVENTION
Fig. 1. Study design. GG = Ginkgo Group; PC = Placebo Group; GA1/GA2 = Gait analysis 1/2.  
The participants will be randomly allocated to either the intervention group (GG) or the placebo control 
group (PC) at a ratio of 1:1. After six months, GBE will be administered to all participants for another 6 
months (Fig. 1) free of charge. The daily administered dose (taken with meals in the morning and 
evening) will consist of twice-daily 1 capsule study medication containing 120mg Ginkgo biloba extract 
LI1370  (15mg = 25%  flavone glycoside content and 3.6mg = 6%  terpene lactone content) or an 
identically appearing placebo (same capsule in color (beige and brown) and size containing excipients 
and food coloring (E172)). In case patients omit the morning dose, they will be instructed to take the 
missing dose by noon. Should the omission of the morning dose be noticed during the afternoon, the 
missing dose must not be taken anymore and the administration of the evening dose should occur as 
usual. The same applies for omission of evening dose, which is allowed to be taken only until 
midnight. 
At baseline and gait analysis 1 (Fig. 1) the subjects will receive the study medication for 3 months. At 
the time of gait analysis 2, the subjects will receive the study medication for the six month follow-up 
period. The supply of verum and placebo will be the responsibility of Vifor SA. The products will be 
packed and labeled according to the Good Manufacturing Praxis (GMP) annex 13. Both verum and 
placebo will be delivered to and stored at the Basel University Hospital Pharmacy in blisters of 10 
capsules. The investigator will then get single doses of Symfona® forte or placebo according to 
demand. Hence, chain of custody and strict accounting, as well as secure storage conditions are 
provided throughout the distribution process. 
GG
(N = 25) 
PC
(N = 25) 
GBE GBE
Placebo Placebo 
GBE 
GBE
0 3 6 12 months
Baseline Follow-up GA1 GA2
R
outine clinical 
assessm
ent 
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6.2 VISIT AND ASSESSMENT SCHEDULES
6.2.1 Routine Clinical Assessment and Baseline (approx. – 3 to 0 months) 
1. Neuropsychological assessment incl. physical examination and medical history  
at the Memory Clinic Basel (MC) 
(approx. 2 weeks) 
2. Gait analysis and medical assessment at the Basel Mobility Center and MC respectively 
(approx. 3 weeks) 
3. Diagnosis conference at the MC 
(approx. 3 weeks) 
4. Final patient report (with diagnosis) is mailed from MC to referring physician 
MCI patient contacted by telephone (MC) to make an appointment for the diagnosis talk  
 The clinical investigator and study physician evaluate eligibility of the MCI patient for the 
GBE exploratory study based on inclusion/exclusion criteria. 
(approx. 2 weeks) 
5. MCI patient visit at the MC for the diagnosis talk followed by study information by clinical 
investigator 
End of routine clinical assessment/start of recruitment phase 
 The clinical investigator informs the MCI patient about the possibility of participating in a 
GBE exploratory study.  
 Patient information and informed consent form are given to patient.
 The investigator will get a nihil obstat from the patient’s family doctor.
 (approx. 1 week)  
6. The clinical investigator will contact the MCI patient by telephone to make an appointment.
(approx. 1 week) 
7. MCI patient visit and recruitment by clinical investigator (at patient’s home) 
 The MCI patient is given the opportunity to ask questions about the study. 
 Screening for any relevant changes in concomitant medication and disease.
 Informed consent form will be signed. 
 Gait analysis 1 will be scheduled. 
8. Final study inclusion and dispensary of study medication (at patient’s home) 
  
(approx. 1 day) 
9. Intervention start 
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6.2.2 Gait Analysis 1 (after 3 months) 
Physical examination Demographic and anthropometric data 
Gait analysis Gait parameters 
Clinical safety Concomitant medication, AE/SAE review 
Study medication Compliance and dispensary of verum or placebo for further 3 months 
6.2.3 Gait Analysis 2 (after 6 months) 
Physical examination Demographic and anthropometric data 
Gait analysis Gait parameters 
Clinical safety Concomitant medication, AE/SAE review 
Study medication Compliance and dispensary of verum for further 6 months 
6.2.4 Follow-up (after 12 months) 
Physical examination Demographic and anthropometric data 
Gait analysis Gait parameters 
Clinical safety Concomitant medication, AE/SAE review 
Study medication Compliance 
6.3 RANDOMIZATION
The randomization will be conducted independently by the study pharmacist from the Basel University 
Hospital Pharmacy to ensure that all investigators and participants are blinded. The randomization 
code will be broken by the study pharmacist after completion of the gait analysis at follow-up. 
Permuted block randomization (block sizes 2n = 5) is used to ensure treatment group numbers are 
evenly distributed. 
6.4 ANONYMIZATION  
Every study participant will receive a Subject Identification Code (SIC) called a Unique Patient Number 
(UPN). This number is consecutively assigned and does not allow recognition of subjects or personal 
data. For statistical analysis, follow-ups and public presentations, as well as for internal and external 
correspondence the UPN will be used exclusively. Hence, complete patient anonymization is always 
guaranteed. Consequently, personal data such as name or date of birth will remain anonymous.   
7. SELECTION OF SUBJECTS 
7.1 RECRUITMENT
Fifty individuals aged 50-85 years with Mild Cognitive Impairment (MCI) and dual-task dysfunction will 
be included in this study. Participants will be recruited from the Memory Clinic Basel, starting in 
autumn 2009. The diagnosis of MCI will be based on the comprehensive examination at the Memory 
Clinic Basel. This examination assesses the following cognitive domains: psychomotor speed, 
attention, memory, language, gnosis, praxis and executive function (see www.memoryclinic.ch). The 
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Nurses' Observation Scale for Geriatric patients (NOSGER, Spiegel et al., 1991) assesses the impact 
of cognitive dysfunction on every day life (Ehrensperger et al., submitted) and the Informant 
Questionnaire on Cognitive Decline in the Elderly (IQCODE; Jorm, 1994) assesses everyday cognitive 
functions compared to two years earlier. Irregular gait under dual-task conditions will be determined by 
gait analysis at the Mobility Center.
7.2 INCLUSION CRITERIA
 50-85 years old (at recruitment). 
 Swiss German or German speaker. 
 Completed elementary school. 
 Impaired executive function as measured by gait analysis and defined as a gait speed reduction   
 10% under dual-task as compared to normal walking (Springer et al., 2006). 
 No dementia according to International Classifications of Diseases (ICD)-10 and Diagnostic and 
Statistical Manual of Mental Disorders (DSM)-IV. 
 MCI according to Winblad et al. (2004): 
 Cognitive decline (self/informant report or objective task). 
 Preserved basic activities of daily living and minimal impairment in complex instrumental 
functions. 
 Written informed consent from each participant will be obtained before inclusion. 
 Nihil obstat will be obtained from the participants’ private physician. 
7.3 EXCLUSION CRITERIA
 Current drug treatments with antipsychotics, Warfarin-like drugs (Coumarins or Clopidogrel), 
however, acetylsalicylic acid 100mg and 300mg is permitted). 
 Current intake of Ginkgo biloba extract or Ginkgo intake during the last six months. 
 Known hypersensitivity to Ginkgo biloba or its constituents. 
 Diagnosed psychiatric disorders such as schizophrenia, bipolar disorders or severe clinical 
depression as determined by the study physician. 
 Concomitant gait-relevant disorders such as severe cardio, pulmonary and cerebrovascular 
disorders, bleeding diathesis, polyneuropathy, severe orthopedic disorders, organic cerebral 
disease or epilepsy and low vision (if corrected vision in both eyes is below or equal to 0.2). 
 Severe medical conditions e.g. chronic renal insufficiency (creatinine clearance (CL) calculated 
according to Cockcroft and Gault formula (Cockcroft and Gault, 1976), pathologic if CL < 
30ml/min), severe hepatic disorders (if liver enzymes are > 3x normal values), cardio-vascular 
disease, uncontrolled hypertension (systolic blood pressure > 170mm Hg or diastolic blood 
pressure > 100mm Hg) peptic ulcer, malignoma. For further explanation see also blood profile 
(appendix 14.1) where applicable. 
 Participation in another clinical intervention study within the last 2 months. 
 Use of a walking aid. 
 Normal walking speed < 100cm/s. 
During the study, the intake of substances listed in the exclusion criteria and the chronic intake of 
medications which may impair gait analysis is not allowed and leads to the exclusion of the patient 
from the study (see also Dropout Criteria). Co-medication with NSAIDs is permitted; however, caution 
is advised since interactions with drugs which impair blood coagulation cannot be excluded. 
13
8. EFFICACY ASSESSMENT 
8.1 STUDY PROCEDURES
8.1.1 Analysis of Spatio-Temporal Gait Parameters  
Gait analyses at baseline and after 3, 6 and 12 months will be conducted at the Mobility Center of the 
Basel University Hospital (Tab. 1). The GAITRite® system (GAITRite® Gold, CIR Systems, PA, USA) 
will be used to collect spatio-temporal gait data. All participants, after signing a separate informed 
consent form, will be photographed before testing and filmed (with audio) during gait analysis. The gait 
analysis will be performed according to the European guidelines for clinical applications of spatio-
temporal gait analysis in older adults (Kressig and Beauchet, 2006). The GAITRite® system consists of 
an electronic walkway with integrated pressure-sensitive electronic surface of 7.32 x 0.61m that is 
connected to a computer. The pressure-sensors are placed every 1.27cm, giving a total of 
approximately 28’000 sensors. The data from the mechanically activated sensors are collected by 
onboard processors and transferred through a serial port. The data are sampled at a frequency of 
60Hz. The following six gait variables will be selected based on their clinical relevance and their 
association with cognitive function in previous studies (Scherder et al., 2007): gait velocity (cm/s), 
cadence (steps/min), base of support (cm), base of support variability (%), cycle time variability (%) 
and swing time variability (%). In addition, data about age, height, weight, leg length, real and 
imagined Timed Up & Go (TUG) will be collected. 
The participants will perform five walking tasks: walking alone at three different speeds and two walks 
at normal speed while simultaneously performing a cognitive task. Before testing, standardized verbal 
instructions regarding the test procedure will be given, as well as a visual demonstration if needed. No 
practice walks will be performed before testing. Subjects will be instructed to walk the entire walkway 
length of 14m. The electronically active walkway is 10m long and flanked at the beginning and end by 
2m-long optically identical yet electronically inactive walkway sections. This is to ensure gait 
measurements under steady state conditions, with acceleration and deceleration phases of gait 
occurring on the electronically inactive 2m-long sections at the beginning and end of the active 
GAITRite® walkway, respectively. Subjects will be instructed to wear the same pair of shoes for all gait 
analyses. Every subject will wear a safety belt and be accompanied for each walk. No feedback of the 
walking performance will be provided to the subjects. 
Fig. 3. Gait analysis at the Basel Mobility Center. 
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8.1.2 Walking Alone 
Subjects will walk at their normal (self-selected and comfortable) pace, walk at a slow speed and walk 
at a fast speed. The testing will always begin with the normal speed trials. The order of the slow and 
fast conditions will be randomized. For slow speed trials, subjects will be instructed to walk slower 
than their normal pace. For fast speed trials, subjects will be instructed to walk as quickly as possible 
without running.   
Tab. 1. Procedures of gait analysis.  
Gait analysis procedures Unit of measurement 
Patient history i.e. demographic data, footwear, etc. 
Height [cm] 
Weight [kg] 
Body Mass Index (BMI) [kg/m2] 
Leg length (left and right side) [cm] 
Timed Up & Go Test (TUG) real [s] 
Timed Up & Go Test (TUG) imagined [s] 
Uses armrest for TUG [yes or no] 
Stops walking when talking [yes or no] 
Normal walking several gait parameters (e.g. velocity [cm/s]) 
Fast walking several gait parameters (e.g. velocity [cm/s]) 
Slow walking several gait parameters (e.g. velocity [cm/s]) 
Dual-task working memory (50 - 2s) gait parameters including named numbers 
Dual-task semantic memory (animals) gait parameters including named animals 
    
8.1.3 Walking while Dual-Tasking 
After completing the above-mentioned walks, two walks under dual task conditions (presented in a 
randomized order for each gait analysis) will be performed. These will require the subjects to walk at 
their normal speed while simultaneously performing a cognitive dual task. For the verbal fluency task, 
subjects will be instructed to walk at their normal pace while simultaneously enumerating animals out 
loud. For the working memory task, subjects will be instructed to walk at their normal pace and 
simultaneously perform serial subtractions from 50 by 2s out loud. Subjects will be instructed to walk 
and simultaneously perform the cognitive task, yet no instructions regarding task prioritization will be 
given. During the dual tasks, subject’s responses will be documented. If for safety reasons the security 
belt needs to be firmly held during an entire walk, participant responses to dual-task tests will be 
recorded by a hand-held recorder and transcribed to the test protocol immediately after the gait 
analysis. 
15
9. SAFETY
9.1 DRUG ACCOUNTABILITY  
The Basel University Hospital Pharmacy will document incoming study medication including badge 
number and expiry date. The investigator will document the dispensed and returned amount of study 
medication per patient. In addition, he will also record the amount of lost and destroyed study 
medication. 
Participants are not allowed to dispense study medication to nonstudy subjects. They will be instructed 
to return the blisters on testing days (gait analysis 1, 2 and follow-up) to assess adherence to the 
verum and placebo intake regime. The investigator will count the remaining capsules and calculate 
approximate compliance ratios. In addition, compliance will be promoted by the same interviewer 
based on, at least, monthly contact with the participants (via email, text message or phone). 
Participants excluded from the study will be instructed to return remaining blisters and capsules to the 
Basel Mobility Center or to their local pharmacist. Study drop-outs will not undergo follow-up gait 
analysis. 
9.2 STUDY MEDICATION LABELLING
Fig. 2. Study medication label.
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10. STATISTICAL ANALYSIS
10.1 POPULATION FOR ANALYSIS  
To our knowledge, no studies have yet examined the association between GBE and gait in MCI 
patients. Hence, this is the first study which addresses a possible effect of GBE on different gait 
parameters in this population, specifically under dual-task conditions. Due to a lack of existing 
estimates of standard deviation in the literature, no power analysis was conducted. However, the 
results of this exploratory study may provide valuable data for future research in this field.  
10.2 STATISTICAL METHODS 
Baseline characteristics and gait parameters will be descriptively summarized by using box-plots, 
means and standard deviations or frequencies and percentages, as appropriate. Then differences 
between the intervention and control group will be assessed using chi-square tests for categorical 
variables and Student’s t-test or the Mann-Whitney U-test for continuous variables dependent on 
distribution of data. Comparisons between the before and after treatment conditions will be performed 
with a non-parametric Wilcoxon-test for paired samples. Statistical significance will be defined as P < 
0.05. All statistical analyses will be conducted using the SPSS software program for Windows (SPSS, 
Inc., Chicago, IL). 
10.3 INCOMPLETE DATA 
To generate our results we will perform the per-protocol (PP) analysis. Consequently, all subjects who 
meet the dropout criteria will be excluded from PP analyses. Demographic data will be calculated for 
all participants. However, gait analysis data from drop-outs will not be included into PP analysis. By 
focusing only on the fully compliant subjects, we will be able to determine the maximal efficacy of the 
GBE (Symfona® forte) intervention. Adverse Events (AE) for all patients having taken the study 
medication at least once will be evaluated. 
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11. STUDY PRECAUTIONS 
11.1 DROPOUT CRITERIA
A participant can withdraw and/or will be withdrawn from the study for following events: 
 The patient wishes to stop participating in the study. 
 Illness which impairs the performance of the study procedures or death. 
 Significant deterioration of an initial medical condition. 
 Side effects of GBE. 
 Patients prescribed an anticoagulant medication after study onset. 
 An illness or treatment listed as exclusion criteria which occur during the study. 
 Necessity of antipsychotic, anxiolytic or sedative drugs and medication for acute severe 
depression after onset of the study. 
Study drop-outs will not undergo follow-up gait analysis. The clinical investigator will inform the 
participant about their exclusion. If a dropout occurs due to medical reasons the study physician will 
report the incident to the subject’s private physician. However, dropouts at any time will receive a 
report of their gait profile.
12. STUDY MANAGEMENT AND PRECAUTIONS
12.1 RESPONSIBILITIES AND COMMITMENTS 
The right to stop participation in the study at anytime is reserved. This clinical trial will be conducted in 
accordance with the Declaration of Helsinki, ICH-Good Clinical Practice (GCP) standards, the 
approved protocol by the IEC, Swiss law and the applicable regulatory requirements. No deviation 
from the protocol will be implemented without prior review and approval of the IEC except where it 
may be necessary to eliminate an immediate hazard to a research subject. In such case, the deviation 
will be reported to the IEC as soon as possible. 
12.2 SAFETY DEFINITIONS AND REPORTING PROCEDURES 
12.2.1 Definition and Obligation to Report (Serious) Adverse Events (SAE) 
The investigator shall assume total responsibility for all reporting of adverse events to regulatory 
authorities and shall comply with all legal and regulatory requirements (ethics committee and 
Swissmedic) in respect of adverse event reporting in connection with the study.  
12.2.2 Adverse Event Documentation 
An adverse event is defined as any untoward medical occurrence in a patient or clinical investigation 
subject administered a pharmaceutical product and which does not necessarily have to have a causal 
relationship with this treatment (CPMP/ICH/377/95).
All adverse events occurring after the patient has signed the informed consent form must be fully 
recorded in the patient’s CRF. Each event should be described in detail along with start and stop 
dates, severity, relationship to investigational product, action taken and outcome.  
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12.2.3 Reporting of Serious Adverse Events 
All SAE must be reported to the sponsor within 24 hours of knowledge. SAE will have to be also 
reported to Swissmedic (vigilance@swissmedic.ch), the local ethics committee (EKBB) (ekbb@bs.ch) 
and Vifor SA (pharmacovigilance@viforpharma.com and confirmed by phone +41 58 851 67 27) within 
the notification period. 
For documentation a trial specific SAE report from must be filled in. Collection of complete information 
concerning SAE is extremely important. If not available at time of the initial report, detailed information 
about SAE should be given in the follow-up report together with all relevant documentation. The 
investigator is responsible for submitting SAE to the responsible IEC.  
A serious adverse event is defined as any untoward medical occurrence that at any dose 
(CPMP/ICH/377/95): 
• Results in death or is life-threatening. 
• Requires hospitalization or prolongation of existing hospitalization. 
• Results in persistent or significant disability/incapacity. 
• Is a congenital anomaly/birth defect. 
• Requires a medical or surgical intervention in order to avoid any of the four above-mentioned 
medical occurrences. 
Exceptions: 
The hospitalization of a patient will not be considered as a serious adverse event, if: 
• The hospitalization is required for routine analysis taking. 
• The hospitalization is an elective treatment which was planned prior to the enrolment into the 
above-mentioned clinical study. 
12.2.4 Suspected Unexpected Serious Adverse Reaction (SUSAR) 
All SUSAR occurring in the framework of this clinic trail will be evaluated by the study physician. 
Required information will be processed by the study physician and then reported to Swissmedic. All 
three criteria (serious + related + unexpected) must be fulfilled and the identity of the blinded trial 
subject must be revealed. Council for International Organizations of Medical Sciences (CIOMS) form 
will be sent to vigilance@swissmedic.ch within seven days for lethal or life-threatening SUSAR (Art. 
23, para, 1, VKlin) and within 15 days for other events requiring notification (Art. 23, para. 2, VKlin).  
12.2.5 Safety Contact Information 
Stephanie A. Bridenbaugh, MD 
Division of Acute Geriatrics, Basel Mobility Center, University and Basel University Hospital  
Basel University Hospital, Basel Mobility Center, Schanzenstrasse 55, CH-4031 Basel 
Phone: +41 61 328 68 82, fax: +41 61 265 37 94, email: bridenbaughs@uhbs.ch  
13. ETHICAL CONSIDERATIONS 
13.1 BENEFIT AND RISK
All participants will profit from a complimentary treatment with Symfona® forte from Vifor SA for at least 
six months and its positive effects on cerebral microcirculation as well as its antioxidant and 
neuroprotective effects. In addition, all participants will receive a comprehensive report on their gait 
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performance. Further, the active agent Ginkgo biloba extract might be associated with improved gait 
parameters, leading to a safer gait among the elderly study participants.  
In general, the participation in this study will help to increase the understanding of possible therapeutic 
interventions to improve mobility and daily functioning in the elderly. Results of our study may lead to 
better treatment strategies for older adults with MCI, thus not only improving cognition, but also 
improving gait performance under dual task and thus reducing fall risk.  
Potential side effects of the Ginkgo product include gastrointestinal disorders, headaches or allergic 
skin reactions (erythema, skin swelling, pruritus). There have been a few reports of increased bleeding 
risk after surgery in patients with long-term treatment of Ginkgo biloba. To date, a causal relationship 
with Ginkgo biloba extract could not be established. However, it is recommended to advise the 
surgeon before surgery. Further, an enhancing interaction with warfarin-similar drugs for blood 
anticoagulation can not be excluded.  
The study participation is voluntary and does not imply any remuneration. The expenses for public 
transport or taxi will be covered. 
13.2 ETHICS AND PATIENT’S RIGHTS  
Subjects will be included in the present study after reading the patient information and signing the 
informed consent forms. A score of at least 20/30 points on the MMSE (Folstein et al., 1975) will 
ensure that participants are mentally capable of providing consent.  
The informed consent form and the informed consent form for video recording and photograph are 
approved by the legal department of the University Hospital Basel.  
  
Participant’s confidentiality will be maintained at all times. Personnel from the sponsor, from regulatory 
authorities and members of IEC are obliged to respect medical secrecy and to refrain from divulging 
the participant’s identity or any other personal information they might fortuitously be aware of.  
14. QUALITY CONTROL AND ASSURANCE
14.1 DIRECT ACCESS TO SOURCE DATA 
The investigator will permit study related monitoring visits, audits, IEC reviews and regulatory 
inspections. Access to all source data (i.e. original records of clinical findings or information necessary 
for reconstruction and evaluation of the study) will be granted at all time.  
Audits or inspections by regulatory authorities may include verification of documents, controlling of 
CRFs and electronic Case Report Forms (eCRFs) and site files. Hence, direct access to all 
documents and premises of the study site is mandatory. 
14.2 MONITORING 
The monitoring will evaluate the progress of the study, verify the accuracy and completeness of CRFs, 
ensure that all protocol requirements, applicable local authority regulations and investigator’s 
obligations are being fulfilled, and resolve any inconsistencies in the study records. The extent of 
monitoring will be in the responsibility of the sponsor. The monitoring will be conducted by the Clinical 
Trial Unit (CTU) Basel.  
An investigator site file (ISF) will be designed to gather all the information related to the study in the 
Mobility Center. Further, the ISF will permit evaluation of study conduct and compliance of the 
investigator with ICH-GCP. The ISF will be maintained and updated throughout the study and kept in a 
secure place.    
20
14.3 FINANCES AND INSURANCE
The sponsor declares that he has taken out an insurance policy by the Zurich insurance company 
(Mythenquai 2, 8002 Zurich) for the total study length, covering the participants in respect of the risks 
involved in this study. In case of injury or disability deriving from participation in the study, the study 
participant is requested to inform without delay the physician responsible for the study.  
14.4 DATA HANDLING AND CASE REPORT FORM 
In this study personal data will be acquired. For this purpose, all relevant data of every patient will be 
documented in the eCRF. Entries in the eCRF must be consistent with the information recorded in the 
source documents and not contain any personal data of study participants. Data will be also generated 
by the GAITRite® system software. All data will be anonymized and only professional experts will have 
access (for trial-related monitoring, audits, Institutional Review Board (IRB)/Independent Ethics 
Commission (IEC) review, and regulatory inspections) to source data and documents. In addition, the 
local ethics committee (EKBB) will be able to access the original data. Data acquired in this study will 
be made available for follow-up studies. The confidentiality will be maintained throughout the entire 
study.  
14.5 ARCHIVING OF STUDY MATERIAL
The investigator commits to archive study material in a safe place at the Basel University Hospital for 
at least 10 years. The investigator will maintain all study-related records, such as CRFs, medical 
records, laboratory reports, informed consent documents, Investigational Medical Product (IMP) 
disposition records, safety reports, information regarding participants who discontinued, and other 
pertinent data. Documents will be destroyed regarding Basel University Hospital policy.  
14.6 PUBLICATION PLAN
The main publication will be created by Yves J. Gschwind as first author in mutual agreement with the 
sponsor. Subsequent publications of subgroups can follow thereafter and will have to be approved by 
the sponsor. 
No unpublished data given to the investigator may be transmitted to a third party without prior written 
approval by the sponsor. No publication or communication involving the results of the study is 
authorized without prior written consent from the sponsor. In view of patent and confidentiality issues, 
however, the investigator must accept requirements on the timing of early publication. The 
investigator’s name should not be used in any publication without the prior written permission of the 
investigator.  
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16. APPENDIX 
16.1 BLOOD PROFILE 
Blood parameters Unit Blood parameters Unit                  
Chemogram mmol/l Hemogram 
Sodium mmol/l Leukocytes x109/l 
Potassium mmol/l Erythrocytes x1012/l 
Chloride μmol/l Hemoglobin g/l 
Creatinine mmol/l Hematocrit l/l 
Urea μmol/l - MCV fl 
Bilirubin U/l - MCH pg 
ASAT U/l - MCHC g/l 
ALAT U/l - EVB % 
GGT U/l - hypochrome Erythrocytes % 
Alcalic phosphatase U/l Thrombocytes x109/l 
Calcium mmol/l Neutrophils absolute (Seg+Stab) x109/l 
Albumin-corrected calcium    mmol/l Lymphocytes absolute x10
9/l 
Phosphate mmol/l Monocytes absolute x10
9/l 
Uric acid μmol/l Eosinophile absolute x10
9/l 
Total protein g/l Basophile absolute x10
9/l 
Albumin g/l LUC absolute x10
9/l 
Globulin g/l 
C-reactive protein mg/l 
LDH U/l Other 
Creatine kinase U/l TSH mlU/l 
Pancreatic amylase U/l Serum folic acid nmol/l 
Fe (iron) μmol/l Vitamin B12 pmol/l  
Transferrin g/l 25-OH-Vitamin D nmol/l 
Transferrin saturation % 
TEBK (calculated) μmol/l 
Ferritin ng/ml 
Soluble transferrin receptor mg/l 
HbA1c % 
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VII. Discussion 
2.1 Main research findings 
In this doctoral thesis research about the association between fall-related gait parameters, and several 
hypothesized fall prevention properties is presented. The main findings are as follows:  
(a) Our first review article summarized important aspects of gait disorders, an increased risk of falling, 
and the association with attentional resources and dual-tasking. It was illustrated that exercise 
interventions, such as JDR and PRT are used as therapeutic interventions to improve gait, and 
decrease fall risk in older people. 
(b) Our review about gait changes and fall risk highlighted the importance of gait analysis as part of fall 
risk assessment. Irregular gait is not an inevitability of older age, because targeted interventions based 
on a thorough fall risk assessment can influence gait in older people.  
(c) Our third systematic literature review presented a summary of our work about fall prevention within 
the Best Practice Health Promotion (Via) project in collaboration with the Swiss Council for Accident 
Prevention (bfu) and Health Promotion Switzerland. The results consisted of a summary of current 
studies on fall prevention, with a particular focus on methodological quality and successful reduction of 
fall incidence in vulnerable older people. Characteristics of effective fall prevention programs in the 
fields of exercise, home modifications, appropriate footwear and walking aids were analyzed. The 
consolidated scientific findings intend to provide a basis for new national recommendations for the 
implementation of fall prevention interventions in vulnerable older people. 
(d) Our salsa intervention trial showed the impact of salsa dancing on intrinsic fall-risk factors (i.e. 
deficits in postural control and muscle power of the leg extensors) in older people. We found a 
tendency towards an improvement of performance in postural control, gait (i.e. increases in stride 
velocity and stride length, and concomitant decreases in stride time), but no significant effect on gait 
variability and leg muscle power. In summary, it was shown that salsa dancing is an appropriate 
exercise for older people to improve dynamic postural control and reduce the risk of falling in older 
people.  
(e) Our most recent cross-sectional study showed that older patients assessed at a memory clinic with 
25(OH)D levels below 39 nmol/L had significantly worse functional mobility (normal and fast walking 
speed and TUG) compared to those with 25(OH)D levels above 81 nmol/L. This association was more 
pronounced in less frail seniors (no previous fall and MMSE 26) compared to pre-frail (previous fall 
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and MMSE <26) older patients. In conclusion, 25(OH)D status measurement may be relevant for 
functional mobility in older people referred to a memory clinic. 
(f) Another recent cross-sectional study improved the understanding of how spatio-temporal gait 
parameters are affected by walking aid use in community-dwelling older people. We were able to show 
that gait in older people who use a walking aid is more irregular and unstable than gait in 
independently ambulating older people. Walking aid users have better gait when using their walking 
aid than when walking without it. The changes in gait were different for the different types of walking 
aids used. These study results may help better understand gait in older people and differentiate 
between pathological gait changes and compensatory gait changes due to the use of a walking aid.  
(g) Due to blinding of participants and investigators we were not able to show any preliminary findings 
about the influence of ginkgo biloba on spatio-temporal gait parameters in older people with MCI, but 
the intervention trial will soon be completed providing valuable information about ginkgo biloba as a 
possible treatment of gait stability for older people with MCI. 
2.2 General discussion of research findings 
(a-b) Many studies have been using the dual task paradigm to assess the relationship between gait, 
cognition, and falls. Recent dual task research focused on older people suffering from cognitive 
decline who are more likely to experience gait disorders and falls compared to cognitively healthy 
older people.215 In a most recent study, dual task spatio-temporal gait parameters predicted multiple 
falls in older people suffering from cognitive impairment.299 This may be mainly explained by a 
negative effect on gait variability and gait velocity.300 Improvement of gait performance (i.e. faster gait 
velocity and lower gait variability), in addition to cognitive performance, is therefore one of the major 
aims in older people with cognitive decline in order to improve dual-tasking and reduce fall risk.218  
Further, our review article illustrated that exercise such as JDR and PRT may improve gait 
performance and reduce fall risk. As discussed in chapter 1.13.2, a recent study showed the 
effectiveness of JDR on decreasing gait variability and fall rate.283 In contrast, evidence about the 
effectiveness of PRT on spatio-temporal gait measures is low. A recent RCT reported that a 21-week 
muscle strength training may improve walking speed (while carrying 10.2 kg at both hands) in older 
men (56.3 ± 9.9 years).301 In a small RCT with 27 older women (61.1 ± 4.3 years), lower limb strength 
exercises for 12 weeks improved walking speed, stride length, and cadence towards a gait pattern 
presented by young healthy individuals who are less prone to falls.302 However, recent research 
confirmed the weak association between lower limb strength and mobility measures.303 This may, at 
least in part, explain the lack of large RCTs in the literature reporting a positive effect of muscle 
strength and muscle power training on gait and related functional outcomes (e.g. fall risk reduction).
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Future research needs to address the possible effect of muscle strength and muscle power on gait 
and fall-related outcomes in older people.304
(c) Current research on fall prevention emphasizes the implementation of research evidence into 
policy and practice.305 As mentioned in our systematic review article,120 key factors in fall prevention 
are the early detection of older people at risk for falls, adherence to exercise interventions, and 
development of evidence-based guidelines. The most recent Cochrane review about interventions for 
preventing falls in community-dwelling older people shows that group (rate ratio 0.71, 95%CI 0.63 to 
0.82) and home-based (rate ratio 0.68, 95%CI 0.58 to 0.80) exercise programs, including balance and 
strength components, are effective in reducing rate of falls.146 In support of our findings, there is further 
evidence that home safety assessment and modification interventions (risk ratio 0.81, 95%CI 0.68 to 
0.97) are effective in reducing fall incidence.146 However, multifactorial interventions are complex and 
their effective factors are not fully determined yet. Due to a lack of detailed information (e.g. type of 
exercise) in the literature, it still remains difficult to translate general guidelines on fall prevention into 
effective interventions.306 The future development of new technologies may help personalize, monitor, 
and tailor fall prevention interventions (e.g. exercise).305,307 Future research should also stress that 
exercise interventions have a range of health benefits (i.e. reduced depression and improved 
cognition) beyond affecting fall risk.306  
(d) Previous research showed that deficits in gait, muscle power, and balance are important risk 
factors for falls in older people.36,303 These factors may be improved by dancing exercises.295 Our 
salsa trial was among the first studies investigating the effects of dancing on gait, postural stability, 
and muscle power in community-dwelling older people. We found that older people who participated in 
an 8-week progressive salsa dance program significantly increased stride velocity (133.8 ± 20.2 cm/s 
to 148.9 ± 25.8 cm/s, P <.001), increased stride length (136.8 ± 22.0 cm to 145.5 ± 26.8 cm, P <.001), 
and decreased stride time (1.02 ± 0.07 s to 0.98 ± 0.07 s, P = .018). Our results confirm findings from 
a previous study that reported stride velocity of 135.0 ± 16.0 cm/s in 45 healthy older people.201 The 
measured decrease in stride time and increase in stride length can be interpreted as an improvement 
in gait pattern33,91 and postural stability.128 However, we did not find any significant changes observed 
in gait variability measures (i.e. CV of stride time, CV of stride length) after the salsa training program. 
In contrast, a recent RCT showed that a 6-month JDR intervention significantly improved gait 
variability (CV of stride length, adjusted mean difference -1.4%, 95%CI -2.3 to -0.6, P <.002) in older 
people.283 These findings can be explained, at least partially, by the longer intervention duration when 
compared to our salsa trial. In addition, the higher gait variability measures at baseline (e.g. 2.3% vs. 
1.7% CV of stride time) may have offered more range for improvement. Future RCTs need to confirm 
a possible effect of dancing interventions on spatio-temporal gait parameters and strength measures 
related to a reduction in fall risk and fall rate. 
(e) To date, only a limited number of studies elucidated the association between 25(OH)D 
concentrations and gait in older people.144,308 Our study was the first to examine the association 
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between functional mobility (normal and fast walking objectively measured with an electronic walkway 
system, and TUG) and serum 25(OH)D concentrations in older patients assessed at a memory clinic. 
Our findings regarding insufficient serum 25(OH)D concentrations (mean 63.2 ± 33.9 nmol/L) are 
consistent with those of previous studies in older patients referred to a memory clinic,309 but below the 
threshold of 75 nmol/L required for fall and fracture prevention.310 We found a trend of better functional 
mobility with higher 25(OH)D quartile status, especially in less frail patients (no previous fall and 
MMSE 26) compared to pre-frail patients (previous fall and MMSE 26 or no previous fall and MMSE 
<26). These results extend previous findings of a cross-sectional study in older women which showed 
that only fast but not normal walking speed was significantly associated with higher serum 25(OH)D 
concentrations (<25 nmol/L vs. >70 nmol/L).144 Our study showed that the entire sample of older 
patients walked with a mean walking speed greater than 100 cm/s under the normal walking condition 
which is considered an unimpaired normal walking speed (see chapter 1.6.3).28 The unadjusted mean 
of older patients in the highest 25(OH)D quartile (>81 nmol/L) was 11.0 cm/s faster in normal walking 
speed, 19.3 cm/s faster in the fast walking speed, and 1.1 s faster in the TUG test compared to those 
in the lowest 25(OH)D quartile (<39 nmol/L). These differences in physical performance are clinically 
important,165 because results of a prospective cohort study showed that any decrease in walking 
speed of 10 cm/s is associated with a 7% increased risk for falls.191 A recent meta-analysis showed 
that the overall hazard ratio for survival for each 10 cm/s faster walking speed in community-dwelling 
older people was 0.88 (95%CI 0.87 to 0.90).28 Further, a TUG score of 14 s or higher is associated 
with increased fall risk.234 Older patients in the highest 25(OH)D quartile therefore tend to have a lower 
fall risk due to faster mean TUG scores compared to those in the lowest 25(OH)D quartile (11.8 ± 3.2 
s vs. 12.9 ± 3.2 s).234 Future research is needed to establish a causal relationship between the 
underlying mechanisms of the effect of vitamin D on mobility and spatio-temporal gait parameters in 
older people. 
(f) There is no data available in the literature on spatio-temporal gait data and the comparison of gait 
alterations in experienced walking aid users during unassisted walking and during walking with a cane, 
crutch or walker. Our results showed a significantly decreased gait performance in walking aid users 
when they did not use their walking aid compared to a matched control group (walking speed 74.4 ± 
19.0 vs. 110.3 ± 20.5, CV of stride time 3.5 ± 1.7 vs. 2.3 ± 1.0, CV of stride length 5.3 ± 3.0 vs. 3.0 ± 
1.5, all P <.001). When the walking aid was used, the walking ability within each of the three walking 
aid groups improved significantly. These findings are generally consistent with those of previous 
studies, demonstrating that experienced walking aid users can improve gait performance after they 
practiced walking with a walking aid.311 In contrast, a small study with older people showed that novice 
use of walking aids may not affect walking performance compared to unaided walking.312 Further, a 
recent observational study reported that older people prefer to choose the appropriate type of walking 
on their own.313 Our results suggest that a cane is the most popular walking aid, probably due to its 
easy maneuverability and social acceptance.314 However, a cane is rarely efficiently used314 which is 
important for safety reasons, because using a walking aid incorrectly may increase the risk of falls.313
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Future research is needed to determine which type of walking aid optimally affects gait in older people 
with mobility impairments. 
g) Several studies examined the effect of ginkgo biloba on the conversion rate from MCI to dementia. 
In a large study with 3,069 older people (cognitive healthy and MCI), ginkgo biloba (240 mg/d) was not 
effective in reducing the incidence rate of dementia.269 Recently, a large randomized placebo-
controlled trial with ginkgo biloba (240 mg/d) also did not show any reduction in the risk of progression 
from MCI (memory) to AD in older people aged 70 years and older.315 Although these findings suggest 
that ginkgo biloba may not benefit the treatment of dementia, there is evidence that long-term intake of 
ginkgo biloba can improve executive function and attention.316 As discussed in chapter 1.8.6, 
executive function and attention properties are required for motor control and walking.30,195,203,229
Previous research about ginkgo biloba and gait predominantly focused on patients with peripheral 
arterial disease317 and intermittent claudication.318 To the best of our knowledge, there is no data 
available in the literature about ginkgo biloba and its effect on gait performance (i.e. walking speed or 
gait variability) in older people suffering from cognitive decline. Similar to our current study, there is 
one other randomized controlled double-blind trial currently examining the effect of ginkgo biloba on 
mobility in older people with MCI.215 However, results for both trials have not been published yet.  
2.3 Important aspects regarding our research findings 
2.3.1 Characteristics of older people 
Older people are not a homogenous group, and individual diversity increases with age.10 As a 
consequence, the ideals of active aging might not be achievable for all older persons, particularly if 
they have complex comorbidities or severe cognitive impairments.319 However, older people should 
never be discriminated because of their health status,319 and always receive the most appropriate 
therapeutic treatment.  
It is in the responsibility of the older people to try and maintain or increase physical activity and 
exercise218 to keep functional abilities.289 Engagement in regular exercise and physical activity, 
undertaking exercises as prescribed, and continuing to practice after completing a course or 
intervention are imperative for a positive effect on health outcomes.10,280 However, a major limitation of 
such public health efforts are low rates of participation5 and dropout rates around 27%.320 To improve 
adherence to a therapeutic intervention, established principles of behavioral change should be 
integrated including social support of partners, regular performance feedback, and positive 
reinforcement.286,321,322 Additionally, the type of exercise or physical activity is crucial, whereas 
interventions with music, rhythmic, and dance components seem especially suited for older people.171
Furthermore, public policies and proven prevention strategies that are tailored to the old people are 
essential for the successful integration of fall-prevention evidence into practice.10 Although fall 
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prevention interventions can be successfully translated from research into clinical practice,323 the 
implementation of fall prevention programs depends highly on the request of older people. In older 
people fall prevention advice is regarded as useful, but often thought to be only relevant for more 
disabled older people.80 If older people do not adhere closely to a fall prevention program, the most 
effective intervention remains useless.324 Falls prevention should therefore include the consideration of 
older people’s preferences to encourage intervention uptake, and identification of strategies to 
enhance intervention sustainability.77
2.3.2 Fall-related outcomes 
A major problem in fall research is the inconsistency in definition and reporting of falls.325 Assessment 
of a fall is often subjective, self-reported, research-oriented, and requires extensive interviewing, 
therefore allowing differences for each study setting.36,82 In addition, (non-injurious) falls in older 
people are commonly not reported due to fear of social consequences (e.g. referral to a nursing 
home),110,326 and thus never attract the attention of a health care professional.40,82 Older people also 
may forget a fall incidence and/or they tend to have different definitions of a fall than clinical 
researchers. As a consequence, a substantial number of falls is likely unreported, and the 
interpretation of fall-related outcomes remains difficult.82,325 Despite differences in study populations, 
fall definitions, and fall recall, fall-related studies in older people provide useful insight in the etiology of 
falls.36 The use of new technologies (e.g. body-worn sensors)307 may be the next step solving several 
of these aforementioned problems in fall assessment. 
Previous research showed that falls prevention interventions vary widely in terms of population setting, 
adherence, intervention, number of falls, cognitive status, and method of reporting falls,85,279 because 
detailed measurements of outcomes are often expensive, invasive (i.e. blood profile), or require a high 
degree of expertise.45 This frequently results in descriptions of interventions which do not provide 
sufficient details to permit evaluation of how an intervention may have affected fall risk or fall rate.279
As a consequence, impact of therapeutic interventions (i.e. drug trials or exercise programs) cannot 
conclusively be evaluated and comparing results from different studies is complicated.81,86 In this 
context a particular issue relates to the highly variable and difficult to interpret measures of therapeutic 
interventions.28 Numerous methodological issues, including the use of different study populations, lack 
of clarity and consistency in definitions, variability in periods of follow-up, and the inevitable difficulties 
of retrospective recall of events106 represent a challenge to effectively directing an intervention to 
improve mobility and functionality in older people.187 In addition, the dose-response relationship 
needed to justify and refine exercise guidelines, particularly of exercise programs including cognitive 
health outcomes (e.g. in a multifactorial program), and the adoption of programs for specific 
populations (e.g. male gender, ethnic minorities, older people with low socioeconomic status), are 
substantially understudied.327 Future research needs to address these problems to develop 
sustainable long-term interventions for older people.6,325
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2.3.3 Potential for improvement in gait analysis 
Gait analysis becomes increasingly important for functional mobility assessment. However, a priority in 
gait analysis remains the understanding of normal gait due to a wide range of age groups, body 
geometry, and gender proportions.16 In older people it is particularly difficult to distinguish normal from 
abnormal gait,16 because even in healthy older people, some decline in gait performance is 
inevitable.188 Although there is no consensual agreement on the definition of normal gait, normative 
and population-based data provide insight about the expected magnitude of certain gait parameters.188
Another issue is the limited knowledge about meaningful change of spatio-temporal gait parameters 
(i.e. gait variability) in therapeutic interventions.196,328 Future research will be required to determine 
normal gait and define criteria for effective gait change in different populations.165 Addressing these 
issues will increase comparability between studies (i.e. normalization of gait and taking potential 
confounders into account),205 and help to implement gait analysis into clinical practice.165
Despite some evidence in the literature the exact number of steps or strides required for a 
representative measurement of spatio-temporal gait parameters has not yet been determined.210,225
Measuring a small number of steps or strides may not be accurate when measuring spatio-temporal 
gait parameters, and if the data is not measured reliably, the data may not be valid and meaningful.176
Future research is needed to define standards and reference values in terms of how many strides 
have to be measured.24 In terms of the applied walking tests, instructions given to the older people are 
often not specified in the literature.185 Particularly, more information about the nature of dual tasks, in 
terms of instructions with specific task prioritization or emphasis to a single task would be needed.241
Currently, there is no consensus on which additional attention-demanding task is most appropriate,116
and optimally causes interference229 in different older populations.84 As a possible solution, a recent 
study suggested to improve validity by adjusting dual task performance relative to single task ability.229
Nevertheless, more standardization regarding dual task gait analysis is required to improve 
comparability between gait laboratories and studies. Another important aspect in in the field of gait and 
fall prevention research are gender differences.212 Several factors that may differ between gait in men 
and women are still to be elucidated for optimization of gait analysis and effectiveness of therapeutic 
interventions.212 Men appear to walk faster, with longer stride lengths, lower cadence, and greater 
stride times, swing times, stance times, and double support times compared to women.17,188 However, 
gender differences in spatio-temporal gait parameters need further evaluation, particularly under dual 
task conditions,212 in order to detect possible deficits and optimize gait and fall prevention 
interventions. 
2.3.4 Difficulties in research with older people suffering from cognitive decline 
Identifying effective interventions that maintain or improve cognition, especially executive functions, 
are important to face the epidemic of dementia and related disorders such as fall risk.209,329 However, 
a wide variety of outcome measures (whether they stem from physical or cognitive function tests), 
interventions, age groups, and cognitive impairments make it difficult to define general 
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recommendations.218 In addition, a large proportion of older people with cognitive impairment vary 
largely in regard to their functionality and mobility.329 At first, an improved operationalization of 
diagnostic criteria for cognitive decline, particularly in older people with MCI is needed,248 which would 
then allow a better determination of dose and outcome in intervention trials of this population. In the 
search of the optimal interventions for older people suffering from cognitive decline there is increasing 
evidence for combining motor and cognitive interventions to improve dual-tasking and functional 
independence.8,218,330 Performing neuropsychological tasks while walking may improve cognitive 
components of dual-tasking,331 while exercise training may improve motor components of dual-tasking 
in older people.332 Future research should therefore compare effects of sequentially and 
simultaneously combined motor and cognitive interventions in older people.8,330 However, it has to be 
taken into consideration that older people with severe cognitive impairment may be unable to perform 
dual tasks properly, thereby increasing measurement error and make drawing conclusions 
impossible.174
2.3.5 Vitamin D supplementation for 25-hydroxyvitamin D deficient older people 
Despite a high prevalence of low 25(OH)D concentrations in the older population,131 no generally 
accepted criteria for vitamin D deficiency have yet been established.132,140 This hinders comparison 
among studies, because universally accepted criteria would be needed to overcome controversy 
regarding optimal 25(OH)D levels for achieving and maintaining health, gait stability, and fall 
prevention.133 In addition, vitamin D supplementation may not uniformly exert a protective effect on 
muscle function, muscle strength, or physical function that normally occurs with aging,333 particularly in 
older people with healthy vitamin D concentrations.333,334 Muscle function may be improved in older 
people with deficient 25(OH)D levels, but no increase in fat-free mass, necessary for consistent 
improvement in strength, could be attributed to vitamin D supplementation.335 To date, the only 
effective strategy to maintain or increase skeletal muscle mass and strength during healthy aging 
therefore remains exercise in form of PRT.333 Vast literature is available on the relevance of PRT in 
older people, but uncertainty remains about the optimal type of PRT (e.g. principle of specificity),2,72
especially in order to improve mobility and prevent falls.69 In terms of the ideal PRT program, both 
muscle strength and muscle power should be generally emphasized so that those who are slow can 
get fast and those who are weak can get strong.63 However, vitamin D remains a safe, inexpensive, 
and well-tolerated supplement with a high compliance in older people and positive health outcomes.131
2.3.6 Conclusion 
The findings presented in my doctoral thesis support the use of gait analysis in the routine clinical 
assessment of motor and cognitive function in older people.220,225 Substantial evidence was provided 
for the probable positive effects of vitamin D, exercise, walking aids, and ginkgo biloba on spatio-
temporal gait parameters. However, future research needs to announce which elements of these 
therapeutic interventions are most effective for improving gait stability in order to prevent falls,85 and 
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how these elements are translated efficient, appropriate, and cost-effective into real-life of older 
people.7,13 In conclusion, gait impairments and falls can be largely prevented, and older people who 
tend to walk with an unstable gait pattern or fall frequently may be enabled to walk safer and fall less 
often.151
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VIII. Abbreviations 
AChEI   Acetylcholine esterase inhibitors 
AD    Alzheimer’s disease 
ADL   Activities of daily living 
bfu   Swiss Council for Accident Prevention 
CHF   Swiss franc 
CA   California 
CI   Confidence interval 
cm   Centimeter(s) 
cm/s    Centimeter(s) per second 
CNS   Central nervous system 
Corp.   Corporation 
CSF   Cerebrospinal fluid 
CT    Computer tomography 
CV   Coefficient of variation 
d   Day 
DE   Germany 
DVD   Digital versatile disc 
e.g.   exempli gratia (for example) 
ff.   Following pages 
Hz   Hertz 
i.e.   id est (that is) 
Inc.   Incorporated 
IT   Italy 
IU   International unit 
JDR   Jaques-Dalcroze eurhythmics 
LED   Light emitting diode 
Ltd.   Limited 
m   Meter(s) 
MA   Massachusetts 
MCI   Mild cognitive impairment 
mg   Milligram(s) 
min    Minute(s) 
MRI   Magnetic resonance imaging 
NL   The Netherlands 
nmol/L   Nanomole(s) per liter 
OR   Oregon 
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PA   Pennsylvania 
PET   Positron emission tomography 
PRT   Progressive resistance training 
RCT   Randomized controlled trial 
s   Second(s) 
SD   Standard deviation 
SE   Sweden 
SPECT   Single-photon emission computer tomography 
SUI   Switzerland 
TV   Television 
UK   United Kingdom 
US   United States 
USD   United States dollar 
Via   Best Practice Health Promotion 
vs.   Versus 
25(OH)D  25-hydroxyvitamin D 
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   Prevention and Rehabilitation  
 Faculty of Medicine 
 Institute of Exercise and Health Sciences 
 University of Basel, Switzerland 
 
 2008 Award for the Best Master’s Thesis 
 Graduate School of Sport Science 
  Cleven Becker Foundation, Germany 
 
 
 10/2002  –  07/2005  Bachelor of Science in Exercise and Sports Sciences  
 Major in Physical Education 
 Major in Exercise and Health Sciences 
 Faculty of Medicine 
 Institute of Exercise and Health Sciences 
 University of Basel, Switzerland 
 
 
 08/1998  –  06/2002  High School Humanistisches Gymnasium am Münsterplatz  
   Major in Spanish 
   Basel, Switzerland 
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Professional Experience 
 03/2009 – present Research fellow (100%)
     Basel Mobility Center, Department of Acute Geriatrics 
     University Hospital Basel, Switzerland 
  
 07/2008 – 12/2008 Research assistant (50%) 
     Prince Of Wales Medical Research Institute  
     Falls Balance and Research Group, Professor Stephen Lord, DSc 
     Sydney, Australia 
 11/2007 – 12/2007 Internship at the Swiss Olympic Association (100%) 
      Organization of the 2nd Youth Sport Session 
      Department of Education. House of Sport, Bern, Switzerland 
 10/2006 – 01/2008 Exercise instructor for older people (1 lesson per week) 
     Retirement home ‘Im Brüehl’. Aesch, Switzerland 
  
 10/2005 – 01/2008 Health and fitness instructor (20-50%) 
     Joggeli Fitness Club, Town Sports PLC. Basel, Switzerland 
 08/2004 – present Exercise instructor for older adults (2 lessons per week)
     Sports Club of University Graduates est. 1931. Basel, Switzerland  
 08/2003 – 01/2008 Physical education teacher (approx. 100 hours in total) 
      High school and secondary school level. Basel/Mumpf, Switzerland 
 04/2001 –  09/2005 Customer service (20-40%) 
     Athleticum Sportmarkets. Basel, Switzerland 
Memberships 
 09/2010 – present  Swiss Society of Sport Sciences (SGS) 
 05/2009 – present  Golden Key International Honours Society 
 08/2006 – present International Olympic Academy Participants Association (IOAPA) 
 04/2005   – present Swiss Snowsports Association (Instructor) 
Language Skills 
German Native language 
English Proficient oral and written skills  
French Advanced skills 
Spanish Advanced skills 
Italian Basic skills 
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PhD Lectures 
 
Summer Semester 2012 
2 ECTS Applied Statistics with “R”, Dr. Gilles Dutilh, Faculty of Psychology, University of Basel 
 
 
Winter Semester 2011/2012   
4 ECTS PhD School in Rehabilitation Research 2011, Prof. Dr. Bength H. Sjölund,          
University of Southern Denmark 
 
 
Summer Semester 2011 
4 ECTS  Seminar: Statistics and SPSS, Dr. Erin Gerlach, Institute for Sport und Sport Sciences,  
 University of Basel 
1 ECTS Seminar: Biomechanics, Motion Analysis, Biocalorimetry and Clinical Research,  
 Prof. Dr. Niklaus F. Friederich, Faculty of Medicine, University of Basel 
 
 
Winter Semester 2010/2011 
2 ECTS Theory Seminar: Functional Neuroanatomy and Developmental Psychology,  
 Prof. Dr. Pasquale Calabrese, Faculty of Psychology, University of Basel 
1 ECTS Lecture: Main Features of Hospital Pharmacy and Clinical Pharmacy,  
 Prof. Dr. Stefan Mühlebach, Department of Pharmaceutical Sciences,  
 University of Basel 
1 ECTS Seminar: Current Topics in Epidemiology and Public Health, Prof. Dr. Marcel Tanner, 
 Swiss Tropical and Public Health Institute, University of Basel 
 
 
Summer Semester 2010 
1 ECTS Colloquium: Scientific Paper Writing, Dr. Karen Thorpe,                                         
Department of Environmental Sciences, University of Basel  
1 ECTS  Mixed Methods Research and Evaluation, Prof. Dr. Manfred M. Bergman,               
Swiss School of Public Health, University of Basel 
2 ECTS Seminar with Exercises: Applied Statistics I and II, Faculty of Psychology,  
 Dr. Andrea H. Meyer, University of Basel 
2 ECTS Lecture with Exercises: Statistics II – Inductive Statistics, Lic. rer. reg. Rainer Volman, 
Department of Human Geography, University of Basel 
 
 
Winter Semester 2009/2010 
3 ECTS Seminar Statistics, Dr. Carmine Maiello, Research and Study Center for Pedagogies, 
University of Basel 
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Publication List 
Peer-reviewed Journal Articles 
Gschwind YJ, Bischoff-Ferrari HA, Bridenbaugh SA, Haerdi I, Kressig RW. Association between 
serum vitamin D status and functional mobility in memory clinic patients Age 65 and older. J Am 
Geriatr Soc; submitted. 
Haerdi I, Bridenbaugh SA, Gschwind YJ, Kressig RW. The effect of three different types of walking 
aids on spatio-temporal gait parameters in community-dwelling older adults. Aging Clin Exp Res; in 
review.  
Granacher U, Muehlbauer T, Bridenbaugh SA, Wolf M, Roth R, Gschwind YJ, Wolf I, Mata R, Kressig 
RW. Effects of salsa dance training on balance and strength performance in older adults. Gerontology 
2012;58:305-12 
Wolf I, Bridenbaugh SA, Gschwind YJ, Kressig RW. Gait changes and fall risk. [Article in German]. 
Praxis 2012;101:1631-7. 
Gschwind YJ, Wolf I, Bridenbaugh SA, Kressig RW. Basis for a Swiss perspective on fall prevention in 
vulnerable older people. Swiss Med Wkly 2011;141:w13305 
Gschwind YJ, Bridenbaugh SA, Kressig RW. Gait disorders and falls. GeroPsych 2010;23:21-32. 
Non-peer-reviewed Journal Articles 
Gschwind YJ, Bridenbaugh SA. Early detection of dementia and fall risk – the role of gait analysis. 
[Article in German]. Der informierte Arzt. 2011;6:39-41. 
Gschwind YJ, Bridenbaugh SA, Kressig RW. Motoric and cognitive dual tasking. [Article in German]. 
Physioactive. 2010;5:7-13. 
Gschwind YJ, Bridenbaugh SA, Kressig RW. Modern fall prevention in old age. [Article in German]. 
Hausarzt Praxis. 2010;7-8:41-4. 
Gschwind YJ, Kressig RW. The importance of physical activity in prevention of sarcopenia and frailty. 
[Article in German]. Schweizerische Zeitschrift für Ernährungsmedizin. 2009;4:32-6.  
Gschwind YJ, Kläy S, Widmer R. The Olympic spirit is alive. [Article in German]. Swiss Sport. 
2006;6:14-5. 
Research Reports 
Gschwind YJ, Pfenninger B. Exercise for fall prevention. Manual for strength and balance exercises for 
fall prevention in older people. [Report in German]. Swiss Council for Accident Prevention (bfu). bfu-
Fachdokumentation 2.104, Bern 2012, in print.  
Gschwind YJ, Wolf I, Bridenbaugh SA, Kressig RW. Fall prevention. [Report in German]. Health 
Promotion Switzerland 2011. Available from: http://www.gesundheitsfoerderung.ch/bpgfa. 
Gschwind YJ, Wolf I, Bridenbaugh SA, Kressig RW. Fall prevention – summary and 
recommendations. [Report in German]. Health Promotion Switzerland 2011. Available from: 
http://www.gesundheitsfoerderung.ch/bpgfa. 
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Publication List (continued)
Book Chapters 
Gschwind YJ, Bridenbaugh SA, Kressig RW. Falls in older people. In: Likar R, Janig H, Schippinger 
W, Kada O, Cernic K, Pinter G (eds.). Strategies and concepts for the geriatric emergency care. [Book 
in German]. Vienna: Springer Verlag; submitted.
Media Activities 
Monsch AU, Langenegger S, Gschwind YJ. Alzheimer’s disease. [Broadcast in German]. Gesundheit 
Sprechstunde, ed. Käch R, Swiss National Television (SF), broadcasted 31/03/2012. 
Karpf C, Schlögl M, Bridenbaugh SA, Wolf I, Gschwind YJ. Eurhythmics helps older people to prevent 
falls. [Broadcast in German]. 7vor7 News, ed. Keller E, TeleBasel, broadcasted 19/09/2010. 
Gschwind YJ, Aebi T, Gschwend M, Jauch G. Sport study at an old people’s home. [Broadcast in 
German]. Schweiz Aktuell, ed. Schärer B, Swiss National Television (SF), broadcasted 04/05/2005. 
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Conferences and Courses 
Presentations 
Gschwind YJ. Fall prevention – what does really work? [Presentation in German]. Presentation at the 
‘Prevention and health promotion in older people: update 2012’. Nursing home Baar and Pro 
Senectute Canton Zug. Nursing home Baar. Baar, Switzerland, 14/11/2012.  
Gschwind YJ. Best Practice – Fall prevention in older people. [Presentation in German]. Presentation 
at Old Age in the Course of Time Congress 2012. Swiss Society of Gerontology. University 
Miséricorde Fribourg. Fribourg, Switzerland, 02-03/02/2012.  
Gschwind YJ, Wolf I, Bridenbaugh SA, Kressig RW. Mobility and functionality assessment in daily life. 
[Presentation in German]. Workshop at medArt Basel 2011. University Hospital Basel. Basel, 
Switzerland, 22/06/2011. 
Gschwind YJ, Wolf I, Bridenbaugh SA, Kressig RW. Best Practice Health Promotion for older people. 
[Presentation in German]. Workshop at the 1st Network Congress Best Practice Health Promotion for 
Older People. Health Promotion Switzerland. Bern, Switzerland, 08/03/2011.  
Gschwind YJ. Ginkgo trial. Movement Progress Report. Laboratory of Biomechanics and 
Biocalorimetry (LOB2) Basel. University of Basel. Basel, Switzerland, 14/04/2011.  
    
Gschwind YJ, Kressig RW. Can Ginkgo improve MCI-related walking disorders? Study protocol 
presented at 3rd Young Researchers’ Meeting. Alzheimer’s Disease Forum Switzerland. Interlaken, 
Switzerland, November 19-21/11/2010. 
Bridenbaugh SA, Gschwind YJ, Kressig RW. The fracture of a geriatric patient – more than broken 
bones! Presentation at the 5th General Meeting of AOTrauma's CPP Fracture Fixation in Osteoporotic 
Bone (Med Academy). University Hospital Basel. Basel, Switzerland, 25/03/2010. 
Poster Sessions 
Gschwind YJ, Wolf I, Bridenbaugh SA, Kressig RW. Swiss perspective on fall prevention in pre-frail 
older people. Poster presentation at the PhD School in Rehabilitation Research 2011. University of 
Southern Denmark. Copenhagen, Denmark, 06-09/12/2012.   
Gschwind YJ, Wolf I, Bridenbaugh SA, Kressig RW. Swiss perspective on fall prevention in pre-frail 
older people. Poster presentation at the Swiss Public Health Conference 2011. Public Health 
Switzerland. Basel, Switzerland, 25-26/08/2011. 
Selected Courses 
Clinical Investigator Course. Good clinical practice, study implementation and study protocol 
(participant). Clinical Trial Unit (CTU), Study Coordination Centre, University Hospital Basel. Basel, 
Switzerland, 17-18 and 25/03/2010. 
4th European GAITRite Meeting. Clinical applications of spatial and temporal gait analysis 
(organisation assistant and participant). Basel Mobility Center, University Hospital Basel. Basel, 
Switzerland, 24-26/09/2009. 
